Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3008295	s-osmol	mosm/kgh2o (mosm/kgh2o)	2792	4185	0.17%
3008295	s-osmol	— (—)	704	858	100.00%	Distribution not available
3008295	p-osmol	— (—)	321	379	100.00%	Distribution not available
3008295	p-osmol	mosm/kgh2o (mosm/kgh2o)	265	478	0.00%
3008295	s-osmolaliteetti	mosm/kgh2o (mosm/kgh2o)	28	31	0.00%
3008295	s-osmolaliteetti,seerumi	mosm/kgh2o (mosm/kgh2o)	5	5	0.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Exclusions for E4_PCOS_BROAD

488

576

8.99

307.65

2.3

1.3

282.86

281.61

mosm/kgh2o

0.43

422

453

Other disorders of fluid, electrolyte and acid-base balance

1321

728

19.23

307.65

1.5

1.4

268.06

284.15

mosm/kgh2o

49.59

1043

537

Hypo-osmolality and hyponatraemia

1145

416

32.38

307.65

1.4

1.3

263.52

282.61

mosm/kgh2o

46.16

905

304

Metabolic disorders

1270

1715

4.68

307.65

1.6

1.5

274.65

285.64

mosm/kgh2o

32.76

1016

1319

Endocrine, nutritional and metabolic diseases

831

966

4.42

255.13

1.7

1.5

282.67

284.11

mosm/kgh2o

0.79

658

751

Disorders of other endocrine glands

658

1570

4.22

241.45

2.1

1.4

282.47

279.82

mosm/kgh2o

1.83

552

1182

Malaise and fatigue

626

1204

4.41

231.98

1.5

1.4

278.86

280.32

mosm/kgh2o

0.61

456

939

Substance abuse, excluding more controls

643

1346

4.25

231.10

1.4

276.72

280.48

mosm/kgh2o

2.67

494

1085

Anaemias

281

148

12.85

226.77

1.7

1.5

278.62

284.99

mosm/kgh2o

2.59

223

120

Diabetes insipidus

121

80.02

219.18

3.8

1.2

294.03

277.59

mosm/kgh2o

2.48

104

Schizophrenia or delusion, excluding more controls

403

750

5.44

202.50

1.6

1.4

283.96

280.25

mosm/kgh2o

1.77

310

604

Implicit Sepsis

846

2037

3.28

202.39

1.4

280.45

278.32

mosm/kgh2o

1.29

638

1582

Benzodiazepine use

1055

2643

2.87

197.88

1.5

277.75

280.23

mosm/kgh2o

2.27

792

2086

General symptoms and signs

1091

1848

2.99

195.58

1.5

280.23

281.29

mosm/kgh2o

0.61

838

1469

Condition for Implicit Sepsis (Organ dysfunction codes)

919

2216

3.05

192.26

1.5

280.23

279.11

mosm/kgh2o

0.56

698

1733

Mood disorders, excluding more controls

938

1911

3.02

182.92

1.6

1.4

281.92

279.69

mosm/kgh2o

1.63

688

1522

Hypothyroidism (congenital or acquired)

277

154

10.47

182.51

1.9

1.5

286.19

285.61

mosm/kgh2o

0.12

228

123

Hypopituitarism

217

236

9.89

182.44

2.3

1.4

285.95

286.22

mosm/kgh2o

0.05

191

175

Benign neoplasm: Pituitary gland, craniopharyngeal duct

169

135

13.61

175.51

2.3

1.3

285.39

279.21

mosm/kgh2o

1.66

156

100

Hypothyroidism, levothyroxine purchases

269

153

10.25

175.19

1.9

1.5

286.25

285.52

mosm/kgh2o

0.15

220

122

Hypothyroidism and >3 levothyroxin purchases

269

153

10.25

175.19

1.9

1.5

286.25

285.52

mosm/kgh2o

0.15

220

122

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

474

1167

4.16

171.59

2.3

1.3

285.67

278.48

mosm/kgh2o

8.53

403

882

Mental and behavioural disorders due to psychoactive substance use

661

1908

3.31

170.22

1.4

1.5

276.93

281.35

mosm/kgh2o

3.86

510

1513

Substance abuse

643

1883

3.31

165.70

1.4

1.5

276.72

281.47

mosm/kgh2o

4.23

494

1492

Alcohol use disorder, Swedish definition

616

1720

3.37

162.37

1.4

1.5

275.36

281.53

mosm/kgh2o

6.22

465

1361

656

1862

3.20

157.34

1.4

1.5

275.94

281.52

mosm/kgh2o

5.70

499

1473

634

1816

3.25

157.12

1.4

1.5

275.71

281.52

mosm/kgh2o

5.99

487

1434

Unspecified mental disorder

499

1359

3.73

156.28

1.6

1.5

284.85

279.86

mosm/kgh2o

3.58

368

1082

Kela-code for severe mental illness

469

1234

3.87

154.56

1.6

1.5

285.03

279.60

mosm/kgh2o

3.83

346

983

Depression medications

279

161

8.81

152.75

1.6

1.5

283.81

284.87

mosm/kgh2o

0.23

221

130

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

311

605

5.23

150.42

1.7

1.4

282.71

280.88

mosm/kgh2o

0.52

227

495

Any mental disorder

1048

2015

2.63

150.16

1.5

1.4

280.13

279.84

mosm/kgh2o

0.12

791

1597

Psychiatric diseases

1023

1945

2.66

149.74

1.5

1.4

280.39

280.03

mosm/kgh2o

0.15

773

1541

Mental and behavioural disorders due to alcohol

561

1645

3.37

149.36

1.5

275.93

281.60

mosm/kgh2o

4.96

426

1299

Convulsions, not elsewhere classified

327

659

5.00

149.25

1.5

1.6

276.02

283.52

mosm/kgh2o

4.65

255

524

Implicit bacterial Sepsis

479

1182

3.79

149.19

1.4

281.88

276.82

mosm/kgh2o

3.31

364

901

Benign neoplasm: Pituitary gland, craniopharyngeal duct

169

175

10.47

147.68

2.3

1.3

285.39

280.75

mosm/kgh2o

1.20

156

130

Mental and behavioural disorders due to alcohol, excluding acute intoxication

511

1471

3.53

147.00

1.4

1.5

274.89

281.94

mosm/kgh2o

6.42

384

1167

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

209

286

7.65

144.91

1.3

1.4

285.28

279.26

mosm/kgh2o

2.61

195

216

Hypokalaemia

203

270

7.81

144.11

1.7

1.4

275.69

283.33

mosm/kgh2o

3.34

162

192

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

949

2682

2.56

143.85

1.5

277.13

280.69

mosm/kgh2o

3.92

736

2079

Bacterial Sepsis

520

1342

3.51

143.62

1.4

281.39

277.35

mosm/kgh2o

2.44

397

1033

Alcohol use disorder, ICD-based

481

1354

3.61

143.52

1.4

275.35

281.62

mosm/kgh2o

4.87

362

1089

Cerebrovascular diseases (FINNGEN)

366

560

4.75

140.72

1.6

1.5

282.17

280.50

mosm/kgh2o

0.53

298

452

Mood disorders

984

2604

2.50

139.41

1.6

1.5

281.92

279.35

mosm/kgh2o

2.27

726

2086

Mood [affective] disorders

982

2603

2.50

139.11

1.6

1.5

282.00

279.31

mosm/kgh2o

2.46

725

2086

Anxiety disorders, excluding more controls

751

1748

2.88

138.83

1.6

1.4

281.58

279.98

mosm/kgh2o

0.96

561

1403

Other antidepressants

966

1948

2.61

138.66

1.5

1.4

278.99

280.21

mosm/kgh2o

0.70

709

1559

Other bacterial diseases

921

2519

2.55

137.44

1.4

1.5

279.76

279.47

mosm/kgh2o

0.11

714

1956

Schizophrenia or delusion

403

1059

3.88

133.19

1.6

1.5

283.96

280.32

mosm/kgh2o

1.78

310

827

Schizophrenia, schizotypal and delusional disorders

403

1066

3.85

131.94

1.6

1.5

284.00

280.33

mosm/kgh2o

1.79

308

834

873

2129

2.59

130.98

1.4

1.6

278.90

280.48

mosm/kgh2o

0.91

669

1653

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

873

2129

2.59

130.98

1.4

1.6

278.90

280.48

mosm/kgh2o

0.91

669

1653

Influenza and pneumonia

990

2711

2.42

130.85

1.4

1.6

279.37

280.67

mosm/kgh2o

0.79

770

2124

Constipation

857

2424

2.56

129.61

1.6

1.4

277.64

279.97

mosm/kgh2o

1.71

628

1910

Non-invasive ventilation

249

422

5.64

128.10

1.6

1.3

280.01

279.25

mosm/kgh2o

0.19

211

339

All pneumoniae

952

2737

2.42

127.41

1.4

1.5

278.85

280.71

mosm/kgh2o

1.24

732

2149

Benign neoplasm of other and unspecified endocrine glands

220

365

6.25

127.03

2.1

1.4

283.17

278.43

mosm/kgh2o

1.85

198

277

Renal tubulo-interstitial diseases

833

2545

2.53

125.85

1.5

283.02

278.62

mosm/kgh2o

4.45

657

1965

Pneumonias (Asthma/COPD co-morbidities)

944

2731

2.42

125.81

1.4

1.6

278.76

280.72

mosm/kgh2o

1.34

724

2145

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

930

2721

2.42

125.19

1.4

1.6

278.43

280.70

mosm/kgh2o

1.71

714

2135

Pneumonia, organism unspecified

859

2516

2.49

123.63

1.4

1.5

278.23

280.47

mosm/kgh2o

1.56

661

1968

Personality disorders, excluding more controls

268

553

4.92

121.17

1.7

1.4

283.31

281.25

mosm/kgh2o

0.57

204

455

Anxiety (asthma-related co-morbidities)

538

1380

3.10

119.37

1.6

281.18

281.85

mosm/kgh2o

0.23

391

1125

Depression

862

2475

2.42

115.09

1.6

1.5

281.29

279.59

mosm/kgh2o

1.16

637

1990

Bipolar affective disorders

244

492

5.07

113.59

1.7

1.4

290.04

280.45

mosm/kgh2o

5.33

181

407

Symptoms and signs involving the urinary system

744

2286

2.54

113.34

1.5

1.4

280.98

278.21

mosm/kgh2o

2.16

559

1785

GASTRO-related operations

722

1330

2.74

112.63

1.6

281.09

281.82

mosm/kgh2o

0.30

569

1004

Any gastric operation

722

1330

2.74

112.63

1.6

281.09

281.82

mosm/kgh2o

0.30

569

1004

Used for control exclusion in common control thyroid runs

935

1996

2.39

111.93

1.7

1.4

283.26

279.15

mosm/kgh2o

4.79

738

1524

Malignant neoplasm of head and neck

173

257

7.06

111.54

1.3

285.40

276.27

mosm/kgh2o

5.65

161

187

Epilepsy

385

1110

3.52

110.41

1.5

278.48

280.59

mosm/kgh2o

0.81

281

850

Any reimbursement code in KELA

482

697

3.49

110.06

1.6

1.7

284.15

282.38

mosm/kgh2o

0.77

381

543

Aplastic and other anaemias

487

1568

2.99

105.63

1.5

1.4

275.65

278.59

mosm/kgh2o

1.61

380

1177

Benign neoplasm of other and unspecified endocrine glands

220

444

5.13

102.84

2.0

1.4

283.17

278.14

mosm/kgh2o

2.29

198

342

Fever of other and unknown origin

468

1464

2.99

101.82

1.5

280.66

281.11

mosm/kgh2o

0.14

366

1157

Exclusions for E4_PCOS_CONSORTIUM

702

1747

2.54

101.48

2.2

1.4

282.54

278.84

mosm/kgh2o

3.82

580

1337

Other and unspecified nonorganic psychotic disorders

250

568

4.49

100.73

1.6

1.5

283.91

282.04

mosm/kgh2o

0.47

190

446

Headache

536

1618

2.79

100.42

1.6

1.5

281.24

281.31

mosm/kgh2o

0.02

416

1286

Hyperfunction of pituitary gland

119

129

9.74

100.08

2.4

1.4

276.52

282.25

mosm/kgh2o

1.36

103

100

Bacterial infection, other or unspecified

524

1710

2.80

99.94

1.4

280.66

278.04

mosm/kgh2o

1.28

396

1325

Hypertensive diseases (excluding secondary)

466

851

3.21

99.49

1.5

1.6

281.56

282.04

mosm/kgh2o

0.14

375

678

Intracranial trauma

509

1329

2.89

98.42

1.4

1.6

279.34

280.33

mosm/kgh2o

0.34

389

1065

Other and unspecified anaemias

447

1464

3.00

98.01

1.4

275.17

278.65

mosm/kgh2o

1.94

345

1101

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

115

124

9.88

97.24

1.4

285.62

275.45

mosm/kgh2o

3.59

108

Other anaemias

449

1481

2.97

96.70

1.4

275.22

278.54

mosm/kgh2o

1.81

346

1114

Symptoms and signs concerning food and fluid intake

168

280

6.19

96.39

2.1

1.6

279.43

282.16

mosm/kgh2o

0.61

125

219

Symptoms and signs involving cognition, perception, emotional state and behaviour

844

2659

2.24

95.62

1.5

280.04

279.62

mosm/kgh2o

0.17

637

2099

Use of hypnotics and sedatives

918

2421

2.21

95.60

1.5

279.41

280.28

mosm/kgh2o

0.43

690

1917

Explicit Sepsis

426

1375

3.01

94.06

1.4

280.05

278.57

mosm/kgh2o

0.52

337

1059

Hypertension, essential

656

1472

2.56

93.96

1.5

1.4

280.31

280.25

mosm/kgh2o

0.02

511

1183

Selective serotonin reuptake inhibitors

851

1980

2.28

92.81

1.6

1.5

280.52

280.56

mosm/kgh2o

0.02

663

1586

Anxiety disorders

785

2466

2.27

92.22

1.6

1.5

282.02

280.10

mosm/kgh2o

1.37

589

1970

Neurotic, stress-related and somatoform disorders

777

2440

2.28

92.07

1.6

1.5

281.96

280.24

mosm/kgh2o

1.15

582

1951

Heart failure, not strict

694

2009

2.41

91.63

1.4

278.67

278.46

mosm/kgh2o

0.07

534

1566

All anxiety disorders

541

1658

2.65

90.88

1.6

1.5

281.25

281.20

mosm/kgh2o

0.01

394

1323

Alcohol dependence

304

862

3.59

90.03

1.4

272.86

281.21

mosm/kgh2o

4.91

228

698

Persons encountering health services for specific procedures and health care

924

2704

2.13

89.88

1.5

280.58

280.32

mosm/kgh2o

0.11

712

2114

First line medication for Crohn's disease

943

2418

2.14

89.77

1.5

279.29

281.37

mosm/kgh2o

1.63

749

1862

Depression or dysthymia

573

1200

2.69

89.71

1.6

1.4

277.87

280.68

mosm/kgh2o

1.78

423

977

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

311

911

3.47

87.54

1.7

1.6

282.71

281.54

mosm/kgh2o

0.31

227

735

Tramadol

663

1780

2.41

86.87

1.3

1.5

277.25

280.17

mosm/kgh2o

2.13

477

1400

KRA_PSY_EATING, excluding more controls

112

134

8.54

86.37

3.7

1.8

284.19

287.37

mosm/kgh2o

0.91

109

Syncope and collapse

389

1156

3.01

84.78

1.5

1.4

276.52

279.73

mosm/kgh2o

1.48

276

909

Septicaemia

414

1406

2.87

83.99

1.4

279.88

278.92

mosm/kgh2o

0.29

328

1087

Poisoning by medicine

256

680

3.83

83.57

1.7

1.5

281.79

282.01

mosm/kgh2o

0.04

186

541

Poisoning by drugs, medicaments and biological substances

273

765

3.63

82.36

1.7

1.5

281.52

281.70

mosm/kgh2o

0.04

199

609

Other septicaemia

377

1263

2.97

81.79

1.4

280.03

278.71

mosm/kgh2o

0.42

302

971

Parasetamol

649

1370

2.43

81.07

1.6

281.45

282.61

mosm/kgh2o

0.50

515

1081

Injuries to the head

917

2942

2.04

81.07

1.4

1.6

278.76

280.63

mosm/kgh2o

1.43

688

2319

Bleeding

724

2396

2.22

80.59

1.6

1.4

278.71

279.01

mosm/kgh2o

0.10

560

1846

STROKE

531

1450

2.57

80.55

1.5

1.4

281.31

276.76

mosm/kgh2o

3.56

425

1107

Viral Sepsis

236

611

3.94

80.02

1.5

1.4

281.62

278.64

mosm/kgh2o

0.97

189

468

Implicit viral Sepsis

235

609

3.94

79.58

1.5

1.4

281.55

278.58

mosm/kgh2o

0.96

188

466

Neurological diseases, wide definition

286

357

4.06

79.54

1.5

1.9

284.02

280.88

mosm/kgh2o

1.12

223

302

Focal epilepsy

264

742

3.63

79.36

1.4

1.5

278.50

281.30

mosm/kgh2o

0.98

195

579

Suicide or other Intentional self-harm

275

797

3.51

78.83

1.7

1.5

283.10

280.90

mosm/kgh2o

0.62

200

637

Other functional intestinal disorders

432

1543

2.70

77.94

1.8

1.5

277.22

280.68

mosm/kgh2o

2.09

317

1208

Renal failure

435

1493

2.70

77.70

1.5

1.3

286.73

275.79

mosm/kgh2o

11.35

357

1110

Hypertension

639

1542

2.36

77.25

1.5

280.92

280.66

mosm/kgh2o

0.08

502

1231

Adrenocortical insufficiency

106

9.48

76.95

1.6

1.3

272.60

280.94

mosm/kgh2o

1.96

Polyuria

253

708

3.64

76.61

1.9

1.4

281.88

279.64

mosm/kgh2o

0.78

192

548

Hyperosmolality and hypernatraemia

21.63

76.60

2.7

2.0

304.71

280.81

mosm/kgh2o

3.24

Hypertensive diseases

638

1546

2.35

76.48

1.5

280.92

280.67

mosm/kgh2o

0.08

501

1234

Disorders of adult personality and behaviour

295

911

3.28

76.39

1.7

1.5

284.35

281.22

mosm/kgh2o

1.21

223

734

Other anxiety disorders

394

1253

2.82

76.16

1.7

1.6

279.94

281.09

mosm/kgh2o

0.38

281

997

Other disorders of adrenal gland

106

141

7.95

75.72

1.7

1.4

272.77

282.07

mosm/kgh2o

2.65

106

Substance use, excluding alcohol

219

559

3.99

75.68

1.6

1.5

279.60

281.11

mosm/kgh2o

0.35

166

447

Focal epilepsy, strict definition

247

694

3.63

74.38

1.4

1.5

278.35

280.88

mosm/kgh2o

0.78

178

543

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

198

476

4.24

74.28

1.8

1.5

281.56

282.26

mosm/kgh2o

0.12

143

386

Nausea and vomiting

294

905

3.24

74.20

1.6

1.5

274.23

280.74

mosm/kgh2o

4.48

234

676

Antihypertensive medication - note that there are other indications

481

990

2.68

74.15

1.5

1.7

283.90

285.09

mosm/kgh2o

0.47

378

794

Schizophrenia

208

520

4.09

74.08

1.7

1.4

283.73

280.69

mosm/kgh2o

0.80

158

410

Diseases of oesophagus, stomach and duodenum

864

2609

2.02

73.37

1.5

277.93

280.38

mosm/kgh2o

1.94

670

2036

Oxycodone

342

1137

2.95

73.08

1.4

275.61

278.17

mosm/kgh2o

1.27

272

872

Codeine

749

1923

2.15

72.70

1.4

1.5

279.04

280.66

mosm/kgh2o

1.04

578

1519

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

306

432

3.58

72.59

1.6

282.83

285.08

mosm/kgh2o

0.67

236

339

Acute tubulo-interstitial nephritis

537

2036

2.36

72.36

1.5

281.10

278.09

mosm/kgh2o

1.93

408

1560

Opioids

784

1957

2.12

71.93

1.4

1.5

280.05

280.86

mosm/kgh2o

0.38

599

1547

Infections, IBD-co-morbidities

159

217

5.41

71.30

1.4

1.5

280.67

277.96

mosm/kgh2o

0.54

125

181

Complications of surgical and medical care, not elsewhere classified

793

2816

2.03

70.79

1.4

1.5

279.72

279.42

mosm/kgh2o

0.12

600

2198

Acute renal failure

243

710

3.49

69.00

1.4

1.3

285.81

277.36

mosm/kgh2o

3.79

202

525

Fall on same level

922

2671

1.94

68.13

1.4

1.6

279.31

281.24

mosm/kgh2o

1.30

679

2138

Other disorders of urethra and urinary system

571

1906

2.26

67.41

1.5

278.93

280.54

mosm/kgh2o

0.79

424

1512

Osteopathies and chondropathies

489

1994

2.35

66.04

1.5

1.4

276.28

279.32

mosm/kgh2o

1.95

376

1537

Personality disorders

268

859

3.16

65.32

1.7

1.6

283.31

281.28

mosm/kgh2o

0.61

204

696

Dental caries

265

835

3.19

65.26

1.4

285.57

281.01

mosm/kgh2o

1.82

213

643

Type1 diabetes, definitions combined, early onset

116

197

6.05

65.17

2.6

1.7

300.74

286.36

mosm/kgh2o

8.34

157

Osteoporosis

288

922

3.03

64.25

1.5

1.4

271.36

275.25

mosm/kgh2o

1.69

211

681

Oedema, not elsewhere classified

266

856

3.13

63.69

1.5

1.4

280.88

279.53

mosm/kgh2o

0.36

204

666

Cerebrovascular diseases

632

2145

2.13

63.61

1.5

1.4

280.81

277.09

mosm/kgh2o

2.65

479

1661

Heart failure and antihypertensive medication

228

409

3.73

63.38

1.3

1.4

277.72

280.83

mosm/kgh2o

0.77

173

321

Cardiovascular diseases (excluding rheumatic etc)

479

1136

2.45

63.26

1.5

1.7

283.22

283.95

mosm/kgh2o

0.24

393

906

Invasive ventilation

129

251

5.34

63.13

1.5

1.4

282.97

280.50

mosm/kgh2o

0.37

183

Specific personality disorders

239

731

3.32

63.00

1.8

1.6

284.67

281.28

mosm/kgh2o

1.17

181

590

COPD/asthma related infections

832

2133

1.96

62.00

1.5

1.6

279.80

280.49

mosm/kgh2o

0.32

635

1657

COPD/asthma/ILD related infections

832

2133

1.96

62.00

1.5

1.6

279.80

280.49

mosm/kgh2o

0.32

635

1657

Medical observation and evaluation for suspected diseases and conditions

580

1324

2.26

61.86

1.7

1.4

282.56

279.57

mosm/kgh2o

1.85

431

1045

Type 1 diabetes, definitions combined

136

280

4.95

61.81

2.5

1.6

298.63

284.21

mosm/kgh2o

7.49

104

222

Type 1 diabetes, strict (exclude DM2)

136

281

4.94

61.57

2.5

1.6

298.62

284.22

mosm/kgh2o

7.49

104

223

Asthma, unspecified (mode), excluding more controls

401

1252

2.53

61.56

1.5

278.41

281.45

mosm/kgh2o

1.60

320

970

Neurological diseases

696

1685

2.09

61.43

1.5

1.6

281.32

280.54

mosm/kgh2o

0.34

540

1344

Schizoaffective disorder

122

231

5.45

61.42

1.8

1.6

290.99

282.64

mosm/kgh2o

2.37

183

General examination and investigation of persons without complaint and reported diagnosis

561

1323

2.27

61.36

1.5

1.4

281.01

279.57

mosm/kgh2o

0.66

447

1044

Non-selective monoamine reuptake inhibitors

334

1210

2.71

61.16

1.4

1.3

277.24

278.32

mosm/kgh2o

0.31

258

956

Hypothyreosis and Thyroxine purchase for inclusion criteria

732

2447

1.99

60.36

1.7

1.4

281.38

279.30

mosm/kgh2o

1.49

584

1879

Certain infectious and parasitic diseases

782

1981

1.99

60.27

1.4

1.6

280.66

280.50

mosm/kgh2o

0.06

605

1539

Other diseases of intestines

827

2520

1.92

59.90

1.7

1.5

278.94

281.81

mosm/kgh2o

2.48

623

2011

Concussion

379

1301

2.54

59.83

1.4

1.6

280.72

280.38

mosm/kgh2o

0.09

293

1041

Intracranial injury

477

2054

2.26

59.43

1.4

1.5

277.84

280.35

mosm/kgh2o

1.32

361

1593

Symptoms and signs involving the nervous and musculoskeletal systems

487

2195

2.24

59.40

1.4

1.5

280.58

279.01

mosm/kgh2o

0.73

378

1690

Hypothyroidism, other/unspecified

710

2364

2.00

59.25

1.7

1.4

281.55

279.26

mosm/kgh2o

1.70

565

1813

Other pulmonary diagnosis

634

1502

2.13

58.30

1.5

1.6

279.41

281.43

mosm/kgh2o

1.18

502

1161

Disorders of lipoprotein metabolism and other lipidaemias

519

1458

2.25

58.28

1.4

281.46

284.53

mosm/kgh2o

1.66

394

1108

Dentinal caries

232

729

3.21

58.00

1.3

1.4

285.16

280.65

mosm/kgh2o

1.48

183

559

Focal epilepsy, mode (most common among epilepsy diagnosis)

214

645

3.38

57.90

1.4

1.5

279.52

280.63

mosm/kgh2o

0.25

157

505

Autoimmune diseases excluding thyroid diseases

808

2351

1.92

57.87

1.6

1.5

281.59

280.45

mosm/kgh2o

0.54

626

1828

Complications of medical and surgical care

585

2707

2.07

57.82

1.4

280.13

279.11

mosm/kgh2o

0.46

443

2094

Codeine or tramadol medication

879

2626

1.86

57.77

1.4

1.5

278.91

279.89

mosm/kgh2o

0.58

679

2052

COPD (mode)

279

755

2.97

57.72

1.3

272.54

279.04

mosm/kgh2o

3.24

206

570

Hyperkalaemia

108

7.76

57.51

1.6

1.3

277.90

283.93

mosm/kgh2o

1.02

Cardiovascular diseases

454

1029

2.42

57.40

1.5

1.8

283.76

284.67

mosm/kgh2o

0.31

365

827

Other CVD (FINNGEN)

131

206

5.11

56.83

1.5

1.4

274.13

278.46

mosm/kgh2o

0.89

164

Excluding asthma or asthma-COPD overlap

629

1502

2.11

56.72

1.5

1.6

279.06

281.43

mosm/kgh2o

1.47

499

1161

Persons encountering health services in other circumstances, wide

938

2685

1.82

56.53

1.5

280.21

280.07

mosm/kgh2o

0.06

745

2076

Other heart diseases

356

900

2.63

56.45

1.4

1.6

278.77

283.21

mosm/kgh2o

2.41

283

720

Other symptoms and signs involving cognitive functions and awareness

385

1498

2.44

56.37

1.5

1.4

278.55

277.62

mosm/kgh2o

0.27

279

1155

Behavioural syndromes associated with physiological disturbances and physical factors

291

1060

2.78

56.32

2.4

1.5

282.13

281.99

mosm/kgh2o

0.04

223

830

Recurrent or chronic depression

290

729

2.90

56.27

1.8

1.4

280.02

281.24

mosm/kgh2o

0.38

210

604

Type 1 diabetes

255

866

2.98

56.14

2.0

1.5

292.28

279.59

mosm/kgh2o

10.42

202

682

Persons encountering health services in other circumstances

336

1320

2.57

55.88

1.5

279.49

280.59

mosm/kgh2o

0.33

283

1004

Retention of urine

304

945

2.75

55.71

1.3

278.84

279.25

mosm/kgh2o

0.09

215

743

Eating disorder

112

214

5.35

55.61

3.7

1.8

284.19

287.18

mosm/kgh2o

0.99

174

Autoimmune diseases

861

2370

1.86

55.56

1.5

282.05

280.48

mosm/kgh2o

0.95

668

1840

COPD differential diagnosis

624

1502

2.09

55.16

1.5

1.6

279.15

281.33

mosm/kgh2o

1.28

496

1160

ILD differential diagnosis

624

1502

2.09

55.15

1.5

1.6

279.15

281.33

mosm/kgh2o

1.28

496

1160

Asthma, unspecified (mode)

405

1353

2.39

55.10

1.5

278.37

280.97

mosm/kgh2o

1.28

323

1042

Volume depletion

108

202

5.47

55.01

1.6

1.4

280.16

283.90

mosm/kgh2o

0.64

134

Type 1 diabetes, strict definition

113

220

5.25

54.85

2.6

1.7

300.23

285.80

mosm/kgh2o

9.95

172

Type 1 diabetes, wide definition, subgroup 1

217

682

3.22

54.68

2.0

1.5

292.98

279.93

mosm/kgh2o

10.55

175

534

Autoimmune diseases excluding thyroid diseases, strict definition

747

2172

1.93

54.32

1.6

1.4

281.33

279.83

mosm/kgh2o

0.75

576

1675

Pain, not elsewhere classified

226

735

3.11

53.79

1.5

1.4

278.02

280.89

mosm/kgh2o

0.99

182

592

Dizziness and giddiness

572

2294

2.04

52.94

1.4

280.21

279.08

mosm/kgh2o

0.49

434

1800

Other diseases of urinary system

776

2332

1.88

52.84

1.5

1.6

278.49

280.99

mosm/kgh2o

2.01

579

1860

Dyspnoea

685

2753

1.92

52.73

1.4

1.5

278.26

279.77

mosm/kgh2o

0.82

508

2155

Complications of procedures, not elsewhere classified

619

2741

1.96

52.31

1.3

1.5

279.55

279.36

mosm/kgh2o

0.06

466

2140

Type 1 diabetes, strict definition, subgroup 1

106

204

5.31

52.17

2.6

1.7

300.42

285.66

mosm/kgh2o

9.88

158

ILD medications: prednisolone, methylprednisolone, prednisone

837

2601

1.83

52.10

1.3

1.5

278.80

280.90

mosm/kgh2o

1.52

643

2034

Insulin, fast-acting

335

1360

2.49

52.09

1.7

1.4

290.57

279.16

mosm/kgh2o

11.45

261

1040

Abnormalities of breathing

691

2134

1.93

51.72

1.4

1.6

280.10

281.24

mosm/kgh2o

0.56

524

1676

Diseases of pulp and periapical tissues

295

1133

2.63

51.54

1.3

1.4

281.21

279.71

mosm/kgh2o

0.46

238

877

Type 1 diabetes, wide definition

224

743

3.05

51.51

2.0

1.5

293.07

279.90

mosm/kgh2o

11.14

178

581

Disorders of the thyroid gland

722

2512

1.89

51.48

1.7

1.4

281.68

279.56

mosm/kgh2o

1.55

578

1929

Diabetes mellitus

791

2574

1.84

51.27

1.6

1.5

284.92

278.32

mosm/kgh2o

9.25

615

2021

Benign neoplasms

567

1552

2.08

51.03

1.7

1.6

283.44

281.23

mosm/kgh2o

1.32

475

1183

Diseases of arteries, arterioles and capillaries (FINNGEN)

207

438

3.34

50.18

1.3

1.4

278.62

279.65

mosm/kgh2o

0.22

159

353

Symptoms and signs involving the digestive system and abdomen

782

2117

1.86

49.94

1.4

1.6

280.56

281.21

mosm/kgh2o

0.28

609

1639

Diabetes, varying definitions

784

2570

1.83

49.89

1.6

1.5

284.96

278.31

mosm/kgh2o

9.29

610

2019

Diarrhoea and gastroenteritis of presumed infectious origin

548

2502

2.00

49.48

1.5

281.02

280.23

mosm/kgh2o

0.29

420

1944

Emotionally unstable personality disorder

134

327

4.17

49.44

2.0

1.5

284.10

285.17

mosm/kgh2o

0.18

102

264

Oral corticosteroids

801

2688

1.81

49.36

1.4

1.5

277.30

280.61

mosm/kgh2o

3.26

622

2090

Insulin, fast-acting or short human

336

1401

2.42

49.31

1.7

1.4

290.57

279.43

mosm/kgh2o

10.95

261

1074

Pure hypercholesterolaemia

446

1357

2.22

49.30

1.4

281.17

284.19

mosm/kgh2o

1.45

335

1027

Neoplasms

573

1509

2.05

48.83

1.6

282.80

282.04

mosm/kgh2o

0.30

470

1155

Any event in cancer register

691

2182

1.89

48.21

1.4

1.5

280.89

279.84

mosm/kgh2o

0.54

574

1667

Acute and transient psychotic disorders

143

375

3.89

47.86

1.6

1.4

286.59

280.66

mosm/kgh2o

1.51

111

298

Gastrointestinal diseases

461

1044

2.22

47.43

1.4

1.6

282.51

283.15

mosm/kgh2o

0.20

362

818

Cystitis

633

2018

1.93

47.32

1.5

1.6

278.47

280.86

mosm/kgh2o

1.55

458

1605

Exposure to unspecified factor

729

3138

1.81

47.31

1.5

277.98

280.68

mosm/kgh2o

2.18

535

2478

Asthma, excluding more controls

533

1374

2.08

47.29

1.4

1.6

279.81

281.88

mosm/kgh2o

1.07

403

1067

Diabetes medication

780

2649

1.80

47.01

1.6

1.5

285.14

278.31

mosm/kgh2o

9.77

604

2084

Falls/tendency to fall

827

2324

1.79

46.85

1.4

1.6

279.92

281.41

mosm/kgh2o

0.88

615

1868

Alcohol abuse, main dg, excluding more controls

133

336

4.02

46.78

1.8

1.4

281.06

280.59

mosm/kgh2o

0.06

274

Other medical care

343

1446

2.34

46.40

1.4

275.57

278.01

mosm/kgh2o

1.16

285

1095

External causes of morbidity and mortality

524

1266

2.08

46.06

1.5

1.6

280.64

280.52

mosm/kgh2o

0.03

404

1008

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

730

2468

1.82

45.44

1.5

284.98

278.06

mosm/kgh2o

9.36

566

1937

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

657

2075

1.88

45.37

1.4

1.5

279.78

279.96

mosm/kgh2o

0.07

535

1591

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

718

2709

1.81

45.31

1.6

1.5

280.42

280.21

mosm/kgh2o

0.08

572

2100

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

655

2072

1.88

45.00

1.4

1.5

279.77

279.97

mosm/kgh2o

0.07

534

1589

Malignant neoplasm, wide definition for exclusion

655

2073

1.88

44.94

1.4

1.5

279.77

279.97

mosm/kgh2o

0.07

534

1589

ILD medications

842

2660

1.75

44.87

1.4

1.6

279.13

281.20

mosm/kgh2o

1.52

654

2083

Stroke, including SAH

511

1897

2.01

44.70

1.5

1.4

281.96

276.98

mosm/kgh2o

3.64

393

1460

Other disorders of teeth and supporting structures

200

676

3.00

44.69

1.4

1.3

284.04

278.18

mosm/kgh2o

2.07

165

515

Vocal cord dysfunction

104

206

4.74

44.40

1.5

280.01

278.28

mosm/kgh2o

0.33

170

Nutritional anaemias

394

1784

2.17

44.39

1.5

1.4

276.73

278.48

mosm/kgh2o

0.66

305

1339

Other disorders of electrolyte and fluid balance, not elsewhere classified

19.23

44.33

1.5

1.0

267.17

284.00

mosm/kgh2o

3.38

Nonorganic sleeping disorders, excluding more controls

145

404

3.63

44.32

1.5

1.4

278.30

280.37

mosm/kgh2o

0.46

111

325

Episodal and paroxysmal disorders

830

2435

1.75

44.29

1.6

1.5

281.14

280.03

mosm/kgh2o

0.62

632

1922

Chronic periapical parodontitis

191

637

3.04

43.71

1.3

281.66

278.62

mosm/kgh2o

0.79

153

496

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

491

2312

1.98

43.24

1.5

1.4

275.34

278.64

mosm/kgh2o

2.23

385

1769

Eating disorders

119

294

4.12

43.18

3.6

1.7

284.56

285.21

mosm/kgh2o

0.16

234

Intestinal infectious diseases

691

3021

1.79

43.11

1.5

281.51

280.22

mosm/kgh2o

0.64

525

2355

Dysphagia

214

767

2.82

42.97

1.4

281.26

279.65

mosm/kgh2o

0.38

159

580

Asthma

547

1488

1.98

42.89

1.4

1.6

279.66

281.42

mosm/kgh2o

0.87

412

1149

Type 2 diabetes, wide definition

605

2106

1.88

42.85

1.4

282.57

276.63

mosm/kgh2o

6.01

468

1650

Status epilepticus

104

6.82

42.79

1.4

1.2

279.68

280.60

mosm/kgh2o

0.09

Other reaction to severe stress, and adjustment disorders

275

1122

2.47

42.42

1.5

283.10

280.76

mosm/kgh2o

1.05

213

888

Abdominal and pelvic pain

749

2116

1.79

42.36

1.4

1.6

280.84

281.21

mosm/kgh2o

0.14

586

1639

Iron deficiency anaemia

347

1552

2.24

42.34

1.5

1.4

276.95

278.64

mosm/kgh2o

0.56

267

1171

Other symptoms and signs involving the nervous and musculoskeletal systems

339

1520

2.25

42.15

1.4

280.92

279.81

mosm/kgh2o

0.38

276

1188

Hypothyroidism, drug reimbursement

6.15

41.65

1.4

1.5

287.48

284.49

mosm/kgh2o

0.41

Asthma (only as main-diagnosis), excluding more controls

469

1374

2.04

41.12

1.5

1.6

280.10

281.88

mosm/kgh2o

0.85

365

1067

Malignant neoplasm

651

2125

1.83

41.11

1.3

1.5

280.10

279.76

mosm/kgh2o

0.13

535

1620

Other soft tissue disorders, not elsewhere classified

687

2383

1.79

40.99

1.5

281.76

279.81

mosm/kgh2o

1.40

517

1883

Alcoholic liver disease

116

295

4.02

40.64

1.3

273.14

280.20

mosm/kgh2o

1.84

224

Heart failure,strict

413

1438

2.09

39.99

1.3

276.29

278.16

mosm/kgh2o

0.68

310

1109

Gastro-oesophageal reflux disease

495

2292

1.92

39.82

1.6

1.4

278.52

279.62

mosm/kgh2o

0.45

388

1778

Benign neoplasms

720

2293

1.76

39.81

1.7

1.5

282.75

279.73

mosm/kgh2o

2.73

593

1769

Inflammatory bowel disease treatment related agents

829

2799

1.69

39.79

1.4

1.5

278.16

281.11

mosm/kgh2o

2.82

644

2181

Acute alcohol intoxication

213

796

2.71

39.49

1.6

1.4

279.91

281.78

mosm/kgh2o

0.44

163

636

Dialysis, with operation codes

140

413

3.46

39.43

1.5

1.3

287.53

279.38

mosm/kgh2o

2.27

113

304

Diabetes, insulin treatment (Kela reimbursement)

745

2649

1.73

39.42

1.5

284.84

278.15

mosm/kgh2o

9.01

576

2074

Insulin medication

465

2038

1.96

39.42

1.6

1.4

289.17

277.47

mosm/kgh2o

15.79

357

1584

Diseases of liver

288

1247

2.33

39.03

1.3

1.4

276.07

279.79

mosm/kgh2o

1.52

224

974

Diseases of the skin and subcutaneous tissue

760

2213

1.73

38.52

1.5

280.43

280.32

mosm/kgh2o

0.04

581

1742

Traumatic subdural haemorrhage

127

350

3.63

38.45

1.5

1.2

276.39

277.23

mosm/kgh2o

0.13

268

Atrial fibrillation and flutter with reimbursement

199

438

2.94

38.41

1.3

1.4

275.06

279.18

mosm/kgh2o

1.39

157

353

Sub-endpoint used in defining T1D endpoints

259

1063

2.42

38.01

2.0

1.4

292.01

280.69

mosm/kgh2o

9.01

207

812

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

448

2309

1.95

37.99

1.4

279.38

278.54

mosm/kgh2o

0.31

334

1781

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

288

767

2.40

37.56

1.5

281.64

281.38

mosm/kgh2o

0.06

239

617

Insulin, intermediate and long-acting

428

2149

1.97

37.37

1.6

1.4

289.68

278.04

mosm/kgh2o

14.70

331

1659

Other special examinations and investigations of persons without complaint or reported diagnosis

506

1324

1.94

37.11

1.5

1.4

280.72

279.57

mosm/kgh2o

0.49

397

1045

Early onset COPD, excluding more controls

165

556

3.00

37.09

1.3

272.90

280.76

mosm/kgh2o

2.85

124

434

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

149

475

3.19

37.03

1.3

276.45

279.56

mosm/kgh2o

0.65

120

369

Pain in throat and chest

597

2030

1.81

36.71

1.4

1.5

281.53

280.88

mosm/kgh2o

0.26

465

1594

Examination and observation for other reasons

432

1311

2.01

36.69

1.5

1.4

280.58

279.46

mosm/kgh2o

0.40

313

1035

Atrial fibrillation and flutter

219

535

2.69

36.39

1.3

1.4

275.67

279.85

mosm/kgh2o

1.59

177

431

Injuries to the abdomen, lower back, lumbar spine and pelvis

320

1479

2.17

36.36

1.6

1.4

278.31

279.12

mosm/kgh2o

0.23

236

1142

Open wound of head

384

1883

2.02

36.33

1.4

1.5

278.42

280.49

mosm/kgh2o

0.90

277

1475

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

313

1257

2.21

36.30

1.2

1.4

276.69

277.07

mosm/kgh2o

0.11

262

942

Disorders of lens

500

1670

1.90

36.22

1.4

278.22

278.55

mosm/kgh2o

0.10

389

1317

Factors influencing health status and contact with health services

257

505

2.57

36.06

1.3

1.5

283.11

280.27

mosm/kgh2o

0.79

189

406

Stroke, excluding SAH

466

1816

1.92

36.03

1.4

1.3

282.20

277.05

mosm/kgh2o

3.57

361

1387

Asthma (only as main-diagnosis)

475

1488

1.93

36.01

1.5

1.6

279.89

281.42

mosm/kgh2o

0.69

369

1149

Diseases of the digestive system

362

1776

2.05

35.57

1.5

1.4

276.51

279.64

mosm/kgh2o

1.45

279

1347

Hypothyroidism, strict autoimmune

487

1713

1.89

35.27

1.4

1.3

279.28

278.41

mosm/kgh2o

0.35

380

1293

Insulin, combination of fast acting with intermediate-acting or long-acting

466

2308

1.87

34.83

1.6

1.4

289.17

278.25

mosm/kgh2o

14.11

357

1780

Other heart diseases, wide

651

2344

1.73

34.82

1.4

1.6

277.92

281.84

mosm/kgh2o

3.75

517

1850

COPD

351

1403

2.08

34.66

1.3

273.46

278.62

mosm/kgh2o

2.96

263

1078

Dermatitis

439

2330

1.90

34.54

1.4

279.71

279.27

mosm/kgh2o

0.15

332

1819

Other chronic obstructive pulmonary disease, including avohilmo

405

1726

1.97

34.32

1.3

1.4

273.81

278.65

mosm/kgh2o

2.99

299

1330

Other chronic obstructive pulmonary disease

340

1360

2.10

34.30

1.3

273.35

278.58

mosm/kgh2o

2.89

254

1048

Other diseases of pleura

351

1522

2.06

34.26

1.4

1.3

274.54

278.52

mosm/kgh2o

2.16

280

1143

Alcohol withdrawal state with delirium

220

4.25

34.26

1.3

273.06

281.52

mosm/kgh2o

1.62

178

Organic, including symptomatic, mental disorders

394

1432

2.00

34.14

1.5

1.3

277.33

276.80

mosm/kgh2o

0.14

286

1073

Cardiac arrhythmias

392

1292

2.02

34.08

1.4

1.5

277.63

280.02

mosm/kgh2o

1.22

318

1031

Diseases of the eye and adnexa

588

1648

1.79

33.85

1.5

1.6

281.94

281.61

mosm/kgh2o

0.12

467

1313

Asthma (mode)

508

1502

1.87

33.83

1.4

1.6

279.98

281.33

mosm/kgh2o

0.60

387

1160

Hard cardiovascular diseases

571

2071

1.78

33.80

1.4

280.54

277.32

mosm/kgh2o

2.24

468

1599

Nephropathy related operations

134

425

3.21

33.66

1.4

1.3

286.97

281.24

mosm/kgh2o

1.33

114

318

Accidents

604

1713

1.77

33.46

1.6

1.5

280.68

280.77

mosm/kgh2o

0.03

462

1374

Presence of other functional implants

436

1619

1.92

33.44

1.5

1.3

277.04

277.58

mosm/kgh2o

0.17

350

1230

Spondylopathies

573

1968

1.78

33.43

1.4

278.01

279.68

mosm/kgh2o

0.80

422

1570

Persons encountering health services for other counselling and medical advice, not elsewhere classified

767

2671

1.64

33.35

1.5

281.72

279.99

mosm/kgh2o

1.17

599

2065

Infections of the skin and subcutaneous tissue

414

2172

1.91

33.31

1.4

1.5

281.86

281.18

mosm/kgh2o

0.24

321

1707

Pain in limb

559

2301

1.77

33.09

1.5

281.85

279.53

mosm/kgh2o

1.52

413

1816

Fungal Sepsis

105

5.94

33.08

1.3

1.4

281.37

279.03

mosm/kgh2o

0.30

Chronic kidney disease

241

1034

2.34

33.07

1.5

1.3

288.50

277.08

mosm/kgh2o

7.78

195

750

Other external causes of accidental injury

602

1713

1.77

32.99

1.6

1.5

280.27

280.77

mosm/kgh2o

0.18

460

1374

Diseases of the respiratory system

477

1261

1.90

32.99

1.5

1.6

279.09

281.00

mosm/kgh2o

0.85

371

971

Other neurological diseases

523

2369

1.79

32.75

1.5

1.4

279.78

278.18

mosm/kgh2o

0.85

422

1809

Other and unspecified iron deficiency

266

1203

2.23

32.57

1.5

1.4

276.17

279.08

mosm/kgh2o

1.01

201

908

Other diseases of blood and blood-forming organs, wide

199

793

2.54

32.55

1.6

1.4

277.47

279.75

mosm/kgh2o

0.69

169

608

Malignant neoplasm of other and unspecified parts of tongue

9.78

32.55

1.3

1.5

285.15

276.03

mosm/kgh2o

1.45

Disorders of mineral metabolism

186

4.44

32.53

1.5

278.29

283.45

mosm/kgh2o

0.85

137

Anorexia (incl.atypical)

174

4.58

32.49

4.5

1.8

282.74

283.56

mosm/kgh2o

0.16

136

Acute alcohol intoxication, ICD10

171

633

2.73

32.44

1.6

1.5

279.77

281.59

mosm/kgh2o

0.36

132

508

Low back pain

511

2205

1.79

32.30

1.5

278.97

280.75

mosm/kgh2o

0.95

384

1771

Asthma, hospital admission 2, infections

429

2279

1.86

31.94

1.4

1.5

279.65

280.30

mosm/kgh2o

0.21

326

1744

Asthma-related infections

429

2279

1.86

31.94

1.4

1.5

279.65

280.30

mosm/kgh2o

0.21

326

1744

Paralytic ileus and intestinal obstruction

208

853

2.46

31.93

1.3

1.4

276.33

279.38

mosm/kgh2o

0.89

149

660

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

412

2203

1.88

31.70

1.4

278.84

278.49

mosm/kgh2o

0.11

307

1698

Delirium, not induced by alcohol and other psychoactive substances

117

355

3.35

31.53

1.5

1.2

275.82

276.57

mosm/kgh2o

0.10

260

Mental and behavioural disorders due to sedatives or hypnotics

214

4.11

31.16

2.0

1.5

275.46

281.49

mosm/kgh2o

1.13

166

Fracture of lumbar spine and pelvis

193

774

2.52

31.08

1.6

1.3

279.29

277.82

mosm/kgh2o

0.30

138

585

Heart failure, strict

435

1685

1.87

31.00

1.3

275.84

277.60

mosm/kgh2o

0.65

325

1292

Diseases of oral cavity, salivary glands and jaws

655

2002

1.69

30.61

1.5

281.17

279.45

mosm/kgh2o

0.92

500

1537

Osteoporosis with pathological fracture (FG)

226

4.00

30.59

1.4

1.2

266.76

273.03

mosm/kgh2o

1.27

161

All-cause Heart Failure

428

1660

1.87

30.51

1.3

276.03

277.61

mosm/kgh2o

0.55

319

1269

severe traumatic brain injury, does not include concussion

195

795

2.48

30.41

1.5

1.4

276.35

279.41

mosm/kgh2o

0.81

144

602

Erysipelas

378

1813

1.91

30.25

1.4

280.71

277.98

mosm/kgh2o

1.09

288

1415

Senile cataract

450

1516

1.85

30.15

1.4

277.40

277.83

mosm/kgh2o

0.13

351

1191

Cerebral cysts

169

4.49

30.02

1.4

1.6

285.26

282.91

mosm/kgh2o

0.39

131

Implicit fungal Sepsis

5.96

29.95

1.4

280.93

279.72

mosm/kgh2o

0.13

Asthma-related pneumonia or sepsis

285

1368

2.10

29.93

1.3

1.4

278.43

279.19

mosm/kgh2o

0.19

214

1031

Asthma, hospital admissions 3, pneumonia

285

1368

2.10

29.93

1.3

1.4

278.43

279.19

mosm/kgh2o

0.19

214

1031

Symptoms and signs involving the circulatory and respiratory systems

702

2146

1.65

29.89

1.5

1.6

281.01

281.34

mosm/kgh2o

0.14

545

1687

Persons encountering health services for examination and investigation

482

1324

1.83

29.80

1.5

1.4

281.09

279.57

mosm/kgh2o

0.60

372

1045

Dermatitis and eczema

750

3097

1.59

29.75

1.5

279.86

280.14

mosm/kgh2o

0.11

564

2428

Asthma-related pneumonia

284

1366

2.09

29.67

1.3

1.4

278.38

279.20

mosm/kgh2o

0.22

213

1030

COPD, early/later onset

341

1467

1.98

29.55

1.3

273.35

278.54

mosm/kgh2o

2.88

254

1130

Other specified and unspecified personality disorders

265

3.65

29.24

1.9

1.5

283.26

282.71

mosm/kgh2o

0.06

216

Secondary hypertension

191

4.17

29.23

1.4

1.5

284.15

282.47

mosm/kgh2o

0.20

146

COPD, hospital admissions

337

1457

1.97

29.03

1.3

1.4

273.40

278.51

mosm/kgh2o

2.78

253

1120

Nontraumatic intracranial haemmorrhage

178

712

2.53

28.93

1.6

1.3

281.34

276.86

mosm/kgh2o

1.65

137

529

787

2647

1.58

28.48

1.5

279.47

280.20

mosm/kgh2o

0.36

607

2052

Problems related to lifestyle

289

3.48

28.43

1.7

1.4

279.60

280.71

mosm/kgh2o

0.14

228

Other eating disorders

125

4.99

28.19

3.9

1.9

284.73

289.10

mosm/kgh2o

1.16

Cushing syndrome

11.49

28.09

1.4

1.1

282.39

278.35

mosm/kgh2o

0.27

Other metabolic disorders

101

301

3.40

28.05

1.6

1.5

281.82

284.92

mosm/kgh2o

0.72

225

Chronic lower respiratory diseases

833

2924

1.55

27.94

1.4

1.6

278.02

281.09

mosm/kgh2o

2.83

633

2290

Covid-19 confirmed case

226

1020

2.24

27.92

1.4

1.5

279.59

280.27

mosm/kgh2o

0.15

168

781

Unspecified fall

360

1908

1.88

27.89

1.5

276.00

280.35

mosm/kgh2o

2.61

252

1473

COPD related to multimorbidity

292

1214

2.04

27.68

1.3

272.43

278.08

mosm/kgh2o

2.78

215

920

Genitourinary diseases

437

1192

1.85

27.68

1.6

1.5

283.62

282.04

mosm/kgh2o

0.59

342

965

Neuromuscular dysfunction of bladder

257

3.61

27.53

1.4

277.93

279.49

mosm/kgh2o

0.23

203

Injury, poisoning and certain other consequences of external causes

392

1033

1.91

27.51

1.4

1.6

280.03

280.53

mosm/kgh2o

0.14

307

822

Generalized anxiety disorder

119

397

3.03

27.41

2.0

1.6

283.51

281.85

mosm/kgh2o

0.31

319

Other headache syndromes

292

1464

2.01

27.34

1.5

1.4

279.00

279.29

mosm/kgh2o

0.08

218

1147

Other and unspecified myopathies

278

3.49

27.27

1.4

1.3

283.01

276.59

mosm/kgh2o

1.14

198

Later onset COPD, excluding more controls

169

516

2.58

27.19

1.3

273.40

276.77

mosm/kgh2o

0.88

128

370

Other disorders of optic [2nd] nerve and visual pathways

214

3.88

27.10

1.4

1.5

288.12

279.51

mosm/kgh2o

2.64

161

Chronic periodontitis

126

439

2.91

26.91

1.4

1.3

281.20

277.91

mosm/kgh2o

0.68

101

340

322

1665

1.93

26.91

1.5

1.6

280.85

281.41

mosm/kgh2o

0.16

241

1292

Postprocedural endocrine and metabolic disorders, not elsewhere classified

275

3.46

26.90

1.7

1.6

281.33

284.42

mosm/kgh2o

0.69

207

Other and unspecified dermatitis

355

1914

1.87

26.78

1.4

279.48

279.31

mosm/kgh2o

0.05

266

1489

Other diseases of the digestive system

245

1162

2.13

26.73

1.5

1.4

276.04

278.82

mosm/kgh2o

0.81

185

864

Fracture of skull and facial bones

165

664

2.51

26.51

1.5

1.4

277.94

281.26

mosm/kgh2o

0.91

125

523

Care involving use of rehabilitation procedures

427

2317

1.76

26.30

1.5

281.80

279.69

mosm/kgh2o

0.93

323

1798

Dorsalgia

672

2280

1.60

26.27

1.4

1.6

279.38

280.90

mosm/kgh2o

0.92

500

1831

Pain (limb, back, neck, head abdominally)

533

1568

1.71

26.22

1.5

1.6

281.69

280.63

mosm/kgh2o

0.42

402

1239

Panic disorder

114

381

3.02

26.20

1.7

1.6

282.64

282.12

mosm/kgh2o

0.08

308

Use of disulfiram, acamprosate or naltrexone

276

3.43

26.11

1.3

1.4

275.39

283.44

mosm/kgh2o

1.50

227

Type 2 diabetes

658

2455

1.60

25.94

1.4

1.5

282.22

278.00

mosm/kgh2o

3.76

513

1926

Obsessive-compulsive disorder

138

4.57

25.94

2.5

1.7

284.35

285.56

mosm/kgh2o

0.16

109

Dental caries 1 and operation codes

617

1942

1.64

25.92

1.4

1.5

279.66

279.68

mosm/kgh2o

0.00

485

1482

Disorders resulting from impaired renal tubular function

127

4.83

25.90

2.3

1.4

295.00

280.96

mosm/kgh2o

3.57

GI-bleeding

244

1170

2.10

25.88

1.5

1.4

276.09

278.79

mosm/kgh2o

0.77

182

869

Missing teeth due to accident, extraction or parodontitis

109

359

3.08

25.77

1.5

1.3

281.73

276.99

mosm/kgh2o

1.08

273

Asthma (diagnoses ohter than nonallergic)

583

3101

1.61

25.64

1.5

279.04

280.28

mosm/kgh2o

0.62

444

2416

Hypotension

146

565

2.62

25.51

1.5

1.3

273.88

277.04

mosm/kgh2o

0.67

105

416

Acidosis

8.27

25.33

1.7

1.2

286.04

282.73

mosm/kgh2o

0.25

Kidney transplant status

175

4.11

25.32

1.3

1.5

282.98

284.13

mosm/kgh2o

0.12

133

Hyperkinetic disorders, excluding more controls

173

4.04

25.25

1.7

2.1

290.27

292.19

mosm/kgh2o

0.44

135

COPD, hospital admission 2, with asthma infections

244

997

2.11

25.23

1.3

272.88

278.73

mosm/kgh2o

2.65

181

754

Disorders of thyroid, IBD co-morbidities

111

259

3.15

25.22

1.5

1.6

284.65

279.73

mosm/kgh2o

1.05

221

Symptoms and signs involving the skin and subcutaneous tissue

461

2717

1.70

25.18

1.4

1.5

280.71

279.24

mosm/kgh2o

0.77

357

2108

Alcohol abuse, main dg

133

495

2.72

25.11

1.8

1.5

281.06

281.49

mosm/kgh2o

0.06

395

Persistent mood disorders

149

588

2.56

24.97

1.6

1.4

281.27

277.54

mosm/kgh2o

0.90

110

466

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

182

651

2.37

24.86

1.2

1.4

276.16

277.05

mosm/kgh2o

0.18

150

488

Sequelae of cerebrovascular disease

266

1164

2.02

24.83

1.5

1.3

282.55

276.84

mosm/kgh2o

2.85

191

883

Dental caries 3 and operation codes

632

2038

1.60

24.15

1.4

1.5

279.71

279.95

mosm/kgh2o

0.08

494

1563

Hernia of abdominal wall, postoperative

113

394

2.89

24.10

1.5

1.4

278.02

277.87

mosm/kgh2o

0.02

302

Manic episode

5.58

23.97

1.6

1.4

286.97

280.57

mosm/kgh2o

0.71

Lower back pain or/and sciatica

674

3033

1.55

23.92

1.4

1.5

278.74

279.77

mosm/kgh2o

0.55

507

2378

Diseases of the myoneural junction and muscle

118

424

2.83

23.91

1.5

1.4

283.56

278.62

mosm/kgh2o

1.01

312

Gingivitis and periodontal diseases

611

1972

1.61

23.91

1.5

280.94

279.30

mosm/kgh2o

0.83

456

1519

COPD, hospital admissions 3, with asthma pneumonia sepsis

207

808

2.20

23.89

1.2

1.3

274.13

278.97

mosm/kgh2o

1.69

151

600

Other mental disorders due to brain damage and dysfunction and to physical disease

110

381

2.94

23.86

1.6

1.3

278.90

276.39

mosm/kgh2o

0.44

279

Disorders of optic nerve and visual pathways

313

3.15

23.81

1.5

287.08

281.88

mosm/kgh2o

1.42

239

Nerve, nerve root and plexus disorders

697

2854

1.54

23.78

1.4

279.19

279.36

mosm/kgh2o

0.06

528

2226

Hyperlipidaemia, other/unspecified

216

963

2.14

23.77

1.3

280.53

283.68

mosm/kgh2o

0.92

168

721

Gastroduodenal ulcer

195

884

2.22

23.76

1.3

276.79

278.30

mosm/kgh2o

0.31

155

666

Provisional assignment of new diseases of uncertain etiology

311

1673

1.87

23.70

1.4

1.5

279.96

281.06

mosm/kgh2o

0.33

233

1289

Other CVD

159

664

2.42

23.66

1.5

1.3

274.60

277.41

mosm/kgh2o

0.59

115

492

Codes for special purposes

311

1675

1.87

23.61

1.4

1.5

279.96

281.06

mosm/kgh2o

0.34

233

1291

Dental operations

453

1348

1.73

23.53

1.4

279.75

279.11

mosm/kgh2o

0.20

359

1006

Enlarged lymph nodes

112

394

2.87

23.52

1.3

1.4

283.88

280.86

mosm/kgh2o

0.73

316

Haemorrhage from respiratory passages

247

1139

2.03

23.51

1.6

1.4

277.34

279.43

mosm/kgh2o

0.62

191

878

Transplanted organ and tissue status

326

3.09

23.48

1.2

1.4

283.90

283.83

mosm/kgh2o

0.01

243

Other degenerative diseases of the nervous system

186

617

2.30

23.45

1.4

1.3

274.78

277.05

mosm/kgh2o

0.47

134

485

Other disorders of skin and subcutaneous tissue

457

2517

1.67

23.35

1.5

1.4

279.32

278.57

mosm/kgh2o

0.26

357

1929

Visual disturbances and blindness

353

1984

1.79

23.34

1.5

1.4

281.82

279.06

mosm/kgh2o

1.40

278

1516

Somatoform disorder

132

510

2.62

23.17

1.5

280.73

278.80

mosm/kgh2o

0.45

109

393

110

387

2.88

23.14

1.8

1.5

280.36

280.27

mosm/kgh2o

0.01

306

Sleep disorders

162

692

2.36

22.91

1.5

279.68

281.09

mosm/kgh2o

0.31

123

538

Viral hepatitis, IBD co-morbidity

5.75

22.89

2.1

1.6

285.42

280.90

mosm/kgh2o

0.42

Drug-induced adrenocortical insufficiency

7.09

22.74

1.4

1.5

274.00

283.16

mosm/kgh2o

1.26

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

291

3.18

22.71

1.5

1.4

283.70

278.90

mosm/kgh2o

0.85

227

Chronic pancreatitis

113

408

2.81

22.70

1.5

1.3

275.11

279.13

mosm/kgh2o

0.98

312

Psychotic depression

112

4.71

22.66

2.6

1.4

281.32

278.96

mosm/kgh2o

0.26

Diseases of arteries, arterioles and capillaries

458

2058

1.67

22.51

1.4

280.24

277.50

mosm/kgh2o

1.49

342

1589

Glomerular diseases

153

643

2.41

22.50

1.4

283.03

280.53

mosm/kgh2o

0.56

128

490

Mycoses

203

961

2.13

22.39

1.4

281.92

279.86

mosm/kgh2o

0.58

155

734

Other and unspecified drugs and medicaments

279

3.21

22.30

1.5

1.4

284.06

279.41

mosm/kgh2o

0.77

209

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

201

3.64

22.24

1.5

1.7

286.72

283.92

mosm/kgh2o

0.38

161

Abnormal findings on diagnostic imaging of lung

328

1781

1.80

22.21

1.4

1.3

272.46

278.08

mosm/kgh2o

3.94

252

1356

ILD medications: immunosuppressive drugs

401

2270

1.70

22.14

1.4

1.6

279.17

281.42

mosm/kgh2o

1.05

320

1795

Sleep disorders (combined)

638

2725

1.54

22.02

1.5

1.4

282.55

278.87

mosm/kgh2o

3.51

492

2134

Injuries to the thorax

306

1678

1.83

21.98

1.5

1.4

278.60

279.39

mosm/kgh2o

0.21

227

1288

Disorders of eyelid, lacrimal system and orbit

555

2772

1.58

21.92

1.5

1.4

278.18

279.40

mosm/kgh2o

0.62

436

2135

Care involving dialysis

247

3.34

21.87

1.3

1.4

283.71

282.16

mosm/kgh2o

0.20

187

Dental caries 3

574

1848

1.59

21.81

1.4

1.5

280.42

279.77

mosm/kgh2o

0.23

449

1427

Other dorsopathies, not elsewhere classified

667

2298

1.54

21.80

1.4

1.6

278.89

281.06

mosm/kgh2o

1.53

490

1847

Visual field defects

288

3.15

21.80

1.7

1.4

283.00

278.60

mosm/kgh2o

1.03

218

Soft tissue disorders

706

2428

1.52

21.60

1.5

1.6

281.14

280.11

mosm/kgh2o

0.54

531

1922

Other or unspecified ileus, impaction or obstruction

145

606

2.42

21.56

1.3

1.4

276.31

279.24

mosm/kgh2o

0.63

108

474

Sequelae of external causes of morbidity and mortality

197

938

2.12

21.44

1.6

1.4

277.43

279.18

mosm/kgh2o

0.45

155

719

Hepatic failure, not elsewhere classified

114

4.62

21.39

1.4

1.5

274.22

278.43

mosm/kgh2o

0.54

Bronchitis

695

3045

1.50

21.37

1.4

1.5

279.95

279.92

mosm/kgh2o

0.01

525

2377

Hypothyroidism, strict autoimmune, 3 medication purchases required

530

2279

1.59

21.31

1.4

278.28

279.11

mosm/kgh2o

0.35

414

1750

Ischaemic Stroke, excluding all haemorrhages

395

1757

1.71

21.27

1.4

1.3

281.71

276.92

mosm/kgh2o

2.62

299

1336

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

196

923

2.12

21.23

1.6

1.7

285.23

283.87

mosm/kgh2o

0.31

149

730

Intracerebral haemorrhage

110

406

2.74

21.20

1.5

1.3

281.56

276.36

mosm/kgh2o

1.41

297

Amenorrhoea

157

3.94

21.16

4.4

1.6

284.58

284.80

mosm/kgh2o

0.03

127

Polyneuropathies and other disorders of the peripheral nervous system

172

783

2.22

21.00

1.3

1.4

277.55

279.80

mosm/kgh2o

0.54

128

604

Other problems related to primary support group, including family circumstances

108

386

2.76

20.98

1.7

287.67

285.30

mosm/kgh2o

0.43

301

Pneumonitis due to solids and liquids

259

3.22

20.92

1.3

281.75

279.01

mosm/kgh2o

0.35

186

Intestinal stricture

231

1176

1.98

20.92

1.3

1.4

275.45

278.87

mosm/kgh2o

1.19

168

883

Phobic anxiety disorders

337

2.91

20.89

1.7

1.8

282.54

285.84

mosm/kgh2o

0.68

271

All influenza

181

844

2.16

20.77

1.5

1.4

281.20

280.73

mosm/kgh2o

0.10

137

650

Diseases of pulp and periapical tissues, including avohilmo

728

2544

1.49

20.68

1.4

1.6

281.36

280.02

mosm/kgh2o

0.73

565

1984

Superficial injury of head

169

769

2.22

20.62

1.3

1.5

276.64

280.50

mosm/kgh2o

1.22

116

592

Spinal stenosis

345

1549

1.76

20.58

1.3

1.4

276.01

278.33

mosm/kgh2o

0.85

244

1229

Intentional self-harm by sharp object

6.08

20.53

3.5

1.4

286.25

286.50

mosm/kgh2o

0.03

Nonorganic sleeping disorders

145

620

2.36

20.53

1.5

278.30

281.06

mosm/kgh2o

0.71

111

487

Dental pulpitis 4

727

2546

1.49

20.43

1.4

1.6

281.36

280.01

mosm/kgh2o

0.73

563

1987

Dental pulpitis 1

727

2547

1.49

20.42

1.4

1.6

281.38

280.01

mosm/kgh2o

0.75

564

1987

Inflammatory diseases of the central nervous system

289

3.06

20.40

1.5

1.4

284.14

280.71

mosm/kgh2o

0.61

212

Glomerular disorders in diseases classified elsewhere

102

370

2.80

20.37

1.4

286.49

280.43

mosm/kgh2o

1.29

273

Mixed and other personality disorders

233

3.31

20.35

1.5

280.12

284.27

mosm/kgh2o

0.61

188

Dental caries 3, only avohilmo

585

1929

1.56

20.17

1.4

1.5

280.44

279.95

mosm/kgh2o

0.17

453

1491

Dental caries, including avohilmo

537

1735

1.59

20.17

1.4

1.5

280.28

279.50

mosm/kgh2o

0.27

426

1332

Mental and behavioural disorders due to opioids

4.76

20.16

2.1

1.7

284.24

285.70

mosm/kgh2o

0.16

Dental caries 1

537

1736

1.59

20.11

1.4

1.5

280.28

279.50

mosm/kgh2o

0.27

426

1332

Other acute lower respiratory infections

363

2046

1.70

20.06

1.6

1.5

280.20

280.36

mosm/kgh2o

0.04

281

1554

Candidiasis

117

461

2.57

19.84

1.4

282.55

278.25

mosm/kgh2o

1.07

357

Bulimia nervosa (incl. atypical)

5.83

19.82

3.4

2.0

287.57

287.45

mosm/kgh2o

0.01

Unspecified haematuria

271

1258

1.86

19.79

1.4

280.23

278.48

mosm/kgh2o

0.55

196

984

Spondylosis

349

1749

1.72

19.74

1.4

277.48

278.88

mosm/kgh2o

0.53

264

1401

Type 2 diabetes, definitions combined

603

2365

1.53

19.73

1.4

1.5

281.48

277.62

mosm/kgh2o

3.01

463

1856

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

138

531

2.38

19.67

1.9

2.2

288.88

288.03

mosm/kgh2o

0.26

114

416

Diverticular disease of intestine

444

1816

1.63

19.64

1.4

274.14

278.94

mosm/kgh2o

3.34

314

1442

Bacterial pneumonia, not elsewhere classified

258

1227

1.87

19.46

1.4

280.62

278.65

mosm/kgh2o

0.53

195

940

Disorders of calcium metabolism

140

4.00

19.42

1.6

1.5

279.93

282.95

mosm/kgh2o

0.30

102

Other diseases of lip and oral mucosa

126

520

2.45

19.35

1.4

1.3

278.86

277.37

mosm/kgh2o

0.27

108

391

Dissociative [conversion] disorders

4.73

19.21

1.6

286.86

282.10

mosm/kgh2o

0.63

Pleural effusion

124

511

2.46

19.13

1.4

1.3

273.72

278.48

mosm/kgh2o

1.26

383

Type 2 diabetes, strict (exclude DM1)

603

2383

1.52

19.11

1.4

1.5

281.52

277.64

mosm/kgh2o

3.05

462

1870

Disorders of gallbladder, biliary tract and pancreas

632

2732

1.50

19.08

1.4

280.63

278.85

mosm/kgh2o

0.95

489

2123

Use of biperiden

179

3.60

19.06

1.5

1.3

283.71

280.65

mosm/kgh2o

0.34

143

Fracture of rib(s), sternum and thoracic spine

211

1078

1.97

18.97

1.5

1.4

278.85

279.32

mosm/kgh2o

0.08

152

831

Other and unspecified polyneuropathies, also in other diseases

148

662

2.26

18.93

1.3

1.4

278.59

279.70

mosm/kgh2o

0.21

111

510

Visual disturbances

318

1846

1.73

18.92

1.5

1.4

282.08

279.16

mosm/kgh2o

1.43

251

1424

Abnormalities of heart beat

228

1185

1.92

18.91

1.4

279.35

279.61

mosm/kgh2o

0.06

171

915

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

143

3.93

18.90

1.6

1.5

283.96

279.27

mosm/kgh2o

0.74

104

Other disorders of bladder

352

2.76

18.80

1.5

1.4

280.91

281.73

mosm/kgh2o

0.11

287

Secondary parkinsonism, excluding more controls

6.92

18.77

2.0

1.2

298.40

278.87

mosm/kgh2o

2.37

Other diseases of the respiratory system

159

735

2.18

18.75

1.4

275.86

278.83

mosm/kgh2o

0.67

122

546

Other respiratory disorders and diseases

159

735

2.18

18.75

1.4

275.86

278.83

mosm/kgh2o

0.67

122

546

L04AD Calcineurin inhibitors

103

393

2.66

18.70

1.3

1.5

283.35

283.02

mosm/kgh2o

0.04

301

Bacterial pneumoniae

267

1301

1.83

18.68

1.4

280.29

278.89

mosm/kgh2o

0.36

203

998

Dorsopathies

675

2330

1.48

18.67

1.4

1.6

279.49

281.26

mosm/kgh2o

1.06

495

1870

Disorders of parathyroid gland

161

739

2.17

18.67

1.5

1.3

280.20

275.37

mosm/kgh2o

1.45

128

537

Mental and behavioural disorders due to tobacco

273

3.02

18.56

1.3

1.4

276.62

280.83

mosm/kgh2o

0.77

217

Supplementary factors related to causes of morbidity and mortality classified elsewhere

216

1121

1.94

18.55

1.4

1.5

283.79

280.12

mosm/kgh2o

1.30

178

867

Myalgia

157

728

2.17

18.35

1.6

1.4

280.57

279.87

mosm/kgh2o

0.14

114

566

Benign neoplasm: Cerebral meninges

275

2.99

18.32

1.8

1.4

283.97

274.20

mosm/kgh2o

2.97

208

Benign neoplasm of meninges

302

2.89

18.30

1.9

1.4

283.71

274.92

mosm/kgh2o

2.64

226

Ascites

194

3.41

18.21

1.2

1.3

274.90

276.44

mosm/kgh2o

0.22

149

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

220

3.24

18.06

1.6

1.4

284.20

279.72

mosm/kgh2o

0.83

163

Type 2 diabetes, definitions combined, including avohilmo

599

2373

1.50

18.03

1.4

1.5

281.63

277.74

mosm/kgh2o

3.03

457

1865

Postmenopausal osteoporosis with pathological fracture

227

3.20

17.88

1.4

1.3

265.31

272.54

mosm/kgh2o

1.34

164

Bacterial pneumonia (organism specified)

296

1554

1.74

17.82

1.4

280.15

278.77

mosm/kgh2o

0.37

228

1180

Unspecified kidney failure

307

2.84

17.76

1.4

1.3

287.65

275.91

mosm/kgh2o

3.02

221

Speech disturbances, not elsewhere classified

280

2.94

17.76

1.2

1.4

283.43

276.10

mosm/kgh2o

1.25

213

Post-traumatic stress disorder

168

3.55

17.73

2.3

1.7

287.66

284.38

mosm/kgh2o

0.68

132

Other cataract

283

1240

1.78

17.68

1.4

278.25

278.01

mosm/kgh2o

0.06

219

964

Smoking dependency

281

2.93

17.65

1.3

1.4

276.62

281.04

mosm/kgh2o

0.83

222

Sequelae with surgical and medical care as external cause

154

722

2.15

17.57

1.6

1.4

277.42

279.13

mosm/kgh2o

0.39

122

557

Early onset COPD

165

795

2.09

17.51

1.3

1.4

272.90

280.52

mosm/kgh2o

2.86

124

637

Dental caries 1, only avohilmo

544

1824

1.53

17.51

1.4

1.5

280.07

279.84

mosm/kgh2o

0.07

431

1404

Sciatica+with lumbago

313

1754

1.70

17.41

1.3

1.5

278.66

280.18

mosm/kgh2o

0.60

234

1422

Lung cancer and mesothelioma

130

482

2.33

17.36

1.3

269.89

279.18

mosm/kgh2o

3.95

101

359

Dental pulpitis 2

473

1542

1.58

17.33

1.4

1.6

280.24

279.66

mosm/kgh2o

0.18

372

1188

Non-ischemic cardiomyopathy

219

950

1.91

17.26

1.3

273.54

277.52

mosm/kgh2o

1.33

157

710

COPD-related respiratory insufficiency

357

2.67

17.24

1.3

273.22

277.43

mosm/kgh2o

0.78

268

Non-rheumatic valve diseases

314

1342

1.72

17.23

1.3

1.4

276.15

279.99

mosm/kgh2o

1.75

254

1039

Viral pneumonia

381

2.60

17.14

1.5

1.4

281.06

281.28

mosm/kgh2o

0.02

291

Other noninfective gastroenteritis and colitis

184

929

1.99

17.13

1.5

279.75

280.52

mosm/kgh2o

0.16

143

707

Insomnia

120

513

2.36

17.10

1.5

278.10

281.12

mosm/kgh2o

0.74

403

Other diseases of hard tissues of teeth

391

1814

1.61

17.03

1.5

280.13

279.88

mosm/kgh2o

0.07

309

1407

Alcohol-induced chronic pancreatitis

208

3.23

16.99

1.5

1.3

274.32

283.61

mosm/kgh2o

2.02

164

Agranulocytosis

100

396

2.56

16.88

1.9

1.5

278.45

279.15

mosm/kgh2o

0.11

299

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

151

714

2.13

16.85

1.3

1.4

272.25

277.49

mosm/kgh2o

2.28

131

543

Type of accident

199

1039

1.93

16.85

1.5

283.43

280.25

mosm/kgh2o

1.06

165

803

Continuous positive airway pressure

109

382

2.48

16.81

1.6

1.3

283.23

279.20

mosm/kgh2o

0.67

307

Parodontitis and operation codes

530

2759

1.50

16.77

1.4

279.53

278.84

mosm/kgh2o

0.26

406

2157

Acute bronchitis

279

1583

1.74

16.77

1.5

1.4

279.46

279.68

mosm/kgh2o

0.05

214

1194

Other (not insulin) diabetes medications

598

2457

1.47

16.58

1.4

1.5

282.24

277.65

mosm/kgh2o

3.92

459

1928

Valvular heart disease excluding rheumatic fever

313

1353

1.70

16.56

1.3

1.4

276.12

280.04

mosm/kgh2o

1.80

253

1046

Emotional disorders starting during childhood or adolecense, excluding more controls

4.51

16.52

2.4

289.29

296.91

mosm/kgh2o

2.18

Dental pulpitis 2, only avohilmo

480

1588

1.55

16.50

1.4

1.5

280.24

279.53

mosm/kgh2o

0.23

380

1228

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

167

3.16

16.42

1.4

1.5

270.68

277.21

mosm/kgh2o

1.28

139

Migraine

280

1382

1.73

16.32

1.8

1.7

282.11

280.86

mosm/kgh2o

0.51

212

1092

Benign neoplasm of colon, rectum, anus and anal canal

327

1403

1.67

16.29

1.4

278.96

277.73

mosm/kgh2o

0.37

241

1069

Pain in joint

362

1474

1.63

16.19

1.5

1.6

281.21

280.38

mosm/kgh2o

0.30

271

1179

Irritable bowel syndrome

174

882

1.99

16.07

1.9

1.4

277.90

280.57

mosm/kgh2o

0.85

135

700

Cerebral palsy and other paralytic syndromes

394

2.52

16.03

1.8

1.4

281.64

279.37

mosm/kgh2o

0.39

297

Persons encountering health services for specific procedures, not carried out

205

3.17

16.03

1.4

1.5

281.20

281.58

mosm/kgh2o

0.04

158

Parodontitis or operation codes

555

2788

1.47

15.92

1.3

1.4

279.65

278.84

mosm/kgh2o

0.31

423

2183

Disorders of lacrimal system

267

1552

1.73

15.92

1.5

1.4

278.41

277.78

mosm/kgh2o

0.17

202

1178

Fracture of femur

192

918

1.92

15.90

1.4

1.3

272.83

277.19

mosm/kgh2o

1.54

143

676

Autoimmune diseases related-to ILD

523

3119

1.48

15.88

1.4

1.5

278.38

280.23

mosm/kgh2o

0.98

410

2419

Parodontitis

554

2788

1.47

15.82

1.3

1.4

279.59

278.84

mosm/kgh2o

0.28

422

2183

Aneurysms, operations, SAH

128

583

2.22

15.76

1.8

1.3

279.49

277.29

mosm/kgh2o

0.42

100

447

Heart failure and bmi 25plus

234

889

1.83

15.68

1.3

276.32

280.12

mosm/kgh2o

1.25

171

690

Chronic periodontitis, including avohilmo

551

2787

1.47

15.65

1.3

1.4

279.76

278.78

mosm/kgh2o

0.40

421

2180

Chronic gastritis

187

981

1.92

15.64

1.5

1.3

275.79

277.71

mosm/kgh2o

0.43

131

733

Transport accidents

261

1336

1.74

15.62

1.6

281.89

281.13

mosm/kgh2o

0.22

223

1071

Gastric ulcer

128

585

2.21

15.61

1.4

1.2

278.01

278.86

mosm/kgh2o

0.12

102

436

Other and unspecified mood [affective] disorders

163

3.42

15.60

1.7

1.6

287.52

281.97

mosm/kgh2o

0.70

130

Hypoparathyroidism

108

4.09

15.58

1.5

1.2

272.58

276.01

mosm/kgh2o

0.36

Persistent delusional disorders

252

2.90

15.49

1.3

279.87

278.12

mosm/kgh2o

0.20

186

Cough

259

1445

1.73

15.33

1.6

1.5

279.61

280.40

mosm/kgh2o

0.22

192

1134

In situ neoplasms

210

1095

1.84

15.33

1.5

1.4

279.07

276.46

mosm/kgh2o

0.91

160

808

Other intervertebral disc disorders

509

2096

1.49

15.16

1.4

1.5

276.42

280.14

mosm/kgh2o

3.01

379

1680

Drug-induced neutropenia

239

2.94

15.16

1.2

1.3

277.63

278.69

mosm/kgh2o

0.17

183

Dental operations, only avohilmo

462

1548

1.53

15.13

1.4

279.76

279.38

mosm/kgh2o

0.11

363

1180

Other bacterial intestinal infections

131

617

2.14

14.85

1.4

282.28

277.60

mosm/kgh2o

1.11

455

Iron deficiency anaemia secondary to blood loss (chronic)

122

559

2.20

14.83

1.4

277.09

277.65

mosm/kgh2o

0.08

420

Benign neoplasm of mouth and pharynx

326

2.61

14.82

1.5

1.4

284.11

278.87

mosm/kgh2o

1.23

249

Attention to artificial openings

108

3.98

14.74

1.3

283.42

280.96

mosm/kgh2o

0.19

Lung diseases due to external agents

105

453

2.34

14.73

1.4

1.3

280.25

278.78

mosm/kgh2o

0.20

338

Polycystic ovarian syndrome, consortium definition

430

1696

1.53

14.64

1.9

1.5

278.31

278.51

mosm/kgh2o

0.06

334

1304

Injuries to the elbow and forearm

432

2594

1.51

14.62

1.7

1.5

277.65

280.10

mosm/kgh2o

1.30

324

2016

Asthma/COPD (KELA code 203)

588

2902

1.43

14.62

1.4

1.6

278.21

280.99

mosm/kgh2o

2.00

454

2272

Symptoms and signs involving speech and voice

218

1228

1.79

14.57

1.3

1.4

281.59

278.73

mosm/kgh2o

0.90

154

949

Fracture of shoulder and upper arm

242

1406

1.73

14.48

1.6

1.4

275.43

279.84

mosm/kgh2o

1.92

178

1075

Other diseases of upper respiratory tract

724

2720

1.39

14.47

1.6

1.5

278.39

280.11

mosm/kgh2o

1.26

545

2126

Cutaneous abscess, furuncle and carbuncle

167

867

1.94

14.46

1.3

1.5

280.59

280.80

mosm/kgh2o

0.04

128

677

Disorders of ocular muscles, binocular movement, accommodation and refraction

294

1784

1.64

14.46

1.7

1.6

283.89

281.24

mosm/kgh2o

1.24

233

1389

Acute upper respiratory infections

654

2921

1.41

14.41

1.5

279.52

279.89

mosm/kgh2o

0.15

509

2265

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

105

458

2.32

14.38

1.2

1.4

283.18

279.12

mosm/kgh2o

1.29

345

Injuries to the hip and thigh

300

1692

1.63

14.19

1.4

276.93

278.38

mosm/kgh2o

0.43

221

1292

Functional dyspepsia

168

880

1.92

14.18

1.5

1.3

278.15

279.00

mosm/kgh2o

0.16

136

678

Dental pulpitis 4, only avohilmo

707

2662

1.39

14.07

1.4

1.6

280.88

279.87

mosm/kgh2o

0.50

547

2082

Other nutritional deficiencies

373

2377

1.54

13.96

1.5

283.15

280.06

mosm/kgh2o

1.67

284

1859

Unknown and unspecified causes of morbidity

170

3.21

13.95

1.3

1.4

283.17

280.92

mosm/kgh2o

0.28

133

Other disorders of lacrimal gland

214

1215

1.77

13.95

1.5

1.4

278.81

277.91

mosm/kgh2o

0.23

161

912

Noninfective enteritis and colitis

296

1830

1.62

13.94

1.4

1.5

279.08

280.77

mosm/kgh2o

0.57

233

1414

Finngen Rheumatological endpoints

601

2414

1.42

13.93

1.5

280.21

280.74

mosm/kgh2o

0.21

468

1888

Disturbances of skin sensation

172

914

1.89

13.90

1.3

1.4

282.83

279.98

mosm/kgh2o

1.13

128

711

Other complications of surgical and medical care, not elsewhere classified

325

2.55

13.89

1.7

1.5

282.34

278.93

mosm/kgh2o

0.60

260

Leisure time condition

130

628

2.09

13.83

1.5

1.4

284.42

280.67

mosm/kgh2o

1.04

103

480

Dental pulpitis 1, only avohilmo

706

2668

1.39

13.78

1.4

1.6

280.90

279.85

mosm/kgh2o

0.52

547

2085

Hypertensive heart and/or renal disease

155

609

1.98

13.75

1.4

1.3

277.87

278.19

mosm/kgh2o

0.05

109

480

Traumatic subarachnoid haemorrhage

4.39

13.63

1.7

1.2

277.04

276.75

mosm/kgh2o

0.02

Malignant neoplasm of nasal cavity and sinuses

10.06

13.60

1.3

1.1

287.81

272.91

mosm/kgh2o

1.21

Benign neoplasm: Cerebral meninges

323

2.54

13.58

1.8

1.4

283.97

275.82

mosm/kgh2o

2.31

245

Sequelae of injuries, of poisoning and of other consequences of external causes

158

824

1.93

13.54

1.6

1.4

281.50

280.14

mosm/kgh2o

0.28

122

652

Obesity related asthma

209

1190

1.77

13.51

1.4

282.40

279.84

mosm/kgh2o

0.89

162

930

Undetermined asthma, excluding more controls

329

2.51

13.49

1.2

1.3

280.09

281.63

mosm/kgh2o

0.27

256

Hyperprolactinaemia

4.25

13.47

2.2

1.4

290.20

282.15

mosm/kgh2o

1.60

Rheumatism, unspecified

103

459

2.27

13.44

1.5

1.4

281.13

276.29

mosm/kgh2o

1.36

353

Follow-up examination after treatment for conditions other than malignant neoplasms

263

1029

1.68

13.26

1.4

278.01

278.63

mosm/kgh2o

0.16

194

810

Acute sinusitis

305

1791

1.59

13.24

1.4

1.5

279.25

280.93

mosm/kgh2o

0.72

245

1417

Disorders of choroid and retina

490

2466

1.45

13.22

1.4

280.40

277.85

mosm/kgh2o

1.30

378

1894

Unspecified urinary incontinence

292

2.60

13.21

1.4

1.3

279.98

275.33

mosm/kgh2o

0.87

215

Benign neoplasm: Colon

278

1303

1.64

13.20

1.4

278.67

277.54

mosm/kgh2o

0.29

201

989

Explicit bacterial Sepsis

286

2.61

13.20

1.4

281.34

278.53

mosm/kgh2o

0.33

219

Fracture of lower leg, including ankle

337

2170

1.55

13.19

1.3

1.5

278.05

279.06

mosm/kgh2o

0.29

256

1687

Other gastritis (incl. Duodenitis)

151

783

1.94

13.18

1.6

1.3

277.33

278.80

mosm/kgh2o

0.32

126

600

Sequelae of injuries of head

167

3.17

13.07

1.6

1.4

279.90

283.22

mosm/kgh2o

0.41

133

Noninfectious colitis NAS

106

485

2.21

13.00

1.4

1.5

278.84

279.96

mosm/kgh2o

0.17

367

Glucagon-like peptide-1 (GLP-1) analogues

346

1848

1.55

12.95

1.3

1.4

285.65

276.07

mosm/kgh2o

7.17

242

1430

Hydrocephalus

255

2.71

12.93

1.9

1.4

285.86

276.91

mosm/kgh2o

2.41

184

Fall on and from stairs and steps

172

937

1.85

12.92

1.4

277.18

278.87

mosm/kgh2o

0.38

122

716

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

216

2.86

12.92

2.1

1.5

290.78

281.51

mosm/kgh2o

1.96

164

Biguanides

574

2514

1.41

12.91

1.4

281.76

277.73

mosm/kgh2o

3.08

434

1976

Abnormal findings on examination of blood, without diagnosis

291

1709

1.60

12.87

1.5

1.4

282.61

279.25

mosm/kgh2o

1.38

230

1320

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

331

2.47

12.87

1.3

1.4

280.22

274.66

mosm/kgh2o

1.43

229

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

317

1370

1.59

12.85

1.3

1.4

279.41

277.03

mosm/kgh2o

1.03

245

1033

Somnolence, stupor and coma

129

3.47

12.79

1.5

276.65

281.06

mosm/kgh2o

0.43

Other systemic involvement of connective tissue (FG)

170

920

1.85

12.74

1.4

276.49

277.89

mosm/kgh2o

0.37

129

690

Pneumonia due to other infectious organisms, not elsewhere classified

4.07

12.70

1.3

1.6

278.33

279.88

mosm/kgh2o

0.11

Injuries to the neck

146

759

1.94

12.67

1.6

1.5

277.86

281.75

mosm/kgh2o

1.04

112

595

Other disorders of glucose regulation and pancreatic internal secretion

281

2.59

12.64

1.6

1.5

287.82

280.52

mosm/kgh2o

1.11

204

Benign neoplasm of meninges

365

2.39

12.63

1.9

1.4

283.71

276.15

mosm/kgh2o

2.18

276

Dentofacial anomalies [including malocclusion]

161

855

1.87

12.62

1.8

1.7

284.09

281.24

mosm/kgh2o

1.07

135

657

Other/unspecified dorsalgia

226

1335

1.69

12.58

1.4

278.79

279.93

mosm/kgh2o

0.30

151

1062

Extrapyramidal and movement disorders

237

1427

1.67

12.54

1.6

1.4

283.72

277.97

mosm/kgh2o

2.86

172

1086

Monoamine oxidase A inhibitors

318

2.47

12.47

1.6

1.3

280.57

278.05

mosm/kgh2o

0.38

254

Other arrhythmias

368

1865

1.52

12.46

1.4

1.5

275.75

280.50

mosm/kgh2o

4.19

293

1458

Cellulitis

143

743

1.94

12.44

1.4

1.5

282.37

280.71

mosm/kgh2o

0.41

111

581

Chronic periodontitis, complicated

331

2.45

12.44

1.4

1.3

284.30

279.75

mosm/kgh2o

0.76

249

Primary_lymphoid and hematopoietic malignant neoplasms

147

772

1.92

12.37

1.3

1.4

277.91

278.34

mosm/kgh2o

0.07

116

577

Exposure to other specified factors

433

2800

1.45

12.32

1.5

1.6

280.53

280.92

mosm/kgh2o

0.12

310

2224

Polyarthropathies

424

1922

1.47

12.28

1.6

1.5

279.12

280.38

mosm/kgh2o

0.48

333

1501

Other disorders of kidney and ureter

100

458

2.21

12.28

1.9

1.3

289.14

277.79

mosm/kgh2o

3.75

348

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

112

537

2.10

12.22

1.2

1.4

273.90

277.16

mosm/kgh2o

0.75

406

Extracorporeal dialysis

201

2.88

12.20

1.3

1.4

282.92

281.40

mosm/kgh2o

0.16

146

Hydrocephalus in other diseases

9.49

12.17

3.1

1.2

284.53

277.08

mosm/kgh2o

0.42

Cervical disc disorders

219

1302

1.69

12.16

1.4

277.15

279.57

mosm/kgh2o

0.80

168

1046

Hypertensive Heart Disease

133

549

1.99

12.14

1.4

1.3

275.25

277.94

mosm/kgh2o

0.52

428

Hypoglycaemia, other or unspecified

224

2.76

12.09

1.6

1.5

287.21

281.31

mosm/kgh2o

0.79

165

Bacterial intestinal infections, IBD co-morbidities

130

661

1.98

12.08

1.4

281.74

278.85

mosm/kgh2o

0.57

499

Respiratory insufficiency

218

2.78

12.07

1.7

1.2

276.33

280.49

mosm/kgh2o

0.53

158

Injuries to the knee and lower leg

723

3083

1.35

12.06

1.4

1.5

280.06

280.11

mosm/kgh2o

0.02

561

2410

Subarachnoid haemorrhage

342

2.39

12.04

2.0

1.3

284.05

276.84

mosm/kgh2o

1.67

257

COPD, hospital admissions 1, only main diagnosis

223

1131

1.69

12.03

1.2

1.3

273.67

278.28

mosm/kgh2o

1.51

162

859

Diseases of the musculoskeletal system and connective tissue

362

1186

1.54

12.02

1.5

1.7

282.02

282.29

mosm/kgh2o

0.07

266

960

Ulcer of lower limb, not elsewhere classified

102

475

2.17

12.01

1.4

1.3

283.48

278.69

mosm/kgh2o

0.87

354

Temporomandibular joint disorders

449

2.20

11.99

1.9

1.5

282.55

278.97

mosm/kgh2o

0.97

354

Weight loss

339

2.39

11.82

2.3

1.5

277.41

278.35

mosm/kgh2o

0.11

250

Injuries to the shoulder and upper arm

498

2971

1.41

11.76

1.6

1.4

276.81

279.86

mosm/kgh2o

1.95

383

2303

Malignant neoplasm of eye, brain and central nervous system

147

3.19

11.71

1.3

1.4

282.72

280.36

mosm/kgh2o

0.27

108

Other disorders of ear

556

2675

1.39

11.63

1.4

279.06

279.36

mosm/kgh2o

0.11

435

2073

Other symptoms and signs involving the urinary system

317

2.42

11.62

1.5

1.3

286.46

280.58

mosm/kgh2o

1.18

238

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

130

553

1.97

11.60

1.3

1.4

269.89

276.56

mosm/kgh2o

2.34

101

412

Paroxysmal tachycardia

121

509

2.02

11.58

1.4

1.5

281.20

281.51

mosm/kgh2o

0.05

408

Alzheimer disease, excluding more controls

105

324

2.18

11.57

1.4

1.3

276.96

275.53

mosm/kgh2o

0.18

245

Assault

373

2.30

11.56

1.4

1.5

278.79

284.92

mosm/kgh2o

1.34

293

Undetermined asthma

354

2.33

11.56

1.2

1.3

280.09

281.36

mosm/kgh2o

0.22

274

Systemic connective tissue disorders

224

1359

1.66

11.56

1.4

277.17

278.08

mosm/kgh2o

0.25

173

1014

Visual impairment including blindness (binocular or monocular)

214

2.75

11.42

1.6

1.5

283.04

278.12

mosm/kgh2o

0.81

163

Parkinson's disease, excluding more controls

311

2.40

11.37

1.5

1.3

282.61

276.85

mosm/kgh2o

0.99

241

Other symptoms and signs involving the digestive system and abdomen

106

512

2.09

11.36

1.6

1.4

279.36

278.61

mosm/kgh2o

0.13

378

Other endocrine disorders

201

2.77

11.30

2.4

1.6

283.58

289.23

mosm/kgh2o

1.16

152

Other retinal disorders

379

2076

1.47

11.25

1.4

281.09

277.47

mosm/kgh2o

2.00

297

1585

Asthma, hospital admissions , main diagnosis only

492

3161

1.40

11.21

1.5

280.09

280.22

mosm/kgh2o

0.04

382

2455

Fentanyl

286

2.47

11.18

1.4

278.55

278.20

mosm/kgh2o

0.04

213

Peripheral artery disease

276

1419

1.57

11.16

1.2

1.3

281.72

276.81

mosm/kgh2o

2.31

197

1077

Viral infections characterized by skin and mucous membrane lesions

260

1652

1.58

11.08

1.4

1.5

279.56

280.71

mosm/kgh2o

0.34

219

1284

Acute upper respiratory infections of multiple and unspecified sites

436

2289

1.43

11.08

1.4

1.6

280.85

281.19

mosm/kgh2o

0.11

331

1777

Diffuse brain injury

3.98

11.04

1.5

1.3

280.79

279.38

mosm/kgh2o

0.08

Schizotypal disorder

4.45

11.03

1.5

284.50

285.98

mosm/kgh2o

0.10

Abnormal involuntary movements

447

2.15

10.94

1.8

1.5

279.77

279.16

mosm/kgh2o

0.07

343

Social phobias

202

2.75

10.91

1.8

2.0

283.93

285.54

mosm/kgh2o

0.18

166

Asthma, including avohilmo

712

3125

1.33

10.90

1.5

278.73

280.68

mosm/kgh2o

1.32

532

2452

Benign neoplasm: Adrenal gland

214

2.70

10.87

1.2

1.4

277.27

276.50

mosm/kgh2o

0.08

164

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

568

2715

1.37

10.74

1.5

1.4

279.94

278.99

mosm/kgh2o

0.40

440

2118

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

297

1917

1.52

10.73

1.5

1.4

280.30

280.40

mosm/kgh2o

0.03

229

1514

Glaucoma

335

1982

1.49

10.72

1.5

1.3

276.06

277.32

mosm/kgh2o

0.44

270

1485

Disorders of continuity of bone

293

2.41

10.66

1.7

1.5

280.49

281.18

mosm/kgh2o

0.09

236

Localized swelling, mass and lump of skin and subcutaneous tissue

194

1160

1.68

10.63

1.4

278.97

279.30

mosm/kgh2o

0.07

155

891

Diabetic nephropathy, excluding more controls

396

2.11

10.53

1.5

1.4

290.58

280.62

mosm/kgh2o

3.06

300

Erosion of teeth, including avohilmo

119

596

1.94

10.44

1.8

1.5

278.42

280.74

mosm/kgh2o

0.52

476

Later onset COPD

176

801

1.74

10.42

1.3

273.78

276.43

mosm/kgh2o

0.65

130

583

Vascular disorders of the intestines

185

2.79

10.39

1.1

1.4

276.17

276.50

mosm/kgh2o

0.03

137

Malignant neoplasm of respiratory system and intrathoracic organs

137

685

1.85

10.35

1.3

274.37

278.46

mosm/kgh2o

1.53

116

505

Speech and linguistic disorders, excluding more controls

184

2.74

10.33

1.9

2.0

287.24

289.48

mosm/kgh2o

0.24

137

Diseases of the ear and mastoid process

713

2740

1.32

10.28

1.5

281.22

280.39

mosm/kgh2o

0.41

559

2136

Collagenous colitis

307

2.34

10.09

1.4

277.06

277.87

mosm/kgh2o

0.10

233

Benign neoplasm of mouth and pharynx

390

2.18

10.06

1.5

1.4

284.11

278.19

mosm/kgh2o

1.59

306

Intestinal adhesions without obstruction

253

2.48

10.01

1.2

1.4

280.12

277.71

mosm/kgh2o

0.33

196

Abnormal weight loss

309

2.33

9.95

1.5

1.4

278.42

278.20

mosm/kgh2o

0.02

229

Misadventures to patients during surgical and medical care

458

2.07

9.93

1.3

1.4

282.51

278.50

mosm/kgh2o

0.78

352

Elevated blood glucose level

291

2.37

9.90

1.6

1.4

292.50

281.12

mosm/kgh2o

2.46

220

Other encephalitis

3.69

9.87

1.4

1.5

280.18

282.93

mosm/kgh2o

0.17

Fibrosis and cirrhosis of liver

243

2.50

9.86

1.3

1.4

276.70

277.22

mosm/kgh2o

0.05

179

Cirrhosis of liver, NAS

152

2.94

9.85

1.3

1.4

276.53

276.16

mosm/kgh2o

0.03

110

Other general symptoms and signs

140

3.01

9.77

1.4

1.6

283.09

284.78

mosm/kgh2o

0.20

109

Duodenal ulcer

324

2.27

9.75

1.3

274.40

279.34

mosm/kgh2o

0.78

247

Pulmonary heart disease, diseases of pulmonary circulation

199

1226

1.63

9.75

1.4

279.93

278.15

mosm/kgh2o

0.41

149

928

Glaucoma suspect

221

1397

1.59

9.74

1.4

275.75

277.54

mosm/kgh2o

0.57

183

1039

Hyperparathyroidism

123

654

1.87

9.73

1.6

1.3

282.15

274.84

mosm/kgh2o

2.28

473

Acute pancreatitis

125

677

1.86

9.70

1.5

1.4

285.66

278.63

mosm/kgh2o

1.58

526

Meningitis

159

2.87

9.67

1.6

1.5

285.92

281.36

mosm/kgh2o

0.70

119

L04AA Selective immunosuppressants

142

801

1.78

9.66

1.3

1.5

280.57

279.99

mosm/kgh2o

0.10

121

622

Enterocolitis due to Clostridium difficile

364

2.19

9.66

1.5

1.3

280.46

277.04

mosm/kgh2o

0.49

266

Other pleural conditions

332

2.25

9.65

1.4

268.47

277.73

mosm/kgh2o

2.47

244

Drug-induced osteoporosis with pathological fracture

4.59

9.64

1.3

1.4

270.06

275.79

mosm/kgh2o

0.51

Malignant neoplasm of brain

112

3.28

9.63

1.1

1.5

283.86

281.93

mosm/kgh2o

0.17

Personality and behavioural disorders due to brain disease, damage and dysfunction

5.14

9.62

1.7

1.1

284.80

282.17

mosm/kgh2o

0.18

245

1494

1.55

9.60

1.4

1.3

278.39

275.82

mosm/kgh2o

0.92

176

1110

Disturbance of activity and attention

291

2.33

9.57

1.8

2.1

290.64

290.33

mosm/kgh2o

0.06

226

Other disorders of eyelid

260

1652

1.53

9.56

1.4

1.3

276.80

277.18

mosm/kgh2o

0.10

206

1244

Other abnormal uterine and vaginal bleeding

146

584

1.79

9.54

1.6

1.5

275.46

276.72

mosm/kgh2o

0.25

112

464

Encephalitis

3.52

9.52

1.4

1.6

279.30

281.73

mosm/kgh2o

0.16

Stomatitis and related lesions

260

2.41

9.45

1.2

1.3

283.62

278.68

mosm/kgh2o

1.23

193

Hyperkinetic disorders

324

2.24

9.44

1.8

2.1

290.27

289.83

mosm/kgh2o

0.09

253

Other benign neoplasms of skin

197

1198

1.62

9.40

1.4

279.75

277.58

mosm/kgh2o

0.66

158

897

Skin changes due to chronic exposure to nonionizing radiation

232

1413

1.56

9.39

1.4

1.3

278.01

275.45

mosm/kgh2o

0.88

168

1043

Mental disorders, not otherwise specified

231

2.49

9.35

1.6

288.71

282.63

mosm/kgh2o

1.03

184

Migraine without aura

106

551

1.93

9.33

2.2

1.6

282.76

284.07

mosm/kgh2o

0.35

448

Hernia

552

2804

1.34

9.32

1.4

279.22

279.52

mosm/kgh2o

0.10

412

2187

Strabismus

168

1003

1.68

9.27

1.7

1.5

284.92

281.61

mosm/kgh2o

1.06

140

775

Deposits [accretions] on teeth

247

2.41

9.26

1.5

1.6

284.87

284.39

mosm/kgh2o

0.05

178

Paraplegia, diplegia of upper limbs

3.98

9.20

1.3

1.4

277.94

279.79

mosm/kgh2o

0.12

Diagnoses used for exclusion with ILD

159

940

1.70

9.17

1.4

279.44

279.10

mosm/kgh2o

0.05

121

709

Other systemic involvement of connective tissue

172

1040

1.66

9.12

1.4

276.65

277.68

mosm/kgh2o

0.26

131

785

Any dementia, excluding more controls

195

832

1.63

9.11

1.4

1.3

277.39

274.43

mosm/kgh2o

0.80

137

617

Mental and behavioural disorders due to use of other stimulants, including caffeine

3.82

9.09

2.6

1.6

294.74

286.09

mosm/kgh2o

0.87

Direct fill therapy

100

515

1.96

9.09

1.5

282.70

282.05

mosm/kgh2o

0.11

403

Atopic dermatitis

298

1732

1.47

9.08

1.6

280.83

282.26

mosm/kgh2o

0.45

213

1365

Ischemic heart diseases

462

2113

1.37

9.07

1.4

279.62

277.64

mosm/kgh2o

0.89

377

1628

Sleep apnoea

525

2660

1.34

9.03

1.5

1.4

283.05

278.29

mosm/kgh2o

4.70

404

2081

Malignant neoplasm of nasal cavity and middle ear

8.59

8.99

1.2

1.1

287.67

276.56

mosm/kgh2o

—

Postprocedural disorders of digestive system, not elsewhere classified

112

3.19

8.97

1.6

1.4

280.86

277.94

mosm/kgh2o

0.21

Coagulation defects, purpura and other haemorrhagic conditions

120

659

1.83

8.96

1.5

1.4

281.58

280.36

mosm/kgh2o

0.24

502

Atherosclerosis, excluding cerebral and coronary sclerosis

249

1312

1.52

8.85

1.2

1.3

279.98

276.43

mosm/kgh2o

1.47

178

992

Sleep apnoea, including avohilmo

554

2713

1.33

8.84

1.5

1.4

282.95

278.49

mosm/kgh2o

4.34

423

2123

Benign neoplasm: Tongue

3.84

8.83

1.4

284.53

274.14

mosm/kgh2o

1.47

Other diseases of anus and rectum

167

1012

1.66

8.76

1.5

1.4

275.78

279.69

mosm/kgh2o

1.19

115

784

Other diseases of jaws

197

2.57

8.73

1.5

1.4

284.05

277.73

mosm/kgh2o

1.03

144

Actinic keratosis

225

1390

1.54

8.73

1.4

1.3

277.83

275.33

mosm/kgh2o

0.82

162

1027

Deforming dorsopathies

165

999

1.66

8.72

1.3

1.5

275.18

280.50

mosm/kgh2o

2.38

133

804

Emotional disorders and disorders of social functioning with onset specific to childhood

144

2.84

8.68

2.4

2.6

289.86

293.52

mosm/kgh2o

0.83

120

Abnormal findings on diagnostic imaging of central nervous system

152

2.81

8.68

1.9

1.4

280.67

281.81

mosm/kgh2o

0.14

114

In situ neoplasms

210

1350

1.56

8.67

1.5

1.4

279.07

277.14

mosm/kgh2o

0.61

160

1011

Venous thromboembolism

309

2087

1.44

8.63

1.4

1.3

280.39

277.30

mosm/kgh2o

1.30

244

1580

Migraine with aura

125

703

1.79

8.62

1.6

281.45

281.34

mosm/kgh2o

0.02

561

Diseases of salivary glands

115

631

1.83

8.62

1.6

1.4

280.81

278.48

mosm/kgh2o

0.45

481

Ovarian dysfunction

158

2.74

8.60

3.0

1.5

287.56

284.62

mosm/kgh2o

0.39

128

Fracture of neck

187

2.60

8.60

1.5

1.4

271.71

278.66

mosm/kgh2o

0.87

141

Streptococcal septicaemia

253

2.36

8.60

1.2

1.4

281.40

279.12

mosm/kgh2o

0.21

184

Correction of physiology of bite - demanding therapy visit

217

2.47

8.55

2.0

1.5

283.21

280.87

mosm/kgh2o

0.45

172

Chronic rhinitis, nasopharyngitis and pharyngitis

181

1128

1.61

8.53

1.6

1.4

278.67

281.29

mosm/kgh2o

0.85

128

875

Malignant neoplasm of other and unspecified major salivary glands, excluding all cancers (controls excluding all cancers)

7.81

8.48

1.3

1.9

294.08

275.36

mosm/kgh2o

1.62

Other diseases of pancreas

249

2.36

8.45

1.3

273.62

276.93

mosm/kgh2o

0.53

188

Diabetic retinopathy, excluding more controls

160

532

1.70

8.41

1.3

1.5

285.40

280.24

mosm/kgh2o

1.56

129

404

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

269

1244

1.49

8.38

1.3

1.4

278.19

276.45

mosm/kgh2o

0.55

204

940

Disorders of skin appendages

262

1777

1.48

8.38

1.6

1.5

282.12

281.02

mosm/kgh2o

0.32

203

1392

Osteonecrosis

172

2.65

8.38

1.2

1.3

276.40

278.98

mosm/kgh2o

0.32

131

Pulmonary embolism

178

1112

1.61

8.32

1.4

281.56

278.23

mosm/kgh2o

0.94

134

844

Pulmonary heart disease

178

1115

1.60

8.23

1.4

281.56

278.10

mosm/kgh2o

1.00

134

848

Other diseases of liver

109

598

1.83

8.21

1.3

1.4

277.49

278.74

mosm/kgh2o

0.18

459

Acute pancreatitis (for exclusion)

125

715

1.76

8.18

1.5

1.3

285.66

279.55

mosm/kgh2o

1.28

557

Benign neoplasm: Brain, supratentorial

4.64

8.17

1.3

1.5

279.71

281.00

mosm/kgh2o

0.09

Conductive and sensorineural hearing loss

462

2385

1.34

8.16

1.4

277.83

278.30

mosm/kgh2o

0.16

360

1840

Fracture of forearm

315

2081

1.42

8.14

1.5

1.4

276.17

279.14

mosm/kgh2o

1.36

235

1609

Viral encephalitis, not elsewhere classified/unspecified

3.84

8.12

1.4

1.5

273.50

279.66

mosm/kgh2o

0.53

Statin medication

408

1666

1.38

8.06

1.4

1.5

282.88

279.18

mosm/kgh2o

2.17

319

1307

Secondary parkinsonism

3.33

7.98

2.0

1.3

298.40

275.84

mosm/kgh2o

3.16

Personal history of risk-factors, not elsewhere classified

5.30

7.98

1.6

1.2

293.18

287.33

mosm/kgh2o

0.30

Alzheimer’s disease (Late onset), excluding more controls

277

2.03

7.95

1.4

1.2

275.41

275.09

mosm/kgh2o

0.03

209

Focal brain injury

165

2.63

7.94

1.5

1.4

277.56

279.38

mosm/kgh2o

0.17

130

Disorders of psychological development

382

2.00

7.93

2.5

2.0

288.49

287.95

mosm/kgh2o

0.08

291

Secondary parkinsonism+Parkinsonism in other disease

3.29

7.84

2.0

1.3

298.40

275.81

mosm/kgh2o

3.16

Ulcer of oesophagus

202

2.45

7.83

1.4

1.3

279.34

277.45

mosm/kgh2o

0.24

146

Migraine without aura and triptan purchases

444

1.95

7.81

2.3

1.6

282.94

282.81

mosm/kgh2o

0.02

354

Inflammatory diseases of female pelvic organs

329

1768

1.41

7.78

1.6

1.5

280.07

278.12

mosm/kgh2o

0.81

255

1364

Benign neoplasm of colon, rectum, anus and anal canal

350

2287

1.39

7.77

1.4

278.78

277.33

mosm/kgh2o

0.50

258

1765

Other arthritis (FG)

173

1094

1.59

7.73

1.5

1.4

278.99

280.15

mosm/kgh2o

0.28

137

836

Other specific joint derangements/joint disorders

419

2080

1.35

7.72

1.5

1.6

281.95

281.18

mosm/kgh2o

0.31

319

1644

Emotional disorders starting during childhood or adolescence

149

2.69

7.72

2.4

2.3

289.29

292.53

mosm/kgh2o

0.74

121

Soft tissue disorders related to use, overuse and pressure

152

932

1.64

7.71

1.3

1.4

277.46

278.57

mosm/kgh2o

0.17

103

734

Lumbar disc prolapse

344

1972

1.39

7.67

1.4

1.5

276.13

280.13

mosm/kgh2o

2.68

255

1593

Squamous cell neoplasms and carcinomas of the skin

413

1.98

7.65

1.3

280.22

276.22

mosm/kgh2o

0.93

294

Total colectomy operation

140

2.76

7.64

2.2

1.4

280.85

281.76

mosm/kgh2o

0.05

107

Total colectomy

140

2.76

7.64

2.2

1.4

280.85

281.76

mosm/kgh2o

0.05

107

Alzheimer’s disease, wide definition, excluding more controls

297

1.98

7.61

1.4

1.3

274.29

275.30

mosm/kgh2o

0.12

225

Benign neoplasm: Adrenal gland

255

2.26

7.60

1.2

1.3

277.27

277.18

mosm/kgh2o

0.01

192

Ischaemic heart disease, wide definition

445

2085

1.34

7.55

1.4

279.68

277.67

mosm/kgh2o

0.90

361

1611

Irregular menses

239

1314

1.48

7.53

2.3

1.6

281.81

280.12

mosm/kgh2o

0.63

194

1020

Obesity and other hyperalimentation

324

2310

1.39

7.51

1.5

284.30

279.90

mosm/kgh2o

2.63

244

1816

Diabetic nephropathy

100

544

1.83

7.46

1.5

1.4

291.88

282.45

mosm/kgh2o

2.49

401

Intercostal neuropathy

6.15

7.45

1.2

1.6

279.86

272.69

mosm/kgh2o

—

All influenza (not pneumonia)

473

1.89

7.44

1.5

281.81

282.30

mosm/kgh2o

0.07

361

Abnormalities of gait and mobility

397

1.98

7.43

1.5

1.4

284.74

278.95

mosm/kgh2o

1.18

295

Obesity

322

2302

1.39

7.39

1.5

284.22

279.94

mosm/kgh2o

2.51

243

1811

Obesity due to excess calories

244

1677

1.46

7.39

1.5

285.31

280.38

mosm/kgh2o

2.48

186

1321

Volvulus

3.44

7.28

1.5

277.80

276.91

mosm/kgh2o

0.07

Peripheral arterial reconstruction

104

585

1.79

7.27

1.3

281.83

277.48

mosm/kgh2o

0.94

435

Unspecified protein-energy malnutrition

7.26

7.23

1.9

1.2

274.09

271.10

mosm/kgh2o

—

Polyarthrosis

125

710

1.70

7.23

1.3

274.28

276.03

mosm/kgh2o

0.35

529

Lesion of ulnar nerve

457

1.89

7.22

1.5

1.4

280.79

279.92

mosm/kgh2o

0.12

366

Fall on same level involving ice and snow

312

2251

1.39

7.21

1.4

278.17

279.04

mosm/kgh2o

0.29

241

1739

Postprocedural disorders of nervous system

198

2.39

7.18

1.4

1.5

288.18

282.83

mosm/kgh2o

1.30

153

Other and unspecified effects of external causes

156

981

1.60

7.17

1.6

1.5

278.75

281.61

mosm/kgh2o

0.76

115

760

Other and unspecified nerve root and plexus disorders, also in other diseases

110

634

1.74

7.08

1.4

276.76

279.82

mosm/kgh2o

0.77

508

Coxibs

183

622

1.57

7.05

1.4

1.5

279.79

283.92

mosm/kgh2o

1.62

135

493

Vitamin deficiency

152

2.60

7.04

1.6

1.3

277.69

277.80

mosm/kgh2o

0.01

110

Vitamin deficiency, wide

152

2.60

7.04

1.6

1.3

277.69

277.80

mosm/kgh2o

0.01

110

Brain meningioma, excluding all cancers (controls excluding all cancers)

152

2.60

7.04

1.9

1.5

283.88

274.32

mosm/kgh2o

1.78

117

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

420

1.90

7.02

1.2

1.3

272.70

276.83

mosm/kgh2o

0.81

309

Open wound of lower leg

512

1.83

7.00

1.9

1.5

282.87

280.03

mosm/kgh2o

0.48

400

Oral leukoplakia and related diseases, including avohilmo

317

2.07

7.00

1.4

1.3

282.46

277.52

mosm/kgh2o

0.84

244

Sensorineural hearing loss

431

2283

1.32

6.96

1.4

277.10

277.97

mosm/kgh2o

0.33

335

1761

Osteomyelitis

189

2.41

6.95

1.2

1.5

277.31

280.28

mosm/kgh2o

0.42

137

Other sleep disorders

311

2.07

6.94

1.6

1.4

289.34

279.26

mosm/kgh2o

2.99

241

Primary_lymphoid and hematopoietic malignant neoplasms

147

922

1.60

6.87

1.3

1.4

277.91

278.87

mosm/kgh2o

0.19

116

695

Familial hypercholesterolemia

402

1.93

6.83

1.3

279.59

284.12

mosm/kgh2o

0.86

291

Chronic laryngitis and laryngotracheitis

466

1.86

6.82

1.5

1.3

277.85

279.49

mosm/kgh2o

0.29

360

Diffuse large B-cell lymphoma, helper endpoint

126

2.74

6.79

1.4

271.37

276.33

mosm/kgh2o

0.62

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

126

2.74

6.79

1.4

271.37

276.33

mosm/kgh2o

0.62

Paralytic ileus

104

2.92

6.76

1.2

1.4

269.00

279.12

mosm/kgh2o

0.87

Hypertrophy of tongue papillae

4.58

6.76

3.6

1.4

286.38

283.09

mosm/kgh2o

0.21

Benign neoplasm: Brain, supratentorial

3.97

6.76

1.3

1.2

279.71

283.40

mosm/kgh2o

0.34

Acute posthaemorrhagic anaemia

2.97

6.72

2.6

1.3

273.64

276.27

mosm/kgh2o

0.26

Agoraphobia

3.42

6.71

1.7

283.44

283.69

mosm/kgh2o

0.01

Pain associated with micturition

378

1.95

6.66

1.5

282.69

277.76

mosm/kgh2o

1.34

287

Benign neoplasm of other and ill-defined parts of digestive system

550

1.77

6.64

1.3

1.5

278.71

277.35

mosm/kgh2o

0.22

415

Acute alcohol intoxication ICD-9

3.07

6.64

1.7

1.4

291.62

282.45

mosm/kgh2o

0.67

Non-allergic asthma (mode), excluding more controls

102

581

1.75

6.63

1.5

1.4

278.05

282.42

mosm/kgh2o

1.06

443

Carcinoma in situ of skin of other and unspecified parts of face

225

2.24

6.61

1.4

282.82

272.94

mosm/kgh2o

1.59

154

Gout

155

903

1.57

6.61

1.4

1.3

281.39

278.25

mosm/kgh2o

0.72

119

689

DVT of lower extremities and pulmonary embolism

233

1619

1.44

6.60

1.4

282.98

277.45

mosm/kgh2o

2.66

180

1229

Injuries to the ankle and foot

363

2475

1.34

6.60

1.6

282.89

281.60

mosm/kgh2o

0.54

271

1966

Decubitus ulcer and pressure area

170

2.44

6.53

1.3

281.74

277.31

mosm/kgh2o

0.53

118

Heterophoria

266

2.12

6.48

1.6

1.5

288.76

282.79

mosm/kgh2o

1.22

200

Migraine with aura and triptan purchases

439

1.85

6.44

1.7

1.6

282.91

282.18

mosm/kgh2o

0.15

347

Event of undetermined intent

196

2.32

6.43

1.6

1.5

276.37

283.48

mosm/kgh2o

1.20

151

Trochanteric bursitis

454

1.84

6.42

1.2

1.4

273.06

276.35

mosm/kgh2o

0.69

345

Other strabismus

132

820

1.61

6.37

1.8

1.6

286.81

282.01

mosm/kgh2o

1.57

111

633

Chronic ulcer of skin, not elsewhere classified

216

2.25

6.36

1.3

284.33

277.38

mosm/kgh2o

0.92

157

Transient ischemic attack

291

1752

1.38

6.36

1.3

275.91

276.74

mosm/kgh2o

0.26

223

1333

Other disorders of skin and subcutaneous tissue, not elsewhere classified

499

1.80

6.35

1.8

1.4

281.56

278.44

mosm/kgh2o

0.49

378

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

413

1.88

6.34

1.3

1.4

274.56

278.69

mosm/kgh2o

1.05

316

Other symptoms and signs involving the circulatory and respiratory systems

191

2.32

6.34

1.2

1.4

277.81

280.53

mosm/kgh2o

0.32

147

Malignant neoplasm of parotid gland, excluding all cancers (controls excluding all cancers)

5.62

6.33

1.3

1.1

291.42

275.62

mosm/kgh2o

1.55

Mixed disorders of conduct and emotions, excluding more controls

4.26

6.30

2.9

1.6

294.00

293.78

mosm/kgh2o

0.01

Noninflammatory disorders of female genital tract

245

857

1.44

6.29

1.8

1.6

277.88

280.25

mosm/kgh2o

0.87

193

690

Congenital malformations, deformations and chromosomal abnormalities

310

2190

1.36

6.28

1.5

1.6

282.18

281.82

mosm/kgh2o

0.10

249

1711

Other viral diseases

164

1077

1.52

6.22

1.7

1.6

282.92

283.08

mosm/kgh2o

0.03

142

847

Sequelae of injuries of neck and trunk

3.10

6.22

2.1

1.3

276.10

281.75

mosm/kgh2o

0.64

Budesonide

430

1.85

6.21

1.4

1.5

274.67

281.75

mosm/kgh2o

2.16

342

Pediculosis, acariasis and other infestations

193

2.30

6.21

1.2

1.4

285.68

284.42

mosm/kgh2o

0.15

150

Shoulder lesions

427

2006

1.31

6.18

1.4

278.20

278.11

mosm/kgh2o

0.02

326

1585

Excessive, frequent and irregular menstruation

219

836

1.46

6.16

1.7

1.6

278.64

279.81

mosm/kgh2o

0.32

171

670

Oral leukoplakia and related diseases

194

2.30

6.14

1.3

281.66

276.01

mosm/kgh2o

0.69

147

Epidural haemorrhage

5.94

6.14

1.5

2.1

259.00

283.73

mosm/kgh2o

—

Atopic dermatitis, strict definition with reimbursement

157

996

1.53

6.11

1.5

1.8

282.97

283.70

mosm/kgh2o

0.14

113

794

Pain and other conditions associated with female genital organs and menstrual cycle

547

1.72

6.11

1.6

1.7

280.15

282.67

mosm/kgh2o

0.59

439

Allergic asthma (mode), excluding more controls

108

634

1.68

6.11

1.5

1.7

281.74

284.45

mosm/kgh2o

0.66

496

Herpesviral [herpes simplex] infections

390

1.89

6.10

1.2

1.4

279.93

279.20

mosm/kgh2o

0.11

300

Dementia, including avohilmo

249

1219

1.41

6.10

1.4

1.3

275.72

275.25

mosm/kgh2o

0.11

168

902

Other joint disorders

516

2158

1.28

6.09

1.6

282.41

281.26

mosm/kgh2o

0.55

402

1699

Paracetamol of NSAID medication

118

352

1.69

6.09

1.6

2.2

281.06

287.98

mosm/kgh2o

2.56

292

Sleep disorders, other/unspecified

2.96

6.02

1.3

1.5

280.62

284.51

mosm/kgh2o

0.30

Abnormal findings on diagnostic imaging of other body structures

443

1.82

5.98

1.4

278.33

278.39

mosm/kgh2o

0.01

347

Alcohol-induced acute pancreatitis

106

2.78

5.98

1.2

277.43

284.58

mosm/kgh2o

0.82

Varicose veins

351

2001

1.33

5.95

1.4

277.04

277.54

mosm/kgh2o

0.15

274

1529

Arthrosis

417

1759

1.31

5.94

1.4

280.77

279.31

mosm/kgh2o

0.58

311

1371

Toxic effects of substances chiefly nonmedicinal as to source

387

1.87

5.92

1.3

1.4

287.78

281.59

mosm/kgh2o

1.17

292

Gout, FINNGEN

155

1021

1.52

5.90

1.4

1.3

281.39

278.68

mosm/kgh2o

0.60

119

774

Oesophagitis

160

2.40

5.89

1.2

1.3

278.78

279.00

mosm/kgh2o

0.02

120

Other diseases of oesophagus

297

2.00

5.88

1.6

1.3

281.12

278.30

mosm/kgh2o

0.23

219

Amputation

311

1.98

5.86

1.1

1.4

284.86

276.88

mosm/kgh2o

1.26

226

Artificial opening status

173

2.34

5.85

2.1

1.4

279.66

280.77

mosm/kgh2o

0.10

123

Diseases of peritoneum

361

1.90

5.82

1.2

1.4

277.98

278.25

mosm/kgh2o

0.03

272

Arthropathies

538

2172

1.26

5.82

1.6

281.17

281.36

mosm/kgh2o

0.07

428

1710

Insulin, fast-acting (human)

447

1.80

5.81

1.5

285.38

279.88

mosm/kgh2o

1.14

334

Dissocial personality disorder

3.68

5.80

1.2

1.3

279.77

285.57

mosm/kgh2o

0.25

Bacterial meningitis

108

2.72

5.78

1.4

281.82

282.42

mosm/kgh2o

0.05

Extreme obesity with alveolar hypoventilation

132

2.53

5.72

1.2

1.3

279.14

277.63

mosm/kgh2o

0.11

101

Diaphragmatic hernia

202

1413

1.43

5.70

1.4

277.32

277.16

mosm/kgh2o

0.03

141

1088

Non-allergic asthma (mode)

102

608

1.67

5.69

1.5

1.4

278.05

282.29

mosm/kgh2o

1.01

462

Suppurative and necrotic conditions of lower respiratory tract

169

2.33

5.69

1.4

271.42

280.13

mosm/kgh2o

1.37

124

Non-follicular lymphoma, hilmo, excluding all cancers

274

2.02

5.66

1.3

1.4

272.87

277.82

mosm/kgh2o

1.08

208

Disorders of refraction and accommodation

147

963

1.53

5.66

1.8

1.6

283.72

282.03

mosm/kgh2o

0.48

111

752

Cerebral aneurysm, nonruptured

295

1.98

5.64

1.5

1.4

272.11

276.44

mosm/kgh2o

0.60

229

Diseases of inner ear

290

2112

1.35

5.64

1.5

1.4

279.07

277.38

mosm/kgh2o

0.57

225

1618

Other peripheral vascular diseases

261

2.05

5.63

1.6

1.5

276.81

278.34

mosm/kgh2o

0.23

196

Barrett oesophagus

139

2.48

5.63

1.2

1.3

275.46

277.03

mosm/kgh2o

0.12

100

Other specified/unspecified arthritis

149

984

1.52

5.63

1.5

1.4

278.87

279.87

mosm/kgh2o

0.21

116

755

Purpura and other haemorrhagic conditions

474

1.76

5.62

1.6

1.4

278.29

278.96

mosm/kgh2o

0.10

355

Anankastic personality disorder

104

2.72

5.61

1.7

285.15

284.05

mosm/kgh2o

0.10

Fibromyalgia

242

2.08

5.56

1.5

1.4

285.69

279.43

mosm/kgh2o

1.96

194

Other diseases of intestine

381

1.85

5.56

1.4

277.81

278.78

mosm/kgh2o

0.12

304

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

283

2.00

5.56

1.4

277.05

276.78

mosm/kgh2o

0.03

209

Other disorders of white blood cells

190

2.24

5.55

1.5

1.3

272.36

279.37

mosm/kgh2o

1.33

138

Hypothalamic dysfunction, including iatrogenic, not elsewhere classified

17.81

5.55

3.6

1.2

302.00

279.60

mosm/kgh2o

—

Cholelithiasis, broad definition with cholecystitis

465

2516

1.27

5.54

1.4

280.20

278.33

mosm/kgh2o

0.95

361

1958

Lichen simplex chronicus and prurigo

197

2.20

5.51

1.4

1.3

272.39

279.44

mosm/kgh2o

1.18

156

Parodontitis or/and operation codes

376

1714

1.31

5.51

1.4

1.5

280.68

279.39

mosm/kgh2o

0.46

286

1380

Erosion of teeth

3.54

5.49

1.6

1.5

283.38

285.34

mosm/kgh2o

0.14

Chronic sinusitis

221

1581

1.40

5.49

1.4

277.22

280.06

mosm/kgh2o

1.31

175

1238

Scabies

141

2.44

5.47

1.1

1.5

286.46

285.42

mosm/kgh2o

0.10

112

Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)

4.03

5.47

1.7

1.5

284.93

273.33

mosm/kgh2o

0.92

Faecal incontinence

285

1.98

5.45

1.3

1.4

275.84

275.95

mosm/kgh2o

0.01

209

Benign neoplasm: Sigmoid colon

546

1.69

5.44

1.5

1.4

280.38

277.34

mosm/kgh2o

0.49

416

Mental retardation, excluding more controls

121

2.55

5.44

2.0

1.5

296.14

289.88

mosm/kgh2o

0.45

Benign neoplasm of brain and other parts of central nervous system

192

2.21

5.41

1.9

1.4

283.34

278.46

mosm/kgh2o

0.78

149

Excessive attrition of teeth

215

819

1.43

5.41

1.6

278.63

279.72

mosm/kgh2o

0.26

169

651

Temporomandibular joint disorders, including avohilmo

206

1459

1.41

5.40

1.8

1.6

282.35

280.98

mosm/kgh2o

0.42

164

1134

Malignant melanoma, excluding all cancers (controls excluding all cancers)

526

1.70

5.35

1.3

1.4

282.45

276.75

mosm/kgh2o

1.77

397

Ethmoidectomy

452

1.76

5.34

1.3

1.4

280.12

280.18

mosm/kgh2o

0.01

358

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

241

1203

1.39

5.33

1.3

1.4

277.22

276.13

mosm/kgh2o

0.28

178

905

Other arthrosis

292

1561

1.34

5.30

1.4

280.19

278.65

mosm/kgh2o

0.49

224

1214

Benign neoplasm: Tongue

2.75

5.30

1.4

284.53

277.14

mosm/kgh2o

0.96

Injury of eye and orbit

431

1.77

5.29

1.3

1.5

287.74

281.62

mosm/kgh2o

2.07

334

Allergic asthma (mode)

108

660

1.61

5.29

1.5

1.6

281.74

284.42

mosm/kgh2o

0.65

510

TMD related operations

559

1.67

5.26

2.1

1.4

283.46

280.84

mosm/kgh2o

0.72

442

Open wound of abdomen, lower back and pelvis

2.79

5.22

1.2

284.50

285.29

mosm/kgh2o

0.05

FESS (DNB20)

433

1.77

5.22

1.3

1.4

279.52

280.58

mosm/kgh2o

0.18

340

Pruritus

346

1.86

5.22

1.4

281.24

278.30

mosm/kgh2o

0.38

275

Assault by bodily force

235

2.06

5.21

1.3

1.6

281.40

285.54

mosm/kgh2o

0.50

187

Mental and behavioural disorders due to cannabinoids

2.91

5.21

3.1

1.7

284.00

286.31

mosm/kgh2o

0.19

D07AA Corticosteroids, weak (group I)

553

1.67

5.19

1.5

277.66

283.14

mosm/kgh2o

1.34

431

Fenamates

102

418

1.65

5.18

1.9

1.4

280.33

283.52

mosm/kgh2o

0.57

336

Cervicalgia

112

708

1.59

5.18

1.4

276.18

280.17

mosm/kgh2o

1.06

566

Fracture of foot, except ankle

128

835

1.54

5.16

1.5

281.00

280.55

mosm/kgh2o

0.08

653

Abnormal results of function studies

298

1.93

5.16

2.6

1.4

281.40

281.44

mosm/kgh2o

0.00

232

Endometriosis of rectovaginal septum and vagina

236

2.05

5.15

1.2

1.4

276.16

278.09

mosm/kgh2o

0.20

188

Cholelithiasis

446

2484

1.26

5.12

1.4

280.08

278.29

mosm/kgh2o

0.88

347

1933

Amputation of toe

210

2.11

5.12

1.1

1.3

281.38

276.88

mosm/kgh2o

0.51

149

Dementia

227

1132

1.39

5.11

1.4

1.3

277.17

275.30

mosm/kgh2o

0.51

155

839

Disorder of lipoprotein metabolism, unspecified

327

1.87

5.10

1.5

1.2

275.53

284.28

mosm/kgh2o

2.70

241

Parkinson's disease, strict definition, excluding more controls

286

1.93

5.09

1.4

1.3

279.45

277.20

mosm/kgh2o

0.27

220

Pain in thoracic spine

481

1.71

5.09

1.5

1.4

279.91

280.54

mosm/kgh2o

0.09

384

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

159

2.28

5.05

1.3

1.4

269.90

274.34

mosm/kgh2o

0.69

116

Intestinal malabsorption

153

2.31

5.04

1.5

274.96

279.18

mosm/kgh2o

0.52

114

Asthma and allergy, excluding more controls

346

1.83

5.01

1.6

1.8

284.95

285.79

mosm/kgh2o

0.13

275

Fissure and fistula of anal and rectal regions

126

825

1.53

5.01

1.4

279.07

280.64

mosm/kgh2o

0.27

651

Asthma and allergy

347

1.83

4.97

1.6

1.8

284.95

285.55

mosm/kgh2o

0.09

278

Other and unspecified injuries of head

206

2.11

4.96

1.3

1.4

276.50

279.85

mosm/kgh2o

0.31

150

Brain meningioma

180

2.19

4.95

1.9

1.3

283.88

276.29

mosm/kgh2o

1.33

132

Atopic dermatitis, strict definition

153

1024

1.47

4.95

1.6

1.9

283.50

283.97

mosm/kgh2o

0.09

110

819

Infective dermatitis

389

1.78

4.94

1.4

280.00

mosm/kgh2o

0.00

307

Other and unspecified visual disturbances

310

1.88

4.93

1.7

1.5

282.30

278.67

mosm/kgh2o

0.51

248

ILD, hospital admission 2, with pulmonary infections

254

1.98

4.92

1.3

268.76

277.96

mosm/kgh2o

2.46

185

Open wound of forearm

296

1.91

4.92

2.4

1.5

284.44

280.23

mosm/kgh2o

0.68

217

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

346

1.83

4.91

1.3

1.4

275.65

278.64

mosm/kgh2o

0.32

258

Malignant neoplasm of skin

335

1947

1.30

4.91

1.3

278.87

276.48

mosm/kgh2o

1.07

251

1476

Unspecified privation

368

1.81

4.90

1.3

1.4

278.85

279.54

mosm/kgh2o

0.05

285

Other symptoms and signs involving general sensations and perceptions

118

2.49

4.89

1.4

286.44

278.81

mosm/kgh2o

0.78

Other extrapyramidal and movement disorders in other diseases

126

831

1.52

4.86

1.5

1.4

284.64

277.80

mosm/kgh2o

2.40

638

Benign neoplasm of middle ear and respiratory system

235

2.02

4.85

1.3

284.90

278.67

mosm/kgh2o

0.91

177

Other female pelvic inflammatory diseases

565

1.64

4.83

1.5

1.4

276.51

276.64

mosm/kgh2o

0.02

440

Malignant neoplasm of bronchus and lung

100

586

1.60

4.80

1.3

268.64

278.30

mosm/kgh2o

5.03

427

Benign neoplasm: Colon, unspecified

116

750

1.55

4.79

1.5

1.4

277.73

277.17

mosm/kgh2o

0.08

565

Dementia in other diseases classified elsewhere

144

2.32

4.79

1.4

1.3

283.35

275.80

mosm/kgh2o

1.18

103

Seborrhoeic dermatitis

306

1.88

4.78

1.2

1.4

281.11

280.68

mosm/kgh2o

0.05

235

Other abnormal findings in urine

3.34

4.78

2.1

1.1

268.17

274.49

mosm/kgh2o

0.39

Benign neoplasm: Stomach

292

1.90

4.78

1.3

1.4

278.17

276.82

mosm/kgh2o

0.13

216

Dronedarone medication

2.71

4.77

1.3

1.5

272.00

276.60

mosm/kgh2o

0.40

Papulosquamous disorders

208

1513

1.38

4.76

1.5

1.4

278.98

279.01

mosm/kgh2o

0.01

150

1175

Glomerulonephritis

357

1.81

4.76

1.4

275.69

281.14

mosm/kgh2o

1.38

263

Oter anti-inflammatory and antirheumatic agents, non-steroids

139

511

1.51

4.75

1.3

1.4

275.28

282.78

mosm/kgh2o

2.65

399

Thyrotoxicosis, other and/or unspecified

104

661

1.58

4.74

1.6

1.4

282.31

276.75

mosm/kgh2o

1.20

495

Disorders of sclera, cornea, iris and ciliary body

279

2123

1.32

4.74

1.4

1.5

282.20

279.33

mosm/kgh2o

1.29

226

1636

Gout, strict definition

607

1.61

4.73

1.3

282.19

278.94

mosm/kgh2o

0.51

458

Diabetic retinopathy, strict definition

103

572

1.59

4.72

1.4

1.5

289.02

283.07

mosm/kgh2o

1.60

440

Haemorrhoids and perianal venous thrombosis

148

1015

1.46

4.71

1.2

1.3

275.74

278.89

mosm/kgh2o

0.83

109

783

Zoster [herpes zoster]

101

639

1.59

4.70

1.3

1.4

274.66

277.52

mosm/kgh2o

0.56

477

Diseases of male genital organs

281

1067

1.33

4.70

1.5

1.4

283.09

282.90

mosm/kgh2o

0.04

220

866

Disorders of vestibular function (Vertigo)

246

1832

1.34

4.64

1.5

1.4

279.48

277.19

mosm/kgh2o

0.79

187

1393

Other and unspecified local infections of skin and subcutaneous tissue

317

1.84

4.62

1.2

1.5

278.30

280.42

mosm/kgh2o

0.31

233

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

212

1207

1.37

4.60

1.2

1.4

275.18

277.01

mosm/kgh2o

0.53

167

902

Viral hepatitis

233

1.99

4.59

2.0

1.6

285.94

283.09

mosm/kgh2o

0.34

184

Coronary atherosclerosis

371

1884

1.27

4.57

1.4

1.3

279.76

277.35

mosm/kgh2o

1.07

301

1440

Other noninflammatory disorders of vagina

213

2.03

4.56

1.3

1.4

282.89

277.26

mosm/kgh2o

0.69

169

Other viral hepatitis

193

2.09

4.56

2.2

1.5

286.66

284.48

mosm/kgh2o

0.21

151

Viral and other specified intestinal infections

109

690

1.55

4.56

1.7

1.9

288.79

283.07

mosm/kgh2o

2.26

532

Cardiomyopathy

575

1.61

4.52

1.4

275.39

282.05

mosm/kgh2o

1.69

449

Heartburn

284

1.88

4.49

1.6

1.4

279.41

278.39

mosm/kgh2o

0.14

224

Hemiplegia

181

2.12

4.48

1.6

1.3

281.81

278.99

mosm/kgh2o

0.34

133

Acute peritonitis

208

2.04

4.48

1.2

1.4

282.43

278.64

mosm/kgh2o

0.43

151

Benign neoplasm: Colon

279

2098

1.31

4.46

1.4

1.3

278.67

277.12

mosm/kgh2o

0.45

201

1616

L04AX Other immunosuppressants

288

2222

1.30

4.44

1.4

1.5

278.52

280.29

mosm/kgh2o

0.61

226

1725

Small fibre neuropathy

2.72

4.44

1.3

280.43

280.24

mosm/kgh2o

0.01

Voice disturbances

140

963

1.46

4.43

1.4

280.48

278.14

mosm/kgh2o

0.60

100

749

Disorders of muscles

307

1.83

4.43

1.7

1.4

281.79

279.93

mosm/kgh2o

0.27

245

Diffuse large B-cell lymphoma

156

2.21

4.42

1.4

1.3

271.37

277.85

mosm/kgh2o

0.96

113

Inflammatory diseases of prostate (prostatitis)

388

1.74

4.41

1.3

283.40

283.47

mosm/kgh2o

0.01

318

Carcinoma in situ of skin of other and unspecified parts of face

265

1.90

4.40

1.4

1.3

282.82

273.45

mosm/kgh2o

1.53

179

Acute gastritis

223

1.99

4.40

1.4

1.3

278.23

277.41

mosm/kgh2o

0.09

165

Coxarthrosis [arthrosis of hip](FG)

290

1613

1.30

4.40

1.4

275.61

277.84

mosm/kgh2o

0.85

225

1241

Superficial injury of lower leg

129

875

1.48

4.39

1.4

1.5

280.94

280.01

mosm/kgh2o

0.16

679

Any dementia

205

1056

1.37

4.38

1.4

1.3

277.67

274.74

mosm/kgh2o

0.82

142

770

Reimbursement for rheumatic diseases

304

2363

1.29

4.36

1.4

276.39

279.48

mosm/kgh2o

1.48

246

1811

Urethral stricture

144

2.24

4.34

1.3

1.4

280.36

282.13

mosm/kgh2o

0.13

112

Hernia of abdominal wall

232

1744

1.33

4.34

1.5

1.4

278.92

279.46

mosm/kgh2o

0.12

174

1361

Other hearing loss

149

1024

1.44

4.32

1.4

1.3

277.05

277.04

mosm/kgh2o

0.00

115

766

Acetic acid derivatives and related substances

170

622

1.43

4.32

1.4

1.5

281.04

284.02

mosm/kgh2o

0.72

124

492

Flat foot [pes planus] (acquired)

339

1.78

4.32

1.4

281.21

278.26

mosm/kgh2o

0.45

261

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

237

1221

1.34

4.32

1.3

1.4

277.05

276.22

mosm/kgh2o

0.20

173

922

Unspecified acute lower respiratory infection

505

1.63

4.30

1.2

1.5

278.88

280.81

mosm/kgh2o

0.33

389

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

303

1.83

4.30

1.3

1.4

276.70

278.24

mosm/kgh2o

0.13

230

Peripheral artery operations in Hilmo

406

1.71

4.29

1.1

1.3

285.16

277.75

mosm/kgh2o

1.23

300

Spondylopathies (FG)

437

1.68

4.27

1.4

278.46

281.83

mosm/kgh2o

0.62

344

Mild mental retardation

2.59

4.24

1.3

1.4

295.25

288.33

mosm/kgh2o

0.36

Diseases of tongue

199

2.03

4.23

1.8

1.3

277.59

274.97

mosm/kgh2o

0.34

150

Other noninflammatory disorders of uterus, except cervix

125

573

1.49

4.23

1.3

1.4

277.08

275.51

mosm/kgh2o

0.33

452

Oesophageal varices

127

2.31

4.21

1.2

1.3

286.25

281.11

mosm/kgh2o

0.36

Major coronary heart disease event

389

2079

1.25

4.21

1.4

1.3

278.81

277.27

mosm/kgh2o

0.56

311

1592

Meniscus derangement

309

1650

1.28

4.18

1.7

1.4

280.00

278.86

mosm/kgh2o

0.37

237

1288

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

242

1.91

4.16

1.5

1.4

275.88

276.70

mosm/kgh2o

0.06

178

Unspecified misadventure during surgical and medical care

187

2.05

4.15

1.3

1.4

278.52

279.96

mosm/kgh2o

0.15

139

Colectomy operation

605

1.56

4.12

1.6

1.3

276.02

278.39

mosm/kgh2o

0.35

460

Other local infections of skin and subcutaneous tissue

344

1.76

4.12

1.2

1.5

277.54

280.19

mosm/kgh2o

0.40

255

Encephalopathy

4.45

4.11

1.7

1.0

284.60

284.13

mosm/kgh2o

—

Acute lymphadenitis

195

2.02

4.08

2.1

1.6

284.25

283.52

mosm/kgh2o

0.07

145

5-aminosalicylic acid

106

703

1.51

4.06

1.4

1.5

279.07

282.48

mosm/kgh2o

0.74

552

Superficial injury of abdomen, lower back and pelvis

506

1.61

4.04

1.4

1.5

277.20

280.72

mosm/kgh2o

0.70

392

Entropion and trichiasis of eyelid

266

1.85

4.03

1.3

277.47

276.10

mosm/kgh2o

0.13

187

Adverse effects, not elsewhere classified

105

697

1.51

4.01

1.6

1.5

280.24

281.14

mosm/kgh2o

0.13

540

Other benign neoplasms of skin

197

1465

1.35

4.00

1.4

279.75

278.50

mosm/kgh2o

0.33

158

1119

Heart failure and coronary heart disease

180

978

1.38

3.99

1.3

279.93

276.71

mosm/kgh2o

0.85

136

717

Complications of internal orthopaedic prosthetic devices, implants and grafts

124

853

1.46

3.98

1.6

1.4

274.38

276.51

mosm/kgh2o

0.46

661

Other malignant neoplasms of skin (=non-melanoma skin cancer)

288

1777

1.28

3.96

1.3

277.93

276.39

mosm/kgh2o

0.50

210

1344

Superficial injury of thorax

509

1.60

3.95

1.4

277.90

280.13

mosm/kgh2o

0.47

391

Chronic viral hepatitis

157

2.12

3.94

2.3

1.5

285.61

284.91

mosm/kgh2o

0.06

122

Diabetic retinopathy

186

859

1.37

3.93

1.3

1.4

285.44

281.38

mosm/kgh2o

1.24

147

653

Speech and linguistic disorders

313

1.76

3.93

1.9

2.0

287.39

288.35

mosm/kgh2o

0.11

238

Convalescence

171

2.06

3.91

2.2

1.4

282.07

279.78

mosm/kgh2o

0.26

130

Preparatory care for dialysis

138

2.20

3.91

1.3

1.4

288.50

279.27

mosm/kgh2o

1.14

100

Iridocyclitis

118

808

1.47

3.88

1.3

1.4

281.19

279.35

mosm/kgh2o

0.44

623

Secondary uncertain malignant neoplasm

442

1.64

3.87

1.2

1.4

279.20

277.52

mosm/kgh2o

0.29

330

Residual foreign body in soft tissue

145

2.16

3.87

1.6

1.3

275.10

282.40

mosm/kgh2o

0.94

116

Gonarthrosis [arthrosis of knee](FG)

401

1913

1.24

3.86

1.4

281.70

278.64

mosm/kgh2o

1.64

291

1481

Oxicams

141

559

1.44

3.86

1.4

280.24

283.55

mosm/kgh2o

0.88

103

438

Non-small cell lung cancer

536

1.57

3.85

1.3

272.70

278.45

mosm/kgh2o

1.37

400

Vascular diseases of the intestine

107

2.36

3.84

1.1

1.4

276.55

274.00

mosm/kgh2o

0.18

Second line medication for Crohn's disease

289

2279

1.27

3.82

1.4

1.5

278.41

280.33

mosm/kgh2o

0.69

227

1774

Cluster headache, strict

2.44

3.81

1.5

283.44

281.72

mosm/kgh2o

0.11

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

212

1040

1.33

3.81

1.3

1.5

274.55

276.25

mosm/kgh2o

0.47

158

787

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

212

1040

1.33

3.81

1.3

1.5

274.55

276.25

mosm/kgh2o

0.47

158

787

Neuralgia and neuritis, unspecified

146

2.14

3.81

1.3

1.2

272.75

278.46

mosm/kgh2o

0.61

110

Unspecified jaundice

133

2.20

3.80

1.2

1.5

274.68

278.16

mosm/kgh2o

0.18

Injuries to the wrist and hand

523

3170

1.20

3.79

1.6

1.5

282.08

280.11

mosm/kgh2o

1.05

383

2517

Persons with potential health hazards related to communicable diseases

182

1338

1.35

3.79

1.6

1.7

285.89

283.27

mosm/kgh2o

0.99

147

1057

ILD, hospital admissions

508

1.58

3.76

1.4

1.3

272.13

277.80

mosm/kgh2o

1.32

379

Other neurotic disorders

167

2.05

3.76

1.8

1.3

281.43

278.21

mosm/kgh2o

0.37

118

Dermatophytosis

469

1.61

3.76

1.5

1.4

281.73

280.32

mosm/kgh2o

0.19

361

Degeneration of macula and posterior pole

245

1560

1.30

3.75

1.4

1.3

276.92

275.98

mosm/kgh2o

0.24

185

1169

Mixed disorders of conduct and emotions

2.94

3.75

2.9

1.8

294.00

288.44

mosm/kgh2o

0.36

Crohn disease

446

1.62

3.75

1.3

1.5

275.53

281.24

mosm/kgh2o

1.43

343

Dislocation, sprain and strain of joints and ligaments at neck level

470

1.60

3.72

1.5

282.77

282.84

mosm/kgh2o

0.01

372

Other disorders of the musculoskeletal system and connective tissue

518

1.57

3.70

1.2

1.4

278.46

278.41

mosm/kgh2o

0.01

391

Polycystic ovarian syndrome

109

2.31

3.69

2.4

1.4

292.55

285.90

mosm/kgh2o

1.62

Vascular dementia

251

1.82

3.67

1.5

1.3

282.54

273.67

mosm/kgh2o

0.92

169

Recurring oral aphthae

169

2.03

3.65

1.2

1.5

285.31

280.57

mosm/kgh2o

0.76

124

Angina pectoris

327

1767

1.25

3.65

1.4

1.3

279.05

277.12

mosm/kgh2o

0.66

254

1347

Spondylolisthesis/Spondylolysis

632

1.51

3.63

1.3

1.4

277.16

279.85

mosm/kgh2o

0.53

508

Coxarthrosis

271

1441

1.28

3.60

1.4

275.79

278.17

mosm/kgh2o

0.88

211

1114

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

116

773

1.45

3.58

1.4

275.73

274.04

mosm/kgh2o

0.34

579

Amblyopia ex anopsia

150

2.09

3.58

1.6

284.38

285.34

mosm/kgh2o

0.11

115

Asthma and opportunity respiratory infection

150

2.09

3.58

1.5

1.2

268.06

275.35

mosm/kgh2o

0.82

110

Cramp and spasm

150

2.09

3.58

1.5

1.6

282.05

282.54

mosm/kgh2o

0.03

113

Salpingitis and oophoritis

602

1.52

3.58

1.4

279.86

275.58

mosm/kgh2o

0.91

465

Ventral hernia

127

897

1.42

3.58

1.6

1.4

277.30

278.52

mosm/kgh2o

0.19

692

Other and unspecified tonsillitis

159

986

1.37

3.57

1.6

1.8

285.81

284.80

mosm/kgh2o

0.25

139

793

Benign neoplasm of other and ill-defined parts of digestive system

651

1.50

3.57

1.3

1.4

278.71

277.27

mosm/kgh2o

0.25

499

Other interstitial pulmonary diseases

515

1.56

3.56

1.4

1.3

272.13

277.63

mosm/kgh2o

1.26

385

Bell's palsy

398

1.64

3.56

1.4

276.04

279.34

mosm/kgh2o

0.59

318

Other viral diseases, not elsewhere classified

100

674

1.49

3.55

1.9

1.6

284.31

282.47

mosm/kgh2o

0.39

523

Disorders of speech understanding and production

161

2.03

3.54

1.8

1.4

284.48

287.10

mosm/kgh2o

0.26

113

Degenerative diseases of the nervous system

172

958

1.36

3.53

1.4

1.3

274.19

275.21

mosm/kgh2o

0.19

124

692

Interstitial lung disease

517

1.55

3.51

1.4

1.3

272.13

277.61

mosm/kgh2o

1.25

387

Interstitial lung disease endpoints

517

1.55

3.51

1.4

1.3

272.13

277.61

mosm/kgh2o

1.25

387

Thyrotoxicosis

131

934

1.41

3.51

1.5

1.4

281.52

277.36

mosm/kgh2o

1.03

705

Other and unspecified aplastic anaemias

3.62

3.50

1.5

1.6

273.91

286.64

mosm/kgh2o

0.80

ILD, hospital admissions 3, with pneumonia sepsis

228

1.85

3.50

1.4

266.69

277.27

mosm/kgh2o

2.74

168

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

324

1.71

3.49

1.2

1.4

282.07

279.42

mosm/kgh2o

0.44

242

Presbycusis

460

1.59

3.49

1.5

1.3

273.31

274.79

mosm/kgh2o

0.21

312

Inflammatory disease of uterus

416

1.62

3.48

1.7

1.5

285.76

278.76

mosm/kgh2o

1.88

328

Pyothorax

132

2.14

3.46

1.1

1.3

267.45

280.44

mosm/kgh2o

1.99

Complications of other internal prosthetic devices, implants and grafts

119

2.21

3.46

1.8

1.3

287.90

276.65

mosm/kgh2o

1.32

Personal history of other diseases and conditions

362

1.66

3.43

2.1

1.6

290.47

285.46

mosm/kgh2o

1.06

277

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

126

2.16

3.43

1.2

1.4

276.84

276.48

mosm/kgh2o

0.02

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

126

2.16

3.42

1.7

1.4

270.42

273.87

mosm/kgh2o

0.29

Other or ill-defined heart diseases

146

2.07

3.41

1.2

1.5

291.70

283.97

mosm/kgh2o

0.46

111

Other disorders of nervous system

209

1.88

3.40

1.2

1.3

283.55

276.96

mosm/kgh2o

0.87

157

Outcome of delivery

330

0.49

3.38

1.6

1.8

287.21

284.74

mosm/kgh2o

0.59

265

Malignant neoplasm of eye and adnexa

3.80

3.38

2.0

1.1

279.40

276.74

mosm/kgh2o

—

Artificial joint operation, meniscal resection

480

2681

1.19

3.36

1.5

1.4

278.37

278.31

mosm/kgh2o

0.02

369

2072

Coeliac disease

436

1.59

3.35

1.7

1.5

279.83

279.82

mosm/kgh2o

0.00

340

Gout, unspecified

101

693

1.46

3.35

1.4

1.3

281.05

279.28

mosm/kgh2o

0.24

524

Sequelae of other external causes

175

1.96

3.34

1.4

1.3

273.26

280.39

mosm/kgh2o

0.98

134

Psoriasis

143

1045

1.37

3.33

1.4

278.13

279.59

mosm/kgh2o

0.26

104

818

Cervicobrachial syndrome

106

735

1.45

3.33

1.6

1.4

282.20

280.43

mosm/kgh2o

0.30

593

Non-follicular lymphoma

329

1.68

3.32

1.3

272.87

276.37

mosm/kgh2o

0.68

244

Benign neoplasm: Parotid gland

225

1.83

3.32

1.2

1.4

284.42

277.53

mosm/kgh2o

1.92

171

Benign neoplasm of major salivary glands

284

1.73

3.31

1.2

1.4

283.95

276.64

mosm/kgh2o

2.29

212

Menorrhagia

180

744

1.34

3.31

1.5

1.6

277.27

278.50

mosm/kgh2o

0.30

139

596

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

262

1.77

3.31

1.3

1.4

284.58

278.32

mosm/kgh2o

0.72

195

Obesity, other/unspecified

154

1140

1.35

3.30

1.5

283.50

279.83

mosm/kgh2o

1.09

107

897

Pilonidal cyst

240

1.80

3.30

1.1

1.7

282.17

285.35

mosm/kgh2o

0.41

196

Inflammatory bowel disease

157

1167

1.35

3.28

1.3

1.5

277.91

280.52

mosm/kgh2o

0.67

128

900

Other surgical follow-up care

2.31

3.27

2.5

1.7

286.25

279.96

mosm/kgh2o

0.33

TMD related pain

2.31

3.27

2.2

1.7

284.82

280.47

mosm/kgh2o

0.62

Disorders of puberty, all

2.82

3.27

4.2

1.8

292.87

295.89

mosm/kgh2o

0.26

Other bursitis of hip

2.81

3.27

1.1

279.56

273.44

mosm/kgh2o

—

Myocardial infarction, without ST-elevation

201

1428

1.30

3.25

1.4

1.3

278.25

276.70

mosm/kgh2o

0.38

151

1078

Thyroiditis, ILD-related definition

385

1.62

3.25

1.8

1.5

281.02

279.44

mosm/kgh2o

0.23

305

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

227

1.82

3.24

1.4

277.33

275.37

mosm/kgh2o

0.24

167

Disorders of conjunctiva

420

2938

1.20

3.22

1.6

1.5

281.16

280.23

mosm/kgh2o

0.37

313

2300

Spondyloarthritis

609

1.48

3.21

1.4

277.91

279.91

mosm/kgh2o

0.38

474

Benign neoplasm of middle ear and respiratory system

272

1.74

3.21

1.3

284.90

279.07

mosm/kgh2o

0.86

199

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

2.30

3.21

1.9

1.5

280.24

286.56

mosm/kgh2o

0.84

L01XX Other antineoplastic agents

192

1.89

3.20

1.1

1.3

270.00

275.91

mosm/kgh2o

0.99

136

Superficial injury of forearm

310

1.69

3.19

2.1

1.5

277.62

281.46

mosm/kgh2o

0.56

234

Benign neoplasm of brain and other parts of central nervous system

236

1.79

3.18

1.9

1.4

283.34

279.62

mosm/kgh2o

0.56

176

Blepharochalasis

152

1131

1.35

3.17

1.4

1.3

276.11

276.32

mosm/kgh2o

0.04

121

852

Recurring oral aphthae, including avohilmo

506

1.53

3.17

1.3

1.5

283.21

278.93

mosm/kgh2o

0.84

382

Cluster headache, wide

104

2.23

3.16

1.5

1.4

283.44

281.26

mosm/kgh2o

0.15

Other and unspecified rosacea

281

1.72

3.15

1.5

1.4

281.24

280.02

mosm/kgh2o

0.14

217

Cardiomyopathy, other and unspecified

244

1.77

3.14

1.5

1.4

275.92

281.55

mosm/kgh2o

0.80

190

Gout, idiopatic and unspecified

120

861

1.40

3.14

1.4

1.3

281.91

279.01

mosm/kgh2o

0.51

650

Malignant neoplasm of adrenal gland, excluding all cancers (controls excluding all cancers)

4.62

3.14

1.7

1.9

265.44

284.25

mosm/kgh2o

—

Hidradenitis suppurativa

2.26

3.13

1.7

1.6

278.00

284.15

mosm/kgh2o

0.67

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

111

2.18

3.13

1.4

272.81

276.90

mosm/kgh2o

0.40

Other enthesopathies

140

1031

1.36

3.13

1.4

282.77

278.63

mosm/kgh2o

1.54

116

817

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

452

1.56

3.12

1.3

1.4

282.86

277.81

mosm/kgh2o

1.38

341

Nummular dermatitis

267

1.73

3.12

1.2

1.4

280.36

279.47

mosm/kgh2o

0.09

208

Pyogenic arthritis

201

1.85

3.11

1.4

276.97

280.22

mosm/kgh2o

0.22

149

Major coronary heart disease event excluding revascularizations

349

1980

1.22

3.11

1.4

1.3

278.21

277.11

mosm/kgh2o

0.36

280

1509

Anterior Iridocyclitis

104

729

1.43

3.11

1.3

1.4

281.07

279.54

mosm/kgh2o

0.32

568

Opening and dilatation of root channel of tooth

194

1.87

3.11

1.3

1.5

284.62

282.63

mosm/kgh2o

0.20

154

Open wound of wrist and hand

209

1614

1.28

3.11

1.6

1.5

281.88

281.62

mosm/kgh2o

0.06

152

1301

Vasomotor and allergic rhinitis

184

1391

1.31

3.10

1.8

1.6

281.26

282.67

mosm/kgh2o

0.40

141

1091

Glucosamine medication

266

1700

1.25

3.10

1.3

276.16

276.44

mosm/kgh2o

0.06

191

1284

Ankylosing spondylitis

275

1.72

3.10

1.4

1.5

277.44

283.87

mosm/kgh2o

0.95

225

Myeloproliferative diseases

298

1.69

3.09

1.3

271.95

277.35

mosm/kgh2o

0.93

223

Radiculopathy

566

1.49

3.08

1.3

1.4

279.42

279.54

mosm/kgh2o

0.02

448

Redundant prepuce, phimosis and paraphimosis

612

1.47

3.08

1.4

283.03

283.86

mosm/kgh2o

0.10

500

Rotator cuff syndrome

307

1855

1.23

3.06

1.4

277.85

277.61

mosm/kgh2o

0.06

236

1473

Hydronephrosis

360

1.62

3.06

1.3

1.4

279.52

278.04

mosm/kgh2o

0.19

271

2.53

3.05

1.2

1.3

265.40

273.79

mosm/kgh2o

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

170

1292

1.32

3.04

1.7

285.74

282.05

mosm/kgh2o

1.84

122

1038

Use of pramipexole

117

842

1.39

3.03

1.4

277.71

277.20

mosm/kgh2o

0.08

637

Nonalcoholic fatty liver disease

315

1.66

3.03

1.3

1.4

276.77

279.95

mosm/kgh2o

0.38

242

Other disorders of penis

308

1.66

3.00

1.4

287.38

285.00

mosm/kgh2o

0.17

249

147

971

1.34

3.00

1.3

276.90

274.89

mosm/kgh2o

0.50

110

689

Benign neoplasm: Skin of eyelid, including canthus

481

1.52

2.99

1.6

1.5

277.33

276.80

mosm/kgh2o

0.06

365

Abrasion of teeth

131

703

1.37

2.98

1.6

1.5

280.06

278.39

mosm/kgh2o

0.37

108

565

Other respiratory diseases principally affecting the interstitium

636

1.45

2.98

1.3

271.60

278.60

mosm/kgh2o

2.08

473

Rosacea

371

1.60

2.97

1.4

280.51

279.32

mosm/kgh2o

0.15

288

Conjunctivitis

378

2753

1.20

2.94

1.6

1.5

281.04

280.29

mosm/kgh2o

0.27

280

2161

Other diseases of arteries and capillaries

287

1.68

2.94

1.4

283.58

277.74

mosm/kgh2o

0.98

213

Endometriosis

170

767

1.32

2.92

1.3

1.5

279.14

278.62

mosm/kgh2o

0.11

125

616

Acute and subacute iridocyclitis

672

1.43

2.92

1.3

1.4

280.80

279.38

mosm/kgh2o

0.27

521

Malignant neoplasm of parotid gland

4.19

2.91

1.3

1.1

294.89

277.38

mosm/kgh2o

—

Colonic or urogenital fistula

137

1019

1.35

2.90

1.4

278.68

279.44

mosm/kgh2o

0.12

793

Maltreatment syndromes

142

1.98

2.90

1.4

1.7

281.48

285.75

mosm/kgh2o

0.44

106

Non-small cell lung cancer, adenocarcinoma, helper endpoint

199

1.82

2.90

1.3

269.90

275.92

mosm/kgh2o

1.16

143

Non-small cell lung cancer, adenocarcinoma

199

1.82

2.90

1.3

269.90

275.92

mosm/kgh2o

1.16

143

Superficial injury of hip and thigh

509

1.50

2.89

1.5

1.4

276.08

278.58

mosm/kgh2o

0.44

377

Female infertility, associated with anovulation

149

1.95

2.89

3.2

1.8

285.42

287.71

mosm/kgh2o

0.31

120

Hyperplasia of prostate

178

776

1.31

2.88

1.4

1.3

280.94

281.03

mosm/kgh2o

0.02

140

639

109

740

1.40

2.87

1.4

1.3

278.14

274.53

mosm/kgh2o

0.90

520

Abnormal blood-pressure reading, without diagnosis

136

2.00

2.86

1.3

1.5

274.90

279.44

mosm/kgh2o

0.50

106

Sicca syndrome [Sjögren]

305

1.65

2.86

1.2

1.4

278.51

275.92

mosm/kgh2o

0.44

235

Abnormal findings on examination of urine, without diagnosis

150

1.95

2.85

1.7

1.4

272.20

282.19

mosm/kgh2o

1.06

115

Hypermobility syndrome

136

2.00

2.85

1.2

1.7

281.82

280.64

mosm/kgh2o

0.12

115

Special screening examination for other diseases and disorders

230

1.75

2.82

1.3

1.6

281.65

280.60

mosm/kgh2o

0.13

183

Other disorders involving the immune mechanism, not elsewhere classified

103

2.16

2.82

1.9

1.5

280.24

285.94

mosm/kgh2o

0.74

Sequelae of injuries of lower limb

314

1.63

2.81

1.7

1.4

283.73

281.19

mosm/kgh2o

0.34

243

Urticaria and erythema

177

1372

1.29

2.81

1.5

280.48

281.04

mosm/kgh2o

0.12

131

1063

Mental retardation

165

1.89

2.81

2.0

1.4

296.14

288.21

mosm/kgh2o

0.63

120

Melanoma of uvea

3.99

2.79

1.1

1.7

290.00

269.75

mosm/kgh2o

—

Diplopia

457

1.52

2.79

1.6

1.5

281.65

278.97

mosm/kgh2o

0.41

363

Vascular dementia (mixed)

2.90

2.76

1.3

275.43

271.19

mosm/kgh2o

—

Open wound of ankle and foot

339

1.60

2.76

1.5

278.86

281.37

mosm/kgh2o

0.39

257

Other disorders of veins

188

1472

1.28

2.75

1.5

1.4

278.46

278.03

mosm/kgh2o

0.08

125

1132

Specific development disorders of speech and language

216

1.75

2.75

1.7

287.93

287.65

mosm/kgh2o

0.02

159

Bullous disorders

188

1.82

2.75

1.3

276.16

278.74

mosm/kgh2o

0.27

138

Other diseases of blood and blood-forming organs

225

1.74

2.74

1.3

277.93

279.98

mosm/kgh2o

0.17

165

Propionic acid derivatives

180

696

1.30

2.73

1.6

1.8

280.41

285.60

mosm/kgh2o

1.92

127

555

Dystonia

196

1.80

2.72

2.5

1.3

282.62

278.58

mosm/kgh2o

0.46

149

Multiple myeloma and malignant plasma cell neoplasms

132

1.99

2.71

1.5

1.4

278.90

273.81

mosm/kgh2o

0.31

Emphysema

211

1.76

2.70

1.2

1.4

277.26

279.07

mosm/kgh2o

0.16

158

Effects of foreign body entering through natural orifice

120

886

1.36

2.70

1.4

1.5

282.75

281.98

mosm/kgh2o

0.11

699

Pericarditis

105

2.11

2.69

1.0

1.5

288.21

281.96

mosm/kgh2o

0.40

Mental retardation, wide definition

175

1.84

2.68

2.0

1.4

295.52

287.99

mosm/kgh2o

0.61

128

Hypermetropia

257

1.68

2.67

2.6

1.6

283.37

285.32

mosm/kgh2o

0.21

195

Secondary right heart disease

126

2.00

2.66

1.2

1.3

266.00

277.51

mosm/kgh2o

1.23

Use of cabergoline

3.17

2.66

1.2

1.1

288.50

279.52

mosm/kgh2o

—

Labour and delivery complicated by fetal stress [distress]

444

0.60

2.65

2.5

1.8

287.48

285.12

mosm/kgh2o

0.63

346

Tuberculosis, wide

250

1.69

2.65

1.3

277.00

277.01

mosm/kgh2o

0.00

178

Benign neoplasm: Rectum

536

1.46

2.65

1.2

1.4

281.24

277.34

mosm/kgh2o

0.89

405

Dental pulpitis 3

295

1.54

2.64

1.7

2.5

291.88

290.93

mosm/kgh2o

0.27

242

Tuberculosis, IBD comorbidity

243

1.70

2.63

1.3

276.77

277.18

mosm/kgh2o

0.04

176

Gonarthrosis

344

1646

1.20

2.63

1.4

281.42

278.71

mosm/kgh2o

1.26

248

1278

Parkinson's disease

521

1.46

2.62

1.5

1.3

282.61

277.43

mosm/kgh2o

0.86

391

Abscess of anal and rectal regions

251

1.68

2.61

1.4

282.64

281.11

mosm/kgh2o

0.15

197

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

304

1.61

2.61

1.3

282.03

277.65

mosm/kgh2o

0.45

218

Crohn's disease NAS

221

1.73

2.61

1.4

1.6

274.10

282.23

mosm/kgh2o

1.46

162

Nephrotic syndrome

107

2.08

2.58

1.2

1.5

277.76

285.22

mosm/kgh2o

0.76

Renal tubulo-interstitial disorders in diseases classified elsewhere

4.07

2.58

1.1

1.3

275.13

274.00

mosm/kgh2o

—

Melanocytic naevi, other sites/unspecified

222

1.72

2.57

1.7

1.6

280.83

280.19

mosm/kgh2o

0.07

175

Use of memantine

118

761

1.35

2.57

1.3

275.78

274.57

mosm/kgh2o

0.19

532

Use of other anti-dementia drugs

118

761

1.35

2.57

1.3

275.78

274.57

mosm/kgh2o

0.19

532

Toxic effect of ethanol

121

2.00

2.56

1.5

1.4

291.21

286.49

mosm/kgh2o

0.39

Myopia

386

1.53

2.55

1.5

286.84

283.83

mosm/kgh2o

0.66

306

Parkinson's disease, including avohilmo

549

1.44

2.55

1.5

1.3

282.71

277.45

mosm/kgh2o

0.89

410

Benign neoplasm: Stomach

355

1.56

2.53

1.3

1.4

278.17

277.54

mosm/kgh2o

0.06

273

Fitting and adjustment of other devices

167

1213

1.28

2.53

1.4

277.53

277.01

mosm/kgh2o

0.10

128

913

Special screening examination for infectious and parasitic diseases

476

1.42

2.52

2.0

1.4

286.05

282.39

mosm/kgh2o

0.98

394

Anti-inflammatory and antirheumatic products, non-steroids

178

696

1.29

2.51

1.5

1.8

280.76

285.60

mosm/kgh2o

1.72

130

555

Allergic rhinitis

147

1121

1.30

2.50

2.0

1.7

282.75

282.77

mosm/kgh2o

0.00

114

878

Car occupant injured in other and unspecified transport accidents

643

1.40

2.50

1.6

1.5

283.92

281.05

mosm/kgh2o

0.60

497

Viral infections of the central nervous system

247

1.67

2.49

1.3

1.4

276.94

280.62

mosm/kgh2o

0.40

184

Tobacco use

165

1.83

2.49

1.2

1.5

277.67

282.31

mosm/kgh2o

0.51

128

Tubulo-interstitial nephritis, not specified as acute or chronic

217

1.71

2.48

1.2

1.4

282.88

275.77

mosm/kgh2o

1.49

156

Stenosis and insufficiency of lacrimal passages

341

1.56

2.48

1.5

1.4

276.76

277.64

mosm/kgh2o

0.10

254

Thoracic aortic aneurysm

454

1.48

2.47

1.3

278.17

280.84

mosm/kgh2o

0.39

348

Bronchiectasis

271

1.63

2.47

1.5

1.4

268.36

277.30

mosm/kgh2o

1.45

201

Benign neoplasm: Sigmoid colon

663

1.39

2.44

1.5

1.3

280.38

278.16

mosm/kgh2o

0.34

518

Use of antiglaucoma preparations and miotics

272

1.63

2.43

1.5

1.3

272.08

275.17

mosm/kgh2o

0.47

190

Vascular dementia (undefined)

2.10

2.43

2.0

1.3

286.15

270.49

mosm/kgh2o

0.97

Cholecystectomy

348

2605

1.18

2.42

1.4

281.38

278.12

mosm/kgh2o

1.88

277

2003

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

138

1059

1.31

2.42

1.6

1.4

275.64

280.71

mosm/kgh2o

1.90

117

827

Sexual dysfunction

2.98

2.42

5.6

1.4

288.80

285.37

mosm/kgh2o

—

Benign neoplasm: Rectum, anus and anal canal

605

1.41

2.42

1.2

1.4

281.14

277.10

mosm/kgh2o

1.03

454

Deviated nasal septum

152

1182

1.29

2.40

1.6

1.3

279.76

280.84

mosm/kgh2o

0.25

121

945

Malignant neoplasm of adrenal gland

4.28

2.39

1.6

1.9

263.43

282.18

mosm/kgh2o

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

255

2069

1.21

2.38

1.6

1.5

279.30

280.08

mosm/kgh2o

0.22

181

1614

Foreign body in ear

2.44

2.38

1.1

1.8

277.71

285.74

mosm/kgh2o

—

Foreign body in alimentary tract

190

1.75

2.38

1.3

1.5

278.52

281.24

mosm/kgh2o

0.23

139

Injuries to unspecified part of trunk, limb or body region

337

1.55

2.37

2.3

1.5

279.67

279.73

mosm/kgh2o

0.01

250

Brachial plexus disorders

274

1.61

2.37

1.9

1.5

283.24

283.12

mosm/kgh2o

0.01

228

Multiple myeloma, excluding all cancers (controls excluding all cancers)

132

1.91

2.36

1.5

1.4

279.79

273.81

mosm/kgh2o

0.36

Lichen simplex chronicus

111

2.00

2.36

1.5

1.4

270.41

280.57

mosm/kgh2o

1.00

Dipeptidyl peptidase 4 (DPP-4) inhibitors

418

1.49

2.36

1.2

1.3

279.26

276.79

mosm/kgh2o

0.22

323

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

116

873

1.33

2.35

1.4

291.60

278.07

mosm/kgh2o

5.79

703

Myeloproliferative diseases (CML excluded)

275

1.61

2.34

1.3

272.35

276.91

mosm/kgh2o

0.65

206

Vitamin B12 deficiency anaemia

362

1.53

2.34

1.3

1.4

279.82

277.45

mosm/kgh2o

0.26

261

Nail disorders

275

1.61

2.34

1.9

1.3

284.21

280.68

mosm/kgh2o

0.55

208

Other specified/unspecified systemic involvement of connective tissue

191

1.74

2.34

1.8

1.4

276.64

277.62

mosm/kgh2o

0.09

146

Postprocedural musculoskeletal disorders, not elsewhere classified

252

1.64

2.34

1.2

1.3

276.25

277.72

mosm/kgh2o

0.15

189

Ptosis of eyelid

379

1.51

2.32

1.5

1.3

276.76

276.61

mosm/kgh2o

0.02

284

Benign paroxysmal vertigo

143

1110

1.29

2.32

1.4

278.34

277.26

mosm/kgh2o

0.23

110

852

Enthesopathies of lower limb, excluding foot

101

746

1.36

2.32

1.3

1.5

278.56

280.28

mosm/kgh2o

0.34

594

Chronic conjunctivitis

105

2.02

2.32

1.7

1.4

288.56

279.37

mosm/kgh2o

1.26

Cardiac arrest

126

1.85

2.31

1.1

1.3

278.81

280.40

mosm/kgh2o

0.12

Other inflammatory liver diseases

207

1.70

2.30

1.5

1.4

276.79

278.66

mosm/kgh2o

0.16

151

Striking against or struck by other objects

152

1190

1.28

2.30

1.6

1.5

283.28

282.54

mosm/kgh2o

0.14

109

943

Pemphigoid

2.14

2.30

1.2

1.3

270.42

272.93

mosm/kgh2o

0.17

Pedal cyclist injured in transport accident

105

782

1.35

2.29

1.4

1.5

280.53

281.50

mosm/kgh2o

0.17

608

Disorders of tooth development and eruption

187

1.73

2.29

1.5

1.7

288.82

289.86

mosm/kgh2o

0.09

138

Lupus erythematosus

2.24

2.28

1.3

1.4

266.75

278.41

mosm/kgh2o

—

ILD, hospital admissions 1, main diag only

454

1.46

2.28

1.4

1.3

273.22

277.75

mosm/kgh2o

0.79

338

Unspecified event, undetermined intent

2.24

2.28

1.3

1.4

280.55

283.93

mosm/kgh2o

0.33

Allergic conjunctivitis

267

2190

1.20

2.28

1.6

1.5

279.62

280.28

mosm/kgh2o

0.19

190

1714

Benign neoplasm: Transverse colon

285

1.59

2.28

1.3

1.4

278.93

278.41

mosm/kgh2o

0.04

214

Valvular operations

479

1.45

2.27

1.2

1.4

279.38

282.46

mosm/kgh2o

0.45

357

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

108

520

1.35

2.27

2.1

1.8

285.50

285.70

mosm/kgh2o

0.04

422

Malignant neoplasm of urinary organs

341

1.53

2.27

1.4

1.3

274.62

276.68

mosm/kgh2o

0.18

247

Ovarian cyst

173

791

1.27

2.25

1.4

1.6

279.58

278.95

mosm/kgh2o

0.13

125

636

Lymphoid leukaemia

171

1.77

2.25

1.4

1.5

279.87

278.02

mosm/kgh2o

0.19

121

Parodontitis, under 40 years

216

1.67

2.25

1.6

1.9

290.60

287.95

mosm/kgh2o

0.24

169

Acute pharyngitis

469

1.44

2.24

1.5

1.6

283.04

285.46

mosm/kgh2o

0.48

374

Other obstetric conditions, not elsewhere classified

110

533

1.34

2.23

2.1

1.8

285.33

285.74

mosm/kgh2o

0.08

433

Other factor of the environment

3.15

2.23

1.3

1.1

286.89

284.09

mosm/kgh2o

—

Myocardial infarction

263

1569

1.21

2.23

1.4

1.3

276.32

277.21

mosm/kgh2o

0.24

207

1197

Calcific aortic valvular stenosis, diagnosis (helper)

143

1093

1.28

2.22

1.2

1.3

275.71

276.91

mosm/kgh2o

0.26

114

801

Operations 2 for CAVS

143

1093

1.28

2.22

1.2

1.3

275.71

276.91

mosm/kgh2o

0.26

114

801

Contact with venomous snakes and lizards

2.83

2.22

1.6

1.5

290.90

276.58

mosm/kgh2o

—

Other aneurysm

157

1.79

2.22

1.4

269.85

279.22

mosm/kgh2o

1.02

114

Parodontitis, under 40 years, or operation codes

217

1.66

2.21

1.6

1.9

290.60

287.95

mosm/kgh2o

0.24

170

Other and unspecified mononeuropathies, also in other diseases

107

1.98

2.21

1.3

281.94

277.72

mosm/kgh2o

0.24

Polymyalgia rheumatica

474

1.44

2.21

1.4

1.3

272.83

275.11

mosm/kgh2o

0.39

339

Other infectious diseases

264

1.60

2.20

1.2

1.4

280.09

279.69

mosm/kgh2o

0.03

194

Rheumatoid arthritis

155

1112

1.27

2.20

1.4

1.3

274.64

278.27

mosm/kgh2o

1.17

128

845

Other pulmonary heart/vessel disease

143

1.83

2.19

1.2

1.4

270.16

278.43

mosm/kgh2o

0.61

Other shoulder lesions

288

1.57

2.19

1.4

271.66

280.02

mosm/kgh2o

1.79

226

Thrombocytopenia, unspecified

249

1.62

2.19

2.0

1.4

279.32

279.72

mosm/kgh2o

0.04

182

Divergent concomitant strabismus

257

1.60

2.18

1.6

1.5

286.55

282.07

mosm/kgh2o

0.58

198

Malignant neoplasm of kidney, except renal pelvis

313

1.54

2.16

1.3

275.47

277.10

mosm/kgh2o

0.13

229

Calcific aortic valvular stenosis, including rheumatic fever

143

1097

1.28

2.16

1.2

1.3

275.71

276.91

mosm/kgh2o

0.26

114

804

Calcific aortic valvular stenosis, operated

143

1098

1.28

2.16

1.2

1.3

275.71

277.00

mosm/kgh2o

0.29

114

805

Calcific aortic valvular stenosis

143

1098

1.28

2.16

1.2

1.3

275.71

277.00

mosm/kgh2o

0.29

114

805

Superficial injuries involving multiple body regions

2.18

2.15

1.6

1.3

275.63

280.41

mosm/kgh2o

—

Subjective visual disturbances

116

886

1.31

2.15

1.3

1.5

278.46

278.87

mosm/kgh2o

0.06

680

Adjustment and management of implanted device

637

1.37

2.14

1.3

1.4

278.67

278.16

mosm/kgh2o

0.06

478

Orchitis and epididymitis

266

1.58

2.14

1.3

281.84

284.68

mosm/kgh2o

0.41

215

Urticaria

141

1106

1.28

2.14

1.5

280.66

281.22

mosm/kgh2o

0.10

105

855

Parodontitis, under 40 years and operation codes

204

1.67

2.14

1.6

2.0

290.45

287.94

mosm/kgh2o

0.22

159

Parodontitis, operation under 40 years and operation codes

204

1.67

2.14

1.6

2.0

290.45

287.94

mosm/kgh2o

0.22

159

Coxarthrosis, primary

295

2165

1.18

2.14

1.4

1.3

274.98

277.30

mosm/kgh2o

0.94

233

1647

Other Crohn's disease

235

1.63

2.13

1.4

1.6

273.53

281.78

mosm/kgh2o

1.34

176

Acne

298

1.55

2.12

1.8

1.9

289.79

287.77

mosm/kgh2o

0.21

232

Progressive vascular leukoencephalopathy

116

1.91

2.12

1.2

269.42

271.39

mosm/kgh2o

0.11

Impingement syndrome of shoulder

114

871

1.31

2.11

1.4

279.05

278.62

mosm/kgh2o

0.06

704

Other congenital malformations of the digestive system

181

1.71

2.11

1.9

1.7

284.29

286.32

mosm/kgh2o

0.22

128

Artrosis, including avohilmo

444

2118

1.15

2.11

1.5

1.4

279.73

279.47

mosm/kgh2o

0.08

333

1675

Ankle and foot

3.26

2.11

1.3

1.2

286.00

279.89

mosm/kgh2o

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

626

1.36

2.11

1.4

1.7

286.61

283.70

mosm/kgh2o

0.64

479

Tinnitus

113

863

1.31

2.11

1.5

1.3

275.01

278.85

mosm/kgh2o

0.91

669

Dysplasia of cervi uteri

558

1.35

2.09

1.4

1.6

278.39

280.58

mosm/kgh2o

0.37

449

Alzheimer’s disease (Atypical or mixed), excluding more controls

170

1.68

2.09

1.2

275.48

273.11

mosm/kgh2o

0.21

123

Aortic aneurysm

103

764

1.33

2.08

1.5

1.3

279.79

278.97

mosm/kgh2o

0.12

586

Cardiodefibrillation

179

1447

1.24

2.08

1.3

275.87

277.53

mosm/kgh2o

0.32

133

1108

Unspecific neurodegenerative disorder

196

1100

1.23

2.07

1.3

275.60

274.89

mosm/kgh2o

0.14

131

804

Pacemaker

160

1244

1.25

2.06

1.4

1.3

276.25

277.06

mosm/kgh2o

0.15

113

920

Injury of unspecified body region

253

1.59

2.06

2.5

1.5

278.69

280.63

mosm/kgh2o

0.17

185

Primary open-angle glaucoma, strict

129

1004

1.29

2.06

1.6

1.3

277.72

276.01

mosm/kgh2o

0.31

102

738

Congenital malformations of genital organs

283

1.55

2.06

1.4

1.6

279.58

283.73

mosm/kgh2o

0.59

220

Deep endometriosis

325

1.51

2.06

1.2

1.5

276.05

276.73

mosm/kgh2o

0.07

243

Scoliosis

277

1.56

2.05

1.4

1.8

268.74

282.96

mosm/kgh2o

4.17

225

Ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

4.08

2.05

1.7

2.1

269.33

277.00

mosm/kgh2o

—

Degenerative macular diseases

424

1.44

2.04

1.3

276.73

276.12

mosm/kgh2o

0.05

309

Carcinoma in situ of breast, intraductal

254

1.58

2.03

1.2

1.5

276.86

274.54

mosm/kgh2o

0.28

197

Superficial injury of wrist and hand

686

1.34

2.03

1.5

281.84

281.95

mosm/kgh2o

0.02

536

Hodgkin lymphoma

2.12

2.03

1.1

1.6

280.44

280.49

mosm/kgh2o

—

Certain conditions originating in the perinatal period

288

1.51

2.03

2.8

2.3

289.21

288.81

mosm/kgh2o

0.05

232

Other diseases of peritoneum

147

1.78

2.03

1.4

1.3

269.79

276.33

mosm/kgh2o

0.72

103

Other and unspecified glaucoma

223

1.62

2.02

1.3

281.38

274.62

mosm/kgh2o

1.29

154

Ulcerative colitis

113

869

1.30

2.02

1.4

1.5

277.97

280.92

mosm/kgh2o

0.54

672

Paralytic strabismus

239

1.60

2.01

1.4

276.58

278.20

mosm/kgh2o

0.16

171

Clear cell adenocarcinoma of kidney

155

1.76

2.01

1.2

1.4

276.84

277.60

mosm/kgh2o

0.04

111

Burns and corrosions

484

1.41

2.00

1.9

1.5

282.82

282.13

mosm/kgh2o

0.08

369

Viral pneumonia (unknown virus, not influenza)

217

1.62

1.97

1.2

1.4

284.20

283.76

mosm/kgh2o

0.03

167

Crohn's disease of small intestine

225

1.61

1.96

1.4

1.6

277.44

282.36

mosm/kgh2o

0.75

170

Diabetic neuropathy

392

1.45

1.96

1.4

1.3

286.98

283.30

mosm/kgh2o

0.37

304

Vitreous haemorrhage

337

1.49

1.96

1.3

1.4

290.26

277.96

mosm/kgh2o

1.59

249

Benign neoplasm: Skin of other and unspecified parts of face

329

1.49

1.95

1.3

1.4

280.53

277.28

mosm/kgh2o

0.53

245

Conduction disorders

136

892

1.27

1.95

1.4

278.48

280.72

mosm/kgh2o

0.53

680

Vulvovaginal ulceration/inflammation in other diseases

149

1.75

1.94

1.7

290.94

280.61

mosm/kgh2o

2.39

116

Lifestyle-related condition

3.00

1.94

1.4

1.1

285.88

282.00

mosm/kgh2o

—

Melanoma of uvea

2.77

1.94

1.1

1.2

290.00

278.13

mosm/kgh2o

—

Unspecified/other endometriosis

218

1.61

1.93

1.5

1.8

283.26

282.99

mosm/kgh2o

0.03

179

Gonarthrosis,primary

453

2504

1.14

1.92

1.4

280.25

277.45

mosm/kgh2o

1.70

335

1947

Drug-induced cataract

2.07

1.92

1.4

283.22

279.10

mosm/kgh2o

—

Other/unspecified enthesopathies of lower limb, excluding foot

211

1.62

1.91

1.3

1.6

275.95

282.74

mosm/kgh2o

0.94

177

Carpal tunnel syndrome

285

2194

1.17

1.91

1.4

278.30

278.78

mosm/kgh2o

0.13

216

1714

Psoriasis vulgaris

659

1.34

1.91

1.3

1.4

279.05

280.38

mosm/kgh2o

0.19

525

Amputation of thigh

2.07

1.91

1.2

1.3

282.73

273.32

mosm/kgh2o

0.53

Other and unspecified injuries of shoulder and upper arm

1.97

1.90

1.1

1.5

290.08

280.46

mosm/kgh2o

0.63

Ulcerative ileocolitis

128

1.81

1.90

1.1

1.6

278.29

281.20

mosm/kgh2o

0.13

102

AV-block

520

1.37

1.90

1.4

275.47

280.34

mosm/kgh2o

0.97

382

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

158

1.72

1.89

1.1

1.4

283.30

275.75

mosm/kgh2o

0.65

113

Other salmonella infections

121

1.83

1.89

1.1

1.4

280.94

277.28

mosm/kgh2o

0.36

Dementia in Alzheimer disease

519

1.35

1.88

1.2

1.3

274.42

274.02

mosm/kgh2o

0.05

360

Intermittent heterotropia

212

1.61

1.88

1.6

284.68

286.62

mosm/kgh2o

0.23

162

Other disorders of binocular vision

2.68

1.87

1.3

1.2

294.89

289.46

mosm/kgh2o

—

Impotence

151

1.73

1.87

1.3

289.74

283.86

mosm/kgh2o

0.46

123

Embolic stroke

136

1.77

1.87

1.3

1.4

279.26

274.95

mosm/kgh2o

0.20

Polycystic ovarian syndrome, broad definition

236

1.57

1.86

2.4

1.4

286.30

285.83

mosm/kgh2o

0.07

189

Campylobacter enteritis

1.99

1.85

1.3

1.4

275.83

280.72

mosm/kgh2o

0.29

Endovascular or surgical operations to intracerebral aneurysms

213

1.60

1.85

1.8

1.3

276.89

277.12

mosm/kgh2o

0.02

162

Ductal carcinoma of pancreas

3.60

1.85

1.7

1.8

269.33

280.09

mosm/kgh2o

—

Carbimazole or st.post thyroidectomy, condition for graves disease

742

1.31

1.83

1.4

281.04

278.17

mosm/kgh2o

0.49

565

Hereditary corneal dystrophies

108

1.87

1.82

1.6

1.3

276.14

276.27

mosm/kgh2o

0.01

Dental caries 3 and operation codes, only avohilmo

195

805

1.22

1.82

1.5

1.7

282.42

281.32

mosm/kgh2o

0.24

149

648

Internal derangement of knee

175

1434

1.22

1.81

1.7

1.4

280.28

280.20

mosm/kgh2o

0.02

141

1121

Benign neoplasm: Parotid gland

270

1.53

1.81

1.2

1.3

284.42

277.50

mosm/kgh2o

2.07

202

Hallux valgus (acquired)

166

978

1.23

1.81

1.3

1.4

276.23

278.25

mosm/kgh2o

0.59

120

743

Other skin changes

588

1.35

1.81

1.4

282.20

278.77

mosm/kgh2o

0.81

444

Marginal zone B-cell lymphoma

2.81

1.80

1.5

1.6

275.00

277.16

mosm/kgh2o

—

Basal cell carcinoma

272

1850

1.17

1.80

1.3

277.06

276.66

mosm/kgh2o

0.09

196

1404

Diseases of external ear

160

1304

1.23

1.80

1.4

280.41

280.08

mosm/kgh2o

0.06

119

1004

Systemic atrophies primarily affecting the central nervous system

138

1.75

1.80

1.5

269.94

278.63

mosm/kgh2o

0.92

Early complications of trauma

138

1.75

1.80

1.7

1.4

274.50

282.07

mosm/kgh2o

0.76

102

!Aliquae complicationes praecoces traumatis

138

1.75

1.80

1.7

1.4

274.50

282.07

mosm/kgh2o

0.76

102

Tongue abnormality

223

1.58

1.79

1.7

1.2

276.04

276.98

mosm/kgh2o

0.09

167

Other inflammation of eyelid

453

1.40

1.78

1.6

1.5

281.82

278.99

mosm/kgh2o

0.49

338

Nonsuppurative otitis media

112

756

1.28

1.78

1.7

1.9

288.08

283.65

mosm/kgh2o

1.24

588

Melanocytic naevi of trunk

328

1.47

1.78

1.6

1.5

282.67

280.32

mosm/kgh2o

0.40

253

Ankylosing spondylitis, ICD10

304

1.49

1.77

1.4

278.55

282.34

mosm/kgh2o

0.48

235

Long labour

624

0.70

1.77

2.3

1.6

285.35

282.38

mosm/kgh2o

0.37

490

Other diseases of biliary tract

296

1.49

1.77

1.3

1.4

279.09

275.60

mosm/kgh2o

0.36

218

Filling of root of tooth

102

1.88

1.77

1.4

287.54

281.30

mosm/kgh2o

0.70

Severe visual impairment, binocular

3.41

1.76

2.0

1.1

289.33

267.25

mosm/kgh2o

—

Preparation and fitting of bite rail to mouth

446

1.39

1.75

2.2

1.4

284.36

281.42

mosm/kgh2o

0.67

358

Rash and other nonspecific skin eruption

346

1.45

1.75

1.4

1.5

281.65

279.07

mosm/kgh2o

0.32

263

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

506

1.37

1.74

1.8

1.6

279.02

279.39

mosm/kgh2o

0.04

398

Normotensive glaucoma

281

1.50

1.74

1.7

1.3

282.15

274.72

mosm/kgh2o

0.91

196

Benign neoplasm: salivary glands, exclude unknown (D119)

306

1.48

1.73

1.2

1.3

284.08

278.04

mosm/kgh2o

1.65

231

Disorders of synovium and tendon

242

1853

1.18

1.72

1.5

280.29

279.06

mosm/kgh2o

0.39

193

1481

Cholecystitis

473

1.38

1.72

1.3

1.4

280.96

275.82

mosm/kgh2o

0.79

352

Other necrotizing vasculopathies (FG)

186

1.62

1.72

1.6

1.5

277.32

279.04

mosm/kgh2o

0.13

136

Procreative management

154

1058

1.23

1.72

1.7

1.6

282.96

282.91

mosm/kgh2o

0.01

130

824

Coxarthrosis, primary, with hip surgery

224

1796

1.18

1.71

1.4

1.3

273.83

276.77

mosm/kgh2o

1.15

174

1347

Supervision of normal pregnancy

415

0.70

1.71

1.8

284.64

284.28

mosm/kgh2o

0.06

336

Benign lipomatous neoplasm

119

945

1.26

1.70

1.7

1.4

282.09

278.38

mosm/kgh2o

1.37

715

155

1.68

1.70

1.6

1.2

275.94

276.46

mosm/kgh2o

0.04

103

Acne vulgaris

226

1.55

1.70

1.9

2.1

286.28

288.29

mosm/kgh2o

0.27

178

Other fall from one level to another

106

830

1.28

1.70

1.6

1.5

276.37

282.82

mosm/kgh2o

1.75

649

Multiple myeloma and malignant plasma cell neoplasms

156

1.68

1.69

1.5

1.3

278.90

275.21

mosm/kgh2o

0.22

111

Foreign body in respiratory tract

195

1.60

1.69

1.4

1.5

279.68

282.26

mosm/kgh2o

0.28

140

Other specified/unspecified bacterial intestinal infections

227

1.55

1.68

1.3

1.4

286.16

279.42

mosm/kgh2o

0.84

172

Disorders of brain, other and unspecified

3.19

1.67

1.3

1.7

277.50

282.09

mosm/kgh2o

—

Carcinoma in situ of skin of upper limb, including shoulder

2.12

1.66

1.0

1.5

278.50

271.75

mosm/kgh2o

—

Basal cell carcinoma, including avohilmo

277

1880

1.16

1.65

1.3

276.85

276.74

mosm/kgh2o

0.03

200

1428

Other follicular disorders

212

1.56

1.65

1.8

1.5

282.67

282.60

mosm/kgh2o

0.01

166

Dental pulpitis 3, only avohilmo

266

1.43

1.65

1.8

2.6

292.00

291.07

mosm/kgh2o

0.24

216

Unspecified visual impairment (binocular)

2.27

1.64

1.4

1.8

286.00

278.87

mosm/kgh2o

—

Benign neoplasm of urinary organs

127

1.74

1.64

1.2

1.4

291.63

274.36

mosm/kgh2o

1.09

Amputation of foot

1.97

1.60

1.2

277.88

278.88

mosm/kgh2o

—

Other and unspecified degenerative diseases of nervous system

2.02

1.60

1.4

270.22

275.20

mosm/kgh2o

—

Other congenital malformations of brain

3.07

1.59

6.2

2.2

289.67

289.77

mosm/kgh2o

—

Otalgia

279

1.48

1.59

1.4

1.5

283.23

281.39

mosm/kgh2o

0.23

219

Malignant melanoma

515

1.34

1.59

1.3

282.76

278.22

mosm/kgh2o

1.09

393

Dislocation, sprain and strain of joint and ligaments of hip

121

1.75

1.59

1.7

1.2

288.27

274.95

mosm/kgh2o

1.00

Methotrexate

515

1.34

1.59

1.5

272.66

279.60

mosm/kgh2o

1.66

391

Keratitis

161

1334

1.21

1.58

1.5

1.4

282.60

279.64

mosm/kgh2o

0.86

131

1022

Unstable angina pectoris

189

1315

1.19

1.58

1.4

1.3

280.68

276.45

mosm/kgh2o

1.51

148

988

Other noninflammatory disorders of vulva and perineum

247

1.50

1.57

1.6

1.5

273.96

279.44

mosm/kgh2o

0.57

195

Other disorders of bone

682

1.29

1.56

1.5

284.92

280.50

mosm/kgh2o

1.38

546

Primary open-angle glaucoma

152

1222

1.21

1.56

1.5

1.3

276.34

276.52

mosm/kgh2o

0.03

120

891

Burns and corrosions of external body surface, specified by site

372

1.40

1.55

1.8

1.5

281.61

282.53

mosm/kgh2o

0.08

283

Benign neoplasm of major salivary glands

347

1.42

1.55

1.2

1.4

283.95

277.63

mosm/kgh2o

1.93

260

Other and unspecified types of non-Hodgkin lymphoma, hilmo

145

1.67

1.54

1.4

1.3

272.81

277.79

mosm/kgh2o

0.56

107

Gonarthrosis, primary, with knee surgery

275

1948

1.15

1.54

1.4

1.3

279.73

276.25

mosm/kgh2o

1.73

212

1505

Need for other prophylactic measures

200

1.56

1.54

1.5

283.95

280.56

mosm/kgh2o

0.38

148

Ill-defined and unknown causes of mortality

216

1.53

1.54

1.2

1.3

271.00

276.98

mosm/kgh2o

0.93

150

Gonococcal infection

100

1.81

1.53

1.6

1.4

282.45

277.38

mosm/kgh2o

0.43

Certain disorders involving the immune mechanism

693

1.29

1.53

1.7

1.4

280.72

279.60

mosm/kgh2o

0.14

541

Benign neoplasm: Skin of eyelid, including canthus

554

1.32

1.52

1.6

1.4

277.33

277.59

mosm/kgh2o

0.03

421

ILD medications: azathioprine

502

1.34

1.51

1.2

1.6

281.59

283.05

mosm/kgh2o

0.16

394

Other and unspecified psoriasis

217

1.53

1.51

1.6

1.3

270.64

280.51

mosm/kgh2o

0.75

170

Trigeminal neuralgia

193

1.56

1.51

1.4

276.29

277.60

mosm/kgh2o

0.15

144

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

108

1.77

1.50

1.4

279.86

275.82

mosm/kgh2o

0.35

Congenital musculoskeletal deformities of head, face, spine and chest

0.00

1.50

0.0

1.7

—

287.59

—

Calcific tendinitis of shoulder

170

1.59

1.49

1.5

1.3

276.82

279.04

mosm/kgh2o

0.19

130

Right hemicolectomy

194

1.55

1.48

1.2

1.3

274.86

277.28

mosm/kgh2o

0.27

138

Benign neoplasm: Descending colon

186

1.57

1.48

1.3

278.53

274.69

mosm/kgh2o

0.27

139

Foreign body entering into or through eye or natural orifice

292

1.44

1.48

1.5

1.4

280.79

282.22

mosm/kgh2o

0.13

222

Sequelae of infectious and parasitic diseases

259

1.47

1.48

1.3

1.4

280.62

279.97

mosm/kgh2o

0.05

190

Thyrotoxicosis with diffuse goitre

444

1.35

1.48

1.5

1.4

279.91

276.81

mosm/kgh2o

0.40

342

Other noninfective disorders of lymphatic vessels and lymph nodes

109

1.75

1.47

1.2

1.3

286.08

278.53

mosm/kgh2o

1.22

Other coagulation defects

235

1.50

1.46

1.4

1.6

289.67

280.91

mosm/kgh2o

1.72

178

Other and unspecified injuries of lower leg

227

1.50

1.46

1.4

1.6

283.85

281.54

mosm/kgh2o

0.25

180

Specific development disorders of scholastic skills

138

1.66

1.46

2.0

286.00

291.42

mosm/kgh2o

0.57

113

Secondary and unspecified malignant neoplasm of lymph nodes

293

1.44

1.46

1.1

1.3

280.76

277.92

mosm/kgh2o

0.37

215

Lymphoid leukaemia

195

1.55

1.45

1.4

1.5

279.87

279.81

mosm/kgh2o

0.00

140

Melanocytic naevi, other sites/unspecified

260

1.47

1.45

1.7

1.5

280.83

280.30

mosm/kgh2o

0.06

204

Postmenopausal bleeding

132

590

1.23

1.45

1.3

1.4

273.90

275.73

mosm/kgh2o

0.33

470

Pedal cyclist injured in other and unspecified transport accidents

369

1.39

1.45

1.3

1.4

279.39

281.08

mosm/kgh2o

0.19

279

Other bursopathies

429

1.36

1.44

1.4

271.13

279.13

mosm/kgh2o

2.25

342

Female genital prolapse

139

658

1.22

1.43

1.3

1.4

277.28

277.09

mosm/kgh2o

0.04

113

526

204

1.52

1.42

1.5

1.7

287.67

284.66

mosm/kgh2o

0.38

168

Primary gonarthrosis, bilateral

244

1850

1.16

1.42

1.4

1.3

281.33

276.41

mosm/kgh2o

2.81

187

1439

Non-Hodgkin lymphoma, all

118

1.70

1.41

1.2

1.3

270.87

275.80

mosm/kgh2o

0.49

Chronic nephritic syndrome

126

1.68

1.40

1.0

1.4

272.27

281.42

mosm/kgh2o

1.13

Sequelae of other and unspecified infectious and parasitic diseases

181

1.55

1.40

1.4

1.6

282.27

282.70

mosm/kgh2o

0.03

137

Olecranon bursitis

181

1.55

1.40

1.4

1.3

289.81

280.34

mosm/kgh2o

0.43

141

Benign neoplasm: Oesophagus

2.44

1.40

1.9

1.8

279.86

275.94

mosm/kgh2o

—

Other demyelinating diseases of the central nervous system

111

1.72

1.39

1.6

1.7

271.21

283.34

mosm/kgh2o

0.49

Vestibular neuronitis

313

1.41

1.39

1.4

1.3

283.88

277.91

mosm/kgh2o

0.83

243

Fracture at wrist and hand level

152

1271

1.20

1.38

1.7

1.5

280.32

281.00

mosm/kgh2o

0.12

114

1010

Calculus of kidney and ureter

1130

0.80

1.38

1.4

288.97

279.51

mosm/kgh2o

2.61

883

Crohn disease (strict definition, require KELA)

214

1.50

1.38

1.3

1.6

275.72

283.29

mosm/kgh2o

1.26

166

Secondary malignant neoplasm of other and unspecified sites

2.22

1.37

1.0

1.5

273.22

277.19

mosm/kgh2o

—

Hodgkin lymphoma, hilmo

1.81

1.37

1.1

1.6

280.44

281.94

mosm/kgh2o

—

Endocarditis

1.81

1.37

1.8

1.7

278.37

283.30

mosm/kgh2o

0.35

Retinal detachment with retinal break

433

1.34

1.37

1.4

283.05

278.23

mosm/kgh2o

0.79

331

Allergic contact dermatitis

433

1.34

1.37

2.4

1.4

276.67

279.29

mosm/kgh2o

0.37

344

Triptan medication for migraine, single purchase ok

361

2175

1.12

1.37

1.8

1.5

282.27

280.21

mosm/kgh2o

1.22

293

1717

Migraine, single triptan purchase ok & required. ICD-code if available is included

361

2175

1.12

1.37

1.8

1.5

282.27

280.21

mosm/kgh2o

1.22

293

1717

Benign neoplasm: Colon, unspecified

116

947

1.23

1.36

1.5

1.3

277.73

278.05

mosm/kgh2o

0.04

723

Postinfectious hypothyroidism

2.99

1.36

1.8

1.0

285.00

278.67

mosm/kgh2o

—

Viral warts

331

1.39

1.36

1.3

1.5

284.21

281.74

mosm/kgh2o

0.29

249

Melanocytic naevi

110

893

1.23

1.36

1.6

1.5

280.15

280.17

mosm/kgh2o

0.00

685

Vascular dementia (subcortical)

1.84

1.36

1.0

1.3

277.38

271.68

mosm/kgh2o

—

Azathioprine

512

1.31

1.35

1.2

1.6

281.59

283.14

mosm/kgh2o

0.17

400

Presence of cardiac and vascular implants and grafts

208

1353

1.16

1.34

1.3

277.97

277.87

mosm/kgh2o

0.02

148

1034

Disorders of puberty

2.15

1.34

4.5

2.0

297.90

296.59

mosm/kgh2o

—

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

2.16

1.34

1.7

1.5

274.44

269.81

mosm/kgh2o

—

Antenatal screening

428

0.75

1.33

1.7

1.9

284.61

284.11

mosm/kgh2o

0.08

348

Other disorders of eye and adnexa

489

1.31

1.8

1.5

285.77

279.96

mosm/kgh2o

1.33

380

Conductive hearing loss, unspecified

275

1.42

1.30

1.6

1.4

282.03

281.27

mosm/kgh2o

0.08

209

Meralgia paraesthetica

106

1.71

1.30

1.1

1.5

273.92

278.24

mosm/kgh2o

0.39

Ulcerative enterocolitis

106

1.71

1.30

1.4

1.5

285.15

282.43

mosm/kgh2o

0.10

Cholangitis (primary sclerosing, PSC)

201

1.50

1.30

1.2

1.4

280.00

278.61

mosm/kgh2o

0.08

147

Kyphosis

2.38

1.29

1.4

1.6

278.00

283.62

mosm/kgh2o

—

Single spontaneous delivery

164

1031

0.85

1.29

1.4

1.6

276.64

278.51

mosm/kgh2o

0.47

123

773

Seropositive rheumatoid arthritis

114

933

1.22

1.29

1.5

1.4

275.27

277.48

mosm/kgh2o

0.46

709

Retinal vascular disorders

412

1.34

1.29

1.3

272.13

276.37

mosm/kgh2o

0.53

304

Demyelinating diseases of the central nervous system

259

1.43

1.29

1.4

1.5

277.44

281.29

mosm/kgh2o

0.25

208

Secondary thrombocytopenia

2.31

1.27

1.3

1.5

277.75

278.42

mosm/kgh2o

—

Malignant neoplasm of pancreas

194

1.50

1.27

1.3

275.37

277.45

mosm/kgh2o

0.23

131

Contact with and exposure to communicable diseases

129

1070

1.20

1.26

1.8

1.7

287.03

284.28

mosm/kgh2o

0.89

111

845

Acute nasopharyngitis (common cold)

420

1.33

1.25

1.5

1.4

279.81

284.04

mosm/kgh2o

0.99

333

Other maltreatment syndromes

1.75

1.25

1.9

1.3

281.12

286.06

mosm/kgh2o

—

SLE (Finngen)

1.75

1.25

1.1

1.5

269.36

279.46

mosm/kgh2o

0.93

Conjunctivitis (acute, non atopic)

126

1045

1.20

1.25

1.5

282.52

281.45

mosm/kgh2o

0.22

808

Disorders of porphyrin and bilirubin metabolism

2.42

1.25

1.0

1.6

281.00

289.11

mosm/kgh2o

—

Anoxic brain damage

2.24

1.24

1.1

1.2

276.63

280.21

mosm/kgh2o

—

Malignant neoplasm of breast, HER-negative

100

813

1.23

1.24

1.4

276.36

274.30

mosm/kgh2o

0.41

601

Follicular cysts of skin and subcutaneous tissue

644

1.26

1.23

1.5

1.4

279.58

279.41

mosm/kgh2o

0.02

502

Hordeolum and other deep inflammation of eyelid

179

1.51

1.23

1.4

1.5

275.14

282.41

mosm/kgh2o

0.81

138

Bitten or struck by other mammals

355

1.36

1.23

1.9

1.5

279.83

281.95

mosm/kgh2o

0.28

277

Retinal vascular occlusion

407

1.33

1.23

1.3

272.36

276.51

mosm/kgh2o

0.51

299

Dental caries 2

360

2540

1.11

1.23

1.6

281.63

281.22

mosm/kgh2o

0.12

272

2011

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Osmolality of Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS